US20040185484A1 - Method for preparing single-stranded DNA libraries - Google Patents

Method for preparing single-stranded DNA libraries Download PDF

Info

Publication number
US20040185484A1
US20040185484A1 US10/767,894 US76789404A US2004185484A1 US 20040185484 A1 US20040185484 A1 US 20040185484A1 US 76789404 A US76789404 A US 76789404A US 2004185484 A1 US2004185484 A1 US 2004185484A1
Authority
US
United States
Prior art keywords
dna
adaptor
universal
single stranded
dna molecules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/767,894
Other languages
English (en)
Inventor
Gina Costa
John Leamon
Jonathan Rothberg
Michael Weiner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32854649&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20040185484(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Priority to US10/767,894 priority Critical patent/US20040185484A1/en
Assigned to 454 CORPORATION reassignment 454 CORPORATION CHANGE OF ADDRESS OF THE ASSIGNEE Assignors: LEAMON, JOHN H., ROTHBERG, JONATHAN M., COSTA, GINA L., WEINER, MICHAEL P.
Publication of US20040185484A1 publication Critical patent/US20040185484A1/en
Priority to US12/154,901 priority patent/US20090011959A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • B01L3/502707—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by the manufacture of the container or its components
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • B01L3/502715—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by interfacing components, e.g. fluidic, electrical, optical or mechanical interfaces
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1075—Isolating an individual clone by screening libraries by coupling phenotype to genotype, not provided for in other groups of this subclass
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1093—General methods of preparing gene libraries, not provided for in other subgroups
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6865—Promoter-based amplification, e.g. nucleic acid sequence amplification [NASBA], self-sustained sequence replication [3SR] or transcription-based amplification system [TAS]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6867—Replicase-based amplification, e.g. using Q-beta replicase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C12Q1/6874—Methods for sequencing involving nucleic acid arrays, e.g. sequencing by hybridisation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/251—Colorimeters; Construction thereof
    • G01N21/253—Colorimeters; Construction thereof for batch operation, i.e. multisample apparatus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/645—Specially adapted constructive features of fluorimeters
    • G01N21/6452—Individual samples arranged in a regular 2D-array, e.g. multiwell plates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/12—Measuring magnetic properties of articles or specimens of solids or fluids
    • G01R33/1269—Measuring magnetic properties of articles or specimens of solids or fluids of molecules labeled with magnetic beads
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/06—Auxiliary integrated devices, integrated components
    • B01L2300/0627—Sensor or part of a sensor is integrated
    • B01L2300/0636—Integrated biosensor, microarrays
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/08—Geometry, shape and general structure
    • B01L2300/0809—Geometry, shape and general structure rectangular shaped
    • B01L2300/0819—Microarrays; Biochips
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/08—Geometry, shape and general structure
    • B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
    • B01L2300/0877—Flow chambers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/508—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above
    • B01L3/5085—Containers for the purpose of retaining a material to be analysed, e.g. test tubes rigid containers not provided for above for multiple samples, e.g. microtitration plates
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L7/00—Heating or cooling apparatus; Heat insulating devices
    • B01L7/52—Heating or cooling apparatus; Heat insulating devices with provision for submitting samples to a predetermined sequence of different temperatures, e.g. for treating nucleic acid samples
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/645—Specially adapted constructive features of fluorimeters
    • G01N2021/6484—Optical fibres
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/645—Specially adapted constructive features of fluorimeters
    • G01N21/6456—Spatial resolved fluorescence measurements; Imaging
    • G01N21/6458—Fluorescence microscopy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]

Definitions

  • the invention relates to protein chemistry, molecular biology, and methods of preparing single-stranded libraries for sequence analysis. More specifically, this invention includes methods of processing DNA for use in amplification and sequencing reactions.
  • PCR polymerase chain reaction
  • two primers are designed to hybridize to the template DNA at positions complementary to respective primers that are separated on the DNA template molecule by some number of nucleotides.
  • the base sequence of the template DNA between and including the primers is amplified by repetitive complementary strand extension reactions whereby the number of copies of the target DNA fragments is increased by several orders of magnitude.
  • Amplification is exponential as 2 n , where n equals the number of amplification cycles.
  • the amplified DNA may be sequenced through conventional sequencing methods (see, U.S. Pat. No. 6,274,320).
  • Samples comprising large template DNA or whole DNA genomes comprising long nucleotide sequences are not conducive to efficient amplification by PCR. These long molecules do not naturally possess sequences useful for primer hybridization. In addition, if primer hybridization sequences are added to double stranded DNA molecules, it is difficult to ascertain the directionality of the amplified DNA molecules and this frustrates sequencing efforts.
  • U.S. Pat. No. 5,508,169 describes that subsets of nucleic acid fragments may be indexed (i.e., selected or targeted) based upon the information contained in non-identical 5′-protruding or 3′-protruding cohesive ends. This includes fragments having 3, 4 or 5 base cohesive ends, such as those revealed by cleavage of DNA by Type II restriction endonucleases and interrupted palindrome recognizing type II restriction endonucleases.
  • indexing linkers nucleic acid molecules similar to adaptors (called indexing linkers) which contain protruding single strands complementary to the cohesive ends of cleavage sites of restriction endonucleases (rather than the recognition sequences).
  • Various functional groups or specific nucleic acid sequences designed for particular applications may be selectively attached to the aforementioned subsets of fragments. Selective attachment of indexing linkers having known base sequences in their cohesive ends to a subset of fragments bearing the complementary cohesive ends can be used for the detection, identification, isolation, amplification, and manipulation of the subset of fragments.
  • U.S. Pat. No. 6,468,748 describes a method of sorting genes and/or gene fragments comprising several steps.
  • ds cDNA molecules are prepared from mRNA molecules by reverse transcription, using a poly-T primer optionally having a general primer-template sequence upstream from the poly-T sequence, yielding ds cDNA molecules having the poly-T sequence, optionally having the general primer-template sequence.
  • the ds cDNA molecules are digested with a restriction enzyme that produces digested cDNA molecules with cohesive ends having overhanging ssDNA sequences of a constant number of arbitrary nucleotides.
  • the digested cDNA molecules are ligated to a set of dsDNA oligonucleotide adaptors, each of which adaptors has at one of its ends a cohesive-end ssDNA adaptor sequence complementary to one of the possible overhanging ssDNA sequences of the digested cDNA, at the opposite end a specific primer-template sequence specific for the ssDNA adaptor complementary sequence, and in between the ends a constant sequence that is the same for all of the different adaptors of the set.
  • the ligated cDNA molecules are amplified by separate polymerase chain reactions, utilizing for each separate polymerase chain reaction a primer that anneals to the cDNA poly-T sequence optionally having the cDNA general primer-template, and a primer from a set of different specific primers that anneal to the cDNA specific primer-template sequences.
  • the amplified cDNA molecules are sorted into nonoverlapping groups by collecting the amplification products after each separate polymerase chain reaction, each group of amplified cDNA molecules determined by the specific primer that annealed to the specific primer-template sequence and primed the polymerase chain reaction.
  • U.S. Pat. No. 5,863,722 describes a method and materials for sorting polynucleotides with oligonucleotide tags.
  • the oligonucleotide tags are capable of hybridizing to complementary oligomeric compounds consisting of subunits having enhanced binding strength and specificity as compared to natural oligonucleotides.
  • tag complements Such complementary oligomeric compounds are referred to as “tag complements.”
  • Subunits of tag complements may consist of monomers of non-natural nucleotide analogs, referred to as “antisense monomers” or they may comprise oligomers having lengths in the range of 3 to 6 nucleotides or analogs thereof, including antisense monomers, the oligomers being selected from a minimally cross-hybridizing set. In such a set, a duplex made up of an oligomer of the set and the complement of any other oligomer of the set contains at least two mismatches.
  • an oligomer of a minimally cross-hybridizing set at best forms a duplex having at least two mismatches with the complement of any other oligomer of the same set.
  • Tag complements attached to a solid phase support are used to sort polynucleotides from a mixture of polynucleotides each containing a tag. The surface of each support is derivatized by only one type of tag complement which has a particular sequence.
  • the polynucleotides to be sorted each comprise an oligonucleotide tag in the repertoire, such that identical polynucleotides have the same tag and different polynucleotides have different tags.
  • subpopulations of identical polynucleotides are sorted onto particular beads or regions.
  • the subpopulations of polynucleotides can then be manipulated on the solid phase support by micro-biochemical techniques.
  • U.S. Pat. No. 5,728,524 describes a process for the categorization of nucleic acid sequences in which these sequences are linked to a population of adaptor molecules, each exhibiting specificity for linking to a sequence including a predetermined nucleotide base. The resulting linked sequences are then categorized based upon selection for the particular base.
  • the art does not describe methods for generating libraries of unknown fragment sequences additionally comprising two known sequences, each different than the other, one being adjoined at each end.
  • This invention describes a novel method for preparing a library of multiple nucleic acid sequences from a sample where the library is suited to further quantitative and comparative analysis, particularly where the multiple nucleic acid sequences are unknown and derived from large template DNA or whole (or partial) genome DNA.
  • sequences of single stranded DNA are prepared from a sample of large template DNA or whole or partial DNA genomes through fragmentation, polishing, adaptor ligation, nick repair, and isolation of ssDNA.
  • the present invention provides a method for clonally isolating a library comprising a plurality of ssDNAs, wherein each ssDNA comprises a first single stranded universal adaptor and a second single stranded universal adaptor, the method comprising:
  • the single stranded DNA molecules are delivered into droplets in a water-in-oil emulsion (i.e., microreactors), or onto multiwell surfaces (e.g., PicoTiter plates).
  • a water-in-oil emulsion i.e., microreactors
  • multiwell surfaces e.g., PicoTiter plates
  • the single stranded DNA molecules may be delivered via attachment to a solid support (e.g., beads).
  • a solid support e.g., beads
  • the adaptor ligated DNA molecules comprising a first double stranded universal adaptor and second double stranded universal adaptor is attached to a solid support via one strand of the double stranded universal adaptor (via the first or second universal adaptor).
  • the adaptor ligated DNA molecules which have not attached to a solid support are washed away, and one strand of the adaptor ligated DNA molecules is released. This generates a mixture comprising a plurality of ssDNAs comprising a population of single stranded molecules with a first and second universal adaptor pair, thereby generating a library.
  • sequence of the fragmented DNA may be known or unknown.
  • sequence of the fragmented DNA, particularly the sequence of the ends of the fragmented DNA is unknown.
  • the present invention includes a method for generating a ssDNA library linked to solid supports comprising: (a) generating a library of ssDNA templates; (b) attaching the ssDNA templates to solid supports; and (c) isolating the solid supports on which one ssDNA template is attached.
  • the present invention includes a library of mobile solid supports made by the method disclosed herein.
  • FIG. 1 is a schematic representation of the entire process of library preparation including the steps of template DNA fragmentation (FIG. 1A), end polishing (FIG. 1B), adaptor ligation (FIG. 1C), nick repair, strand extension and gel isolation (FIG. 1D).
  • FIG. 1 also depicts a representative agarose gel containing a sample preparation of a 180-350 base pair adenovirus DNA library according to the methods of this invention.
  • FIG. 2A is a schematic representation of the universal adaptor design according one embodiment of the present invention.
  • Each universal adaptor is generated from two complementary ssDNA oligonucleotides that are designed to contain a 20 bp nucleotide sequence for PCR priming, a 20 bp nucleotide sequence for sequence priming and a unique 4 bp discriminating sequence comprised of a non-repeating nucleotide sequence (i.e., ACGT, CAGT, etc.).
  • a non-repeating nucleotide sequence i.e., ACGT, CAGT, etc.
  • FIG. 2B depicts a representative universal adaptor sequence pair for use with the invention.
  • Adaptor A sense strand SEQ ID NO:1;
  • Adaptor A antisense strand SEQ ID NO:2;
  • Adaptor B sense strand SEQ ID NO:3;
  • Adaptor B antisense strand SEQ ID NO:4.
  • FIG. 2C is a schematic representation of universal adaptor design for use with the invention.
  • FIG. 3 represents the strand displacement and extension of nicked double-stranded DNA fragments according to the present invention.
  • double-stranded DNA fragments will be generated that contain two nicked regions following T4 DNA ligase treatment (FIG. 3A).
  • a strand displacing enzyme i.e., Bst DNA polymerase I
  • FIG. 3B strand displace the nicked strand and complete nucleotide extension of the strand
  • FIG. 3D non-nicked double-stranded DNA fragments
  • FIG. 4 represents the isolation of directionally-ligated single-stranded DNA according to the present invention using streptavidin-coated magnetic beads.
  • double-stranded DNA will contain adaptors in four possible combinations: AA, BB, AB, and BA.
  • universal adaptor B contains a 5′-biotin
  • magnetic streptavidin-coated solid supports are used to capture and isolate the AB, BA, and BB populations (population AA is washed away).
  • the BB population is retained on the beads as each end of the double-stranded DNA is attached to a bead and is not released.
  • FIG. 5 represents an insert flanked by PCR primers and sequencing primers.
  • FIG. 6 represents truncated product produced by PCR primer mismatch at cross-hybridization region (CHR).
  • FIGS. 7A-7D depict the assembly for the nebulizer used for the methods of the invention.
  • a tube cap was placed over the top of the nebulizer (FIG. 7A) and the cap was secured with a nebulizer clamp assembly (FIG. 7B).
  • the bottom of the nebulizer was attached to the nitrogen supply (FIG. 7C) and the entire device was wrapped in parafilm (FIG. 7D).
  • FIG. 8 depicts representative BioAnalyzer output from analysis of a single stranded DNA library.
  • FIG. 9A depicts representative results for LabChip analysis of a single stranded DNA library following nebulization and polishing.
  • FIG. 9B depicts representative size distribution results for an adaptor-ligated single stranded DNA library following nebulization, polishing, and gel purification.
  • FIG. 10 depicts the calculation for primer candidates based on melting temperature.
  • This invention relates to the preparation of sample DNA for amplification and sequencing reactions.
  • the invention includes a method for preparing the sample DNA comprised of the following steps: (a) fragmenting large template DNA or whole genomic DNA samples to generate a plurality of digested DNA fragments; (b) creating compatible ends on the plurality of digested DNA samples; (c) ligating a set of universal adaptor sequences onto the ends of fragmented DNA molecules to make a plurality of adaptor-ligated DNA molecules, wherein each universal adaptor sequence comprises a PCR primer sequence, a sequencing primer sequence and a discriminating key sequence and wherein one adaptor is attached to biotin; (d) separating and isolating the plurality of ligated DNA fragments; (e) removing any portion of the plurality of ligated DNA fragments; (f) nick repair and strand extension of the plurality of ligated DNA fragments; (g) attaching each of the ligated DNA fragments to a solid support; and (h) isolating populations
  • the term “universal adaptor” refers to two complementary and annealed oligonucleotides that are designed to contain a nucleotide sequence for PCR priming and a nucleotide sequence for sequence priming.
  • the universal adaptor may further include a unique discriminating key sequence comprised of a non-repeating nucleotide sequence (i.e., ACGT, CAGT, etc.).
  • a set of universal adaptors comprises two unique and distinct double-stranded sequences that can be ligated to the ends of double-stranded DNA. Therefore, the same universal adaptor or different universal adaptors can be ligated to either end of the DNA molecule.
  • the universal adaptor may be referred to as a single stranded universal adaptor.
  • discriminating key sequence refers to a sequence including a combination of the four deoxyribonucleotides (i.e., A, C, G, T). The same discriminating sequence can be used for an entire library of DNA fragments. Alternatively, different discriminating key sequences can be used to track libraries of DNA fragments derived from different organisms. Longer discriminating key sequences can be used for a mixture of more than one library.
  • the term “plurality of molecules” refers to DNA isolated from the same source, whereby different organisms may be prepared separately by the same method.
  • the plurality of DNA samples is derived from large segments of DNA, e.g., genomic DNA, cDNA, viral DNA, plasmid DNA, cosmid DNA, artificial chromosome DNA (e.g., BACs, YACs, MACs, PACs), synthetic DNA, phagemid DNA, phasemid DNA, or from reverse transcripts of viral RNA.
  • This DNA may be derived from any source, including any mammal (i.e., human, nonhuman primate, rodent, or canine), plant, bird, reptile, fish, fungus, bacteria, or virus.
  • library refers to a subset of smaller sized DNA species generated from a larger DNA template, e.g., a segmented or whole genome.
  • unique refers to a sequence that does not exist or exists at an extremely low copy level within the DNA molecules to be amplified or sequenced.
  • compatible refers to an end of double stranded DNA to which an adaptor molecule may be attached (i.e., blunt end or cohesive end).
  • fragmenting refers to a process by which a larger molecule of DNA is converted into smaller pieces of DNA.
  • large template DNA would be DNA of more than 5 kb, 10 kb, or 25 kb, preferably more than 500 kb, more preferably more than 1 MB, and most preferably 5 MB or larger.
  • stringent hybridization conditions refers to those conditions under which only fully complimentary sequences will hybridize to each other.
  • the fragmentation of the DNA sample can be done by any means known to those of ordinary skill in the art.
  • the fragmenting is performed by enzymatic, chemical, or mechanical means.
  • the mechanical means may include sonication, French press, HPLC, HydroShear (GeneMachines, San Carlos, Calif.), and nebulization.
  • the enzymatic means may be performed by digestion with Deoxyribonuclease I (DNase I), nonspecific nucleases, or single or multiple restriction endonucleases.
  • DNase I Deoxyribonuclease I
  • the fragmentation results in ends for which the sequence adjacent to the end is not known.
  • the sequence adjacent to the end may be at least 5 bases, 10 bases, 20 bases, 30 bases, or 50 bases.
  • the enzymatic means is DNase I.
  • DNase I is a versatile enzyme that nonspecifically cleaves double-stranded DNA (dsDNA) to release 5′-phosphorylated oligonucleotide products.
  • DNase I has optimal activity in buffers containing Mn 2+ , Mg 2+ and Ca 2+ .
  • the purpose of the DNase I digestion step is to fragment a large DNA genome into smaller species comprising a library.
  • the cleavage characteristics of DNase I will result in random digestion of template DNA (i.e., minimal sequence bias) and in the predominance of blunt-ended dsDNA fragments when used in the presence of manganese-based buffers (Melgar, E. and D. A.
  • DNase I is used to digest large template DNA or whole genome DNA for 1-2 minutes to generate a population of oligonucleotides that range from 50 to 500 bp, or 50 to 700 bp.
  • the DNase I digestion is performed at a temperature of 10° C.-37° C.
  • the digested DNA fragments are 50 bp to 700 bp in length.
  • nucleic acid fragmentation Another preferred method for nucleic acid fragmentation is mechanical fragmentation.
  • Mechanical fragmentation methods include sonication and nebulization, and use of HydroShear, HPLC, and French Press devices.
  • Sonication may be performed by a tube containing DNA in a suitable buffer (i.e., 10 mM Tris, 0.1 mM EDTA) and sonicating for a varying number of 10 second bursts using maximum output and continuous power Sonicators are commercially available from, e.g., Misonix Inc. (Farmingdale, N.Y.), and can be used essentially as described by Bankier and Barrell (Bankier, A. T., Weston, K. M., and Barrell, B.
  • sonication it is preferred to maintain the nucleic acid at a uniform temperature by keeping the sample on ice. Constant temperature conditions, at 0° C. for example, are preferred to maintain an even fragment distribution.
  • the optimal conditions for sonication may be determined empirically for a given DNA sample before preparative sonication is performed. For example, aliquots of DNA can be treated for different times under sonication and the size and quality of DNA can be analyzed by PAGE. Once optimal sonication conditions are determined, the remaining DNA can be sonicated according to those pre-determined conditions.
  • nucleic acid fragmentation is treatment by nebulizers (e.g., protocols, and hardware available from GeneMachines, San Carlos, Calif. Also see U.S. Pat. Nos. 5,506,100 and 5,610,010).
  • nebulizers e.g., protocols, and hardware available from GeneMachines, San Carlos, Calif. Also see U.S. Pat. Nos. 5,506,100 and 5,610,010).
  • hydrodynamic shearing forces are used to fragment DNA strands.
  • DNA in a aqueous solution can be passed through a tube with an abrupt contraction. As the solution approaches the contraction, the fluid accelerates to maintain the volumetric flow rate through the smaller area of the contraction. During this acceleration, drag forces stretch the DNA until it snaps.
  • the DNA solution can be passed several times (e.g., 15 to 20 cycles) through the contraction until the fragments are too short for further shearing.
  • DNA may be suspended in various solutions including, but not limited to, water, Tris buffer, Tris-EDTA buffer, and Tris-EDTA with up to 0.5 M NaCl.
  • Polishing digestion of genomic DNA (gDNA) templates with DNase I in the presence of Mn 2+ produces fragments of DNA that are either blunt-ended or have protruding termini with one or two nucleotides in length.
  • fragmentation of DNA by mechanical means provides a combination of fragments with blunt-ends or overhanging ends.
  • Polishing also called end repair refers to the conversion of non-blunt ended DNA into blunt ended DNA.
  • polishing may be performed by treatment with a single strand-specific exonuclease, such as BAL32 nuclease or Mung Bean nuclease. Generally, the nuclease should be calibrated prior to use.
  • blunt ends are created with Pfu DNA polymerase.
  • blunt ends are created with other DNA polymerases such as T4 DNA polymerase or Klenow DNA polymerase.
  • Pfu “polishing” or blunt ending can be used to increase the amount of blunt-ended species generated following genomic template digestion with DNase I.
  • Pfu DNA polymerase fills in 5′ overhangs.
  • Pfu DNA polymerase exhibits 3′ ⁇ 5′ exonuclease activity.
  • the enzyme can be used to remove single and double nucleotide extensions to further increase the amount of blunt-ended DNA fragments available for adaptor ligation (see, e.g., Costa, G. L. and M. P. Weiner. 1994a.
  • the universal adaptors can be added to each DNA fragment.
  • the universal adaptors are designed to include: 1) a set of unique PCR priming regions that are typically 10-20 bp in length (any suitable size may be used) located adjacent to; 2) a set of unique sequencing priming regions that are typically 10-20 bp in length (any suitable size may be used) optionally followed by; 3) a unique discriminating key sequence (e.g., 1-12 bp in length) including a combination of at least one of each of the four deoxyribonucleotides (i.e., A, C, G, T).
  • the discriminating key sequence is 4 bases in length.
  • the discriminating key sequence may be combinations of 1-4 bases.
  • the key sequence includes one of each of the four nucleotides.
  • the key sequence includes one or more ribonucleotides, e.g., U.
  • each unique universal adaptor is forty-four bp (44 bp) in length, although any suitable size may be used.
  • the universal adaptors are ligated, using T4 DNA ligase, onto each end of the DNA fragment to generate a total nucleotide addition of 88 bp to each DNA fragment, although any suitable size may be used.
  • Different universal adaptors can be specifically designed for each DNA library preparation and therefore provide a unique identifier for each organism. For example, different library preparations can employ different key sequences. It is understood that the size and sequence of the universal adaptors may be modified as would be apparent to one of skill in the art. Thus, the adaptors for use with the invention are not limited to the size and sequence described herein.
  • first and second single-stranded oligonucleotides may be ordered from a commercial vendor (e.g., Integrated DNA Technologies, IA or Operon Technologies, CA).
  • a commercial vendor e.g., Integrated DNA Technologies, IA or Operon Technologies, CA.
  • all of the first adaptors for a library share one nucleotide sequence, including a PCR priming sequence, sequencing primer sequence, and discriminating key sequence, while all of the second adaptors share another nucleotide sequence.
  • the universal adaptor oligonucleotide sequences are modified during synthesis with one or more phosphorothioate linkages in place of phosphodiester linkages.
  • adaptor oligonucleotides can include two or three phosphorothioate linkages at both the 5′ and 3′ ends, or at one end.
  • Unmodified oligonucleotides are typically subject to rapid degradation by contaminating nucleases that catalyze the hydrolytic cleavage of the phosphodiester linkage between nucleotide bases.
  • nuclease-resistant chemistry available for use in oligonucleotide applications is the phosphorothioate modification. In phosphorothioates, a sulfur atom replaces a non-bridging oxygen in the oligonucleotide backbone making it resistant to all forms of nuclease digestion (i.e.
  • Each oligonucleotide is HPLC-purified to ensure there are no contaminating or spurious oligonucleotide sequences in the synthetic oligonucleotide preparation.
  • the universal adaptors are designed to allow directional ligation to the fragmented DNA.
  • Each set of double-stranded universal adaptors is designed with a PCR priming region that includes non-complementary 5′ four-base overhangs which are unable to ligate to each other or to the blunt-ended DNA fragment.
  • binding occurs between the 3′ end of the adaptor and the 5′ end of the DNA fragment or between the 3′ end of the DNA fragment and the 5′ end of the adaptor.
  • Double-stranded universal adaptor sequences are generated using single-stranded oligonucleotides that are designed with sequences that allow primarily complimentary oligonucleotides to anneal, and to prevent cross-hybridization between two non-complimentary oligonucleotides.
  • 95% of the universal adaptors are formed from the annealing of complimentary oligonucleotides.
  • 97% of the universal adaptors are formed from the annealing of complimentary oligonucleotides.
  • 99% of the universal adaptors are formed from the annealing of complimentary oligonucleotides.
  • 100% of the universal adaptors are formed from the annealing of complimentary oligonucleotides.
  • an overhanging nucleotide e.g., T
  • a polymerase is used to add an overhanging nucleotide (e.g., A) to the blunt 5′ ends of the template DNA.
  • the overhanging nucleotides of the adaptors and template are complementary to allow more efficient adaptor ligation.
  • a plasmid capture system is used in accordance with the disclosed methods.
  • the double stranded universal adaptors can be inserted into a plasmid.
  • the adaptor region can include the following sequences, in order: Restriction Site(s), PCR Primer Sequence 1, Sequencing Primer Sequence 1, Key Sequence 1, Restriction Site(s), Key Sequence 2, Sequencing Primer Sequence 2, PCR Priming Sequence 2, and Restriction Site(s).
  • the plasmid is digested with one or more restriction enzymes that cut between Key Sequence 1 and Key Sequence 2.
  • the fragmented template DNA is ligated between Key Sequence 1 and Key Sequence 2.
  • the ligated construct is then digested to cut after PCR Priming Sequence 2.
  • the digested end next to PCR Priming Sequence 2 is filled in with biotinylated nucleotides.
  • the biotinylated construct is digested to cut prior to PCR Primer Sequence 1.
  • the Adaptor-DNA fragment-Adaptor-biotin segment is excised and isolated, e.g., by binding to a streptavidin magnetic bead.
  • Other embodiments of the plasmid capture system are also possible through application of known cloning techniques. These embodiments are also encompassed by the invention.
  • One of the two adaptors can be linked to a support binding moiety.
  • a 5′ biotin is added to the first universal adaptor to allow subsequent isolation of ssDNA template and noncovalent coupling of the universal adaptor to the surface of a solid support that is saturated with a biotin-binding protein (e.g., streptavidin, NeutrAvidinTM or avidin).
  • Suitable supports include but are not limited to magnetic beads, affinity columns, membranes (e.g., PDVF membrane, nitrocellulose, etc.), which can be coated with streptavidin or another member of a binding pair.
  • Other linkages are well known in the art and may be used in place of biotin-streptavidin.
  • the solid support is a bead, preferably a polystyrene bead.
  • the bead has a diameter of about 2.8 ⁇ m, although any suitable size may be used.
  • the bead is a paramagnetic bead (e.g., Dynal Biotech, Inc., Lake Success, N.Y.). As used herein, this bead is referred to as a “sample prep bead”.
  • Each universal adaptor may be prepared by combining and annealing two ssDNA oligonucleotides, one containing the sense sequence and the second containing the antisense (complementary) sequence. Schematic representation of the universal adaptor design is depicted in FIG. 2.
  • the universal adaptor ligation results in the formation of fragmented DNAs with adaptors on each end, unbound single adaptors, and adaptor dimers.
  • agarose gel electrophoresis is used as a method to separate and isolate the adapted DNA library population from the unligated single adaptors and adaptor dimer populations.
  • the fragments may be separated by size exclusion chromatography, filtration, sucrose sedimentation, or other nucleic acid separation techniques known to those skilled in the art.
  • the procedure of DNase I digestion of DNA typically yields a library population that ranges from 50-700 bp.
  • the addition of the 88 bp universal adaptor set will shift the DNA library population to a larger size and will result in a migration profile in the size range of approximately 130-800 bp; adaptor dimers will migrate at 88 bp; and adaptors not ligated will migrate at 44 bp. Therefore, numerous double-stranded DNA libraries in sizes ranging from 200-800 bp can be physically isolated from the agarose gel and purified using standard gel extraction techniques. In one embodiment, gel isolation of the adapted ligated DNA library will result in the recovery of a library population ranging in size from 200-500 bp. Other methods of distinguishing adaptor-ligated fragments are known to one of skill in the art.
  • gaps will be present at the 3′ junctions of the fragmented DNAs following ligase treatment (see FIG. 3A). These “gaps” or “nicks” can be filled in by using a DNA polymerase enzyme that can bind to, strand displace, and extend the nicked DNA fragments.
  • DNA polymerases that lack 3′ ⁇ 5′ exonuclease activity but exhibit 5′ ⁇ 3′ exonuclease activity have the ability to recognize nicks, displace the nicked strands, and extend the strand in a manner that results in the repair of the nicks and in the formation of non-nicked double-stranded DNA (see FIG. 3B and 3C) (Hamilton, S. C., J. W. Farchaus and M. C. Davis. 2001. DNA polymerases as engines for biotechnology. BioTechniques 31:370).
  • DNA polymerases that can be used in the methods of the invention include, for example, E. coli DNA polymerase I, Thermoanaerobacter thermohydrosulfuricus polymerase I, and bacteriophage phi 29.
  • the strand displacing enzyme Bacillus stearothermophilus polymerase I Bacillus stearothermophilus polymerase I ( Bst DNA polymerase I) is used to repair the nicked dsDNA and results in non-nicked dsDNA (see FIG. 3D).
  • the ligase is T4 DNA ligase and the kinase is T4 polynucleotide kinase.
  • ssDNAs comprising both the first and second adaptor molecules may be isolated.
  • Double-stranded DNA libraries will have adaptors bound in the following configurations:
  • a and B correspond to the first and second adaptors.
  • the desired populations are designated with asterisks.
  • the universal adaptors are designed such that only one universal adaptor has a 5′ biotin moiety.
  • universal adaptor B has a 5′ biotin moiety
  • streptavidin-coated sample prep beads can be used to bind all double-stranded DNA library species with universal adaptor B.
  • Genomic library populations that contain two universal adaptor A species will not contain a 5′ biotin moiety and will not bind to streptavidin-containing sample prep beads and thus can be washed away.
  • the only species that will remain attached to beads are those with universal adaptors A and B and those with two universal adaptor B sequences.
  • DNA species with two universal adaptor B sequences will be bound to streptavidin-coated sample prep beads at each end, as each strand comprised in the double strand will be bound.
  • Double-stranded DNA species with a universal adaptor A and a universal adaptor B will contain a single 5′ biotin moiety and thus will be bound to streptavidin-coated beads at only one end. Where the sample prep beads are magnetic, the beads will remain coupled to a solid support when magnetized.
  • ssDNA libraries that are created according to the methods of the invention are quantitated to calculate the number of molecules per unit volume.
  • the molecules can be annealed to a solid support that includes oligonucleotide capture primers that are complementary to the PCR priming regions of the universal adaptor ends of the ssDNA species.
  • beads comprising capture primers annealed to ssDNA library molecules can be transferred to a thermocycler to allow PCR amplification. Clonal populations of single species of single stranded DNA captured on DNA beads may then sequenced.
  • the solid support is a bead, preferably a sepharose bead. As used herein, this bead is referred to as a “DNA capture bead”.
  • the beads used herein may be of any convenient size and fabricated from any number of known materials.
  • Example of such materials include: inorganics, natural polymers, and synthetic polymers. Specific examples of these materials include: cellulose, cellulose derivatives, acrylic resins, glass; silica gels, polystyrene, gelatin, polyvinyl pyrrolidone, co-polymers of vinyl and acrylamide, polystyrene cross-linked with divinylbenzene or the like (see, Merrifield Biochemistry 1964, 3, 1385-1390), polyacrylamides, latex gels, polystyrene, dextran, rubber, silicon, plastics, nitrocellulose, celluloses, natural sponges, silica gels, glass, metals plastic, cellulose, cross-linked dextrans (e.g., SephadexTM) and agarose gel (SepharoseTM) and solid phase supports known to those of skill in the art.
  • cross-linked dextrans e.g., SephadexTM
  • the diameter of the DNA capture bead is 20-70 ⁇ m. In a preferred embodiment, the diameter of the DNA capture bead is 20-50 ⁇ m. In a more preferred embodiment, the diameter of the DNA capture bead is about 30 ⁇ m.
  • the invention includes a method for generating a library of solid supports comprising: (a) preparing a population of ssDNA templates according to the methods disclosed herein; (b) attaching each DNA template to a solid support such that there is one molecule of DNA per solid support; (c) amplifying the population of single-stranded templates such that the amplification generates a clonal population of each DNA fragment on each solid support; (d) sequencing clonal populations of the ssDNA templates.
  • the solid support is a DNA capture bead.
  • the DNA is genomic DNA, cDNA, or reverse transcripts of RNA (e.g., viral RNA).
  • the DNA may be attached to the solid support, for example, via a biotin-streptavidin linkage, a covalent linkage, or by complementary oligonucleotide hybridization.
  • each DNA template is ligated to a set of universal adaptors.
  • the universal adaptor pair comprises a PCR primer sequence, a sequencing primer sequence, and a discriminating key sequence. Single-stranded DNAs with unique ends are isolated and then attached to a solid support and exposed to amplification techniques for clonal amplification.
  • the DNA may be amplified by PCR.
  • the invention provides a library attached to solid supports made by the methods described herein.
  • the DNA prepared by this method may be used for many molecular biological procedures, such as linear extension, rolling circle amplification, PCR, and sequencing.
  • the linkage reaction can be driven, for example, by using a high molar ratio of bead to DNA.
  • the capture of single-stranded DNA molecules follows a Poisson distribution and results in subsets of beads having no DNA attached, one molecule of DNA attached, or more than one molecule of DNA attached.
  • a single stranded nucleic acid template to be amplified is attached to a capture bead.
  • the nucleic acid template may be attached to the solid support capture bead in any manner known in the art. Numerous methods exist in the art for attaching DNA to a solid support such as the preferred microscopic bead. According to the present invention, covalent chemical attachment of the DNA to the bead can be accomplished by using standard coupling agents, such as water-soluble carbodiimide, to link the 5′-phosphate on the DNA to amine-coated capture beads through a phosphoamidate bond.
  • Another alternative is to first couple specific oligonucleotide linkers to the bead using similar chemistry, and to then use DNA ligase to link the DNA to the linker on the bead.
  • Other linkage chemistries to join the oligonucleotide to the beads include the use of N-hydroxysuccinamide (NHS) and its derivatives.
  • one end of the oligonucleotide may contain a reactive group (such as an amide group) which forms a covalent bond with the solid support, while the other end of the linker contains a second reactive group that can bond with the oligonucleotide to be immobilized.
  • the oligonucleotide is bound to the DNA capture bead by covalent linkage.
  • non-covalent linkages such as chelation or antigen-antibody complexes, may also be used to join the oligonucleotide to the bead.
  • Oligonucleotide linkers can be employed which specifically hybridize to unique sequences at the end of the DNA fragment, such as the overlapping end from a restriction enzyme site or the “sticky ends” of bacteriophage lambda based cloning vectors, but blunt-end ligations can also be used beneficially. These methods are described in detail in U.S. Pat. No. 5,674,743. It is preferred that any method used to immobilize the beads will continue to bind the immobilized oligonucleotide throughout the steps in the methods of the invention.
  • each capture bead is designed to have a plurality of nucleic acid primers that recognize (i.e., are complementary to) a portion of the nucleic template, and the nucleic acid template is thus hybridized to the capture bead.
  • nucleic acid primers that recognize (i.e., are complementary to) a portion of the nucleic template, and the nucleic acid template is thus hybridized to the capture bead.
  • clonal amplification of the template species is desired, so it is preferred that only one unique nucleic acid template is attached to any one capture bead.
  • the beads used herein may be of any convenient size and fabricated from any number of known materials.
  • Example of such materials include: inorganics, natural polymers, and synthetic polymers. Specific examples of these materials include: cellulose, cellulose derivatives, acrylic resins, glass, silica gels, polystyrene, gelatin, polyvinyl pyrrolidone, co-polymers of vinyl and acrylamide, polystyrene cross-linked with divinylbenzene or the like (as described, e.g., in Merrifield, Biochemistry 1964, 3, 1385-1390), polyacrylamides, latex gels, polystyrene, dextran, rubber, silicon, plastics, nitrocellulose, natural sponges, silica gels, control pore glass, metals, cross-linked dextrans (e.g., SephadexTM) agarose gel (SepharoseTM), and solid phase supports known to those of skill in the art.
  • the capture beads are Sepharose beads approximately
  • capture beads with or without attached nucleic acid template may be suspended in a heat stable water-in-oil emulsion. It is contemplated that a plurality of the microreactors include only one template and one bead. There may be many droplets that do not contain a template or which do not contain a bead. Likewise there may be droplets that contain more than one copy of a template.
  • the emulsion may be formed according to any suitable method known in the art. One method of creating emulsion is described below but any method for making an emulsion may be used. These methods are known in the art and include adjuvant methods, counter-flow methods, cross-current methods, rotating drum methods, and membrane methods.
  • the size of the microcapsules may be adjusted by varying the flow rate and speed of the components. For example, in dropwise addition, the size of the drops and the total time of delivery may be varied.
  • the emulsion contains a density of about 3,000 beads encapsulated per microliter.
  • This method involves compartmentalizing a gene, expressing the gene, and sorting the compartmentalized gene based on the expressed product.
  • the microencapsulated sorting method of Griffith is not suitable for parallel analysis of multiple microcapsules because their nucleic acid product is not anchored and cannot be anchored. Since the nucleic acids of Griffiths are not anchored, they would be mixed together during demulsification.
  • the emulsion is preferably generated by adding beads to an amplification solution.
  • amplification solution means the sufficient mixture of reagents that is necessary to perform amplification of template DNA.
  • a PCR amplification solution is provided in the Examples below. It will be appreciated that various modifications may be made to the amplification solution based on the type of amplification being performed and whether the template DNA is attached to the beads or provided in solution.
  • the mixture of beads and amplification solution is added dropwise into a spinning mixture of biocompatible oil (e.g., light mineral oil, Sigma) and allowed to emulsify.
  • biocompatible oil e.g., light mineral oil, Sigma
  • the beads and amplification solution are added dropwise into a cross-flow of biocompatible oil.
  • the oil used may be supplemented with one or more biocompatible emulsion stabilizers.
  • emulsion stabilizers may include Atlox 4912, Span 80, and other recognized and commercially available suitable stabilizers.
  • the emulsion is heat stable to allow thermal cycling, e.g., to at least 94° C., at least 95° C., or at least 96° C.
  • the droplets formed range in size from about 5 microns to about 500 microns, more preferably from about 10 microns to about 350 microns, even more preferably from about 50 to 250 microns, and most preferably from about 100 microns to about 200 microns.
  • cross-flow fluid mixing allows for control of the droplet formation, and uniformity of droplet size.
  • smaller water droplets not containing beads may be present in the emulsion.
  • the microreactors should be sufficiently large to encompass sufficient amplification reagents for the degree of amplification required. However, the microreactors should be sufficiently small so that a population of microreactors, each containing a member of a DNA library, can be amplified by conventional laboratory equipment, e.g., PCR thermocycling equipment, test tubes, incubators and the like.
  • microreactors allows amplification of complex mixtures of templates (e.g., genomic DNA samples or whole cell RNA) without intermixing of sequences, or domination by one or more templates (e.g., PCR selection bias; see, Wagner et al., 1994, Suzuki and Giovannoni, 1996; Chandler et al., 1997, Polz and Cavanaugh, 1998).
  • templates e.g., genomic DNA samples or whole cell RNA
  • the optimal size of a microreactor may be on average 100 to 200 microns in diameter. Microreactors of this size would allow amplification of a DNA library comprising about 600,000 members in a suspension of microreactors of less than 10 ml in volume. For example, if PCR is the chosen amplification method, 10 ml of microreactors would fit into 96 tubes of a regular thermocycler with 96 tube capacity. In a preferred embodiment, the suspension of 600,000 microreactors would have a volume of less than 1 ml. A suspension of less than 1 ml may be amplified in about 10 tubes of a conventional PCR thermocycler. In a most preferred embodiment, the suspension of 600,000 microreactors would have a volume of less than 0.5 ml.
  • Another embodiment of the invention is directed to a method of performing nucleic acid amplification with a template and a bead, but without attachment of the template to the bead.
  • the bead may comprise a linker molecule that can bind the amplified nucleic acid after amplification.
  • the linker may be a linker that can be activated.
  • Such linkers are well known and include temperature sensitive or salt sensitive binding pairs such as streptavidin/biotin and antibodies/antigen.
  • the template nucleic acid may be encapsulated with a bead and amplified. Following amplification, the amplified nucleic acid may be linked to the beads, e.g., by adjustments in temperature or salt concentration.
  • the template nucleic acid may be amplified, while attached or unattached to beads, by any suitable method of amplification including transcription-based amplification systems (Kwoh D. et al., Proc. Natl. Acad Sci. (U.S.A.) 86:1173 (1989); Gingeras T. R. et al., WO 88/10315; Davey, C. et al., EP Publication No. 329,822; Miller, H. I. et al., WO 89/06700), “RACE” (Frohman, M.
  • a nucleic acid template is amplified after encapsulation with a bead in a microreactor.
  • a nucleic acid template is amplified after distribution onto a multiwell surface, e.g., a PicoTiter plate.
  • DNA amplification is performed by PCR.
  • PCR according to the present invention may be performed by encapsulating the target nucleic acid with a PCR solution comprising all the necessary reagents for PCR. Then, PCR may be accomplished by exposing the emulsion to any suitable thermocycling regimen known in the art. In a preferred embodiment, 30 to 50 cycles, preferably about 40 cycles, of amplification are performed. It is desirable, but not necessary, that following the amplification procedure there be one or more hybridization and extension cycles following the cycles of amplification. In a preferred embodiment, 10 to 30 cycles, preferably about 25 cycles, of hybridization and extension are performed (e.g., as described in the examples).
  • the template DNA is amplified until typically at least 10,000 to 50,000,000 copies are immobilized on each bead. It is recognized that for nucleic acid detection applications, fewer copies of template are required. For nucleic acid sequencing applications we prefer that at least two million to fifty million copies, preferably about ten million to thirty million copies of the template DNA are immobilized on each bead. The skilled artisan will recognize that the size of bead (and capture site thereon) determines how many captive primers can be bound (and thus how many amplified templates may be captured onto each bead).
  • the invention encompasses a method for clonally isolating a library comprising a plurality of single stranded DNA molecules comprising: a) fragmenting large template DNA molecules to generate a plurality of fragmented DNA molecules; b) attaching a first or second universal double stranded adaptor to a first end of each fragmented DNA molecule and a first or second universal adaptor to a second end of each fragmented DNA molecule to form a mixture of adaptor ligated DNA molecules; c) isolating a plurality of single stranded DNA molecules each comprising a first single stranded universal adaptor and a second single stranded universal adaptor to obtain a library; and d) delivering the single stranded DNA molecules into reactors such that a plurality of the reactors include one DNA molecule, thereby clonally isolating the library.
  • the invention encompasses a method for generating a library comprising a plurality of single stranded DNA molecules, comprising: a) fragmenting large or whole genomic template DNA molecules to generate a plurality of fragmented DNA molecules; b) ligating a first universal double stranded adaptor or a second universal adaptor to a first end of each fragmented DNA molecule and a first universal adaptor or second universal adaptor to a second end of each fragmented DNA molecule to produce a mixture of adaptor ligated DNA molecules, wherein the first universal adaptor contains a moiety that binds to a solid support; c) attaching to a solid support those DNA molecules comprising a first double stranded universal adaptor; d) washing away adaptor ligated DNA molecules which have not attached to the solid support; e) strand separating those adaptor ligated DNA molecules that are attached to the solid support to release a plurality of single stranded DNA molecules comprising a first single strand
  • (f) can be accomplished by: i) delivering the single stranded DNA molecules onto a location on a reactor array; or ii) delivering the single stranded DNA molecules into droplets in a water-in-oil emulsion.
  • the first universal double stranded adaptor or the second universal adaptor can be attached to the fragmented DNA molecules by ligation.
  • DNA ligase may be used.
  • These methods can further include a step of repairing single stranded nicks in the mixture of adaptor ligated DNA molecules using DNA repair and modifying enzymes, such as a polymerase, ligase, kinase, or combinations thereof.
  • the enzymes can include Bacillus stearothermophilus polymerase I, T4 ligase, and T4 polynucleotide kinase.
  • the template DNA for these methods can comprise genomic DNA, cDNA, plasmid DNA, cosmid DNA, artificial chromosome DNA, synthetic DNA, phasemid DNA, phagemid DNA, or reverse transcripts. Fragmenting may be performed by enzymatic, chemical, or mechanical means.
  • DNase I enzyme can be used in a digestion performed at a temperature of 10-37° C. for 1-2 minutes. Alternatively, a restriction enzyme may be used.
  • the mechanical means can be a nebulizer, French Press, sonicator, or a HydroShear.
  • the fragmented DNA molecules can be 50 bp to 700 bp in length.
  • the compatible ends can be blunt ends, or the compatible ends can include an A or T overhang. Blunt ends can be created with an enzyme such as Pfu polymerase, T4 DNA polymerase, and Klenow fragments.
  • the first or second double stranded universal adaptor may comprise one or more phosphorothioate linkages, and may be attached to a biotin moiety.
  • the first double stranded universal adaptors or the second double stranded universal adaptors or both double stranded universal adaptors may comprise a discriminating key sequence.
  • the discriminating key sequence is 3-12 nucleotides in length and comprise at least one nucleotide selected from the group consisting of A, G, C, U, and T.
  • the first and second double stranded universal adaptor may comprise a PCR priming sequence and a sequencing primer sequence.
  • the PCR priming sequence is 10-20 base pairs in length
  • the sequencing primer sequence is 10-20 base pairs in length.
  • the PCR priming sequence and the sequencing primer sequence may overlap.
  • the mixture of adaptor ligated DNA molecules is separated by a method selected from the group consisting of gel electrophoresis, filtration, size exclusion chromatography, and sucrose sedimentation.
  • the plurality of single stranded DNA molecules may be obtained by a treatment selected from the group consisting of low salt treatment, high pH treatment, and chemical denaturation treatment.
  • the plurality of single stranded DNA molecules may be attached to a DNA capture bead.
  • the DNA capture bead may comprise a component of a binding pair, such as avidin/biotin, ligand/receptor, antigen/antibody or complementary nucleotides.
  • the DNA capture bead is a paramagnetic bead.
  • the invention also encompasses a method for generating a single stranded DNA library attached to solid supports comprising: a) generating a plurality of single stranded DNA templates; b) attaching each of the plurality of ssDNA templates to a solid support; and c) isolating the solid supports on which the single stranded DNA templates are attached.
  • the invention further encompasses a method for generating a single stranded DNA library attached to solid supports comprising: a) fragmenting large template DNA molecules to generate a plurality of fragmented DNA molecules; b) attaching a first or second universal double stranded adaptor to a first end of each fragmented DNA molecule and a first or second universal adaptor to a second end of each fragmented DNA molecule to make a mixture of adaptor ligated DNA molecules; c) isolating those single stranded DNA molecules which comprise a first single stranded universal adaptor and a second single stranded universal adaptor; and d) attaching the isolated single stranded molecules from (c) to a solid support.
  • the solid support may be a DNA capture bead, and the DNA may be genomic DNA, cDNA, plasmid DNA, cosmid DNA, artificial chromosome DNA, synthetic DNA, phasemid DNA, or phagemid DNA.
  • the DNA is attached to the solid support via a binding pair such as avidin/biotin, ligand/receptor, antigen/antibody and complementary nucleotides.
  • a binding pair such as avidin/biotin, ligand/receptor, antigen/antibody and complementary nucleotides.
  • a library of mobile solid supports made by this method.
  • the invention comprises a nucleic acid molecule comprising a first adaptor, a fragment of template DNA, and a second adaptor, wherein the first adaptor and second adaptor each comprise a sequencing primer, a PCR primer, and a discriminating key sequence, and wherein the first adaptor and second adaptor, when dissociated, do not cross-hybridize to each other under stringent hybridization conditions.
  • the PCR primer may be 10-20 base pairs in length
  • the sequencing primer may be 10-20 base pairs in length
  • the discriminating key sequence may be 3 to 12 base pairs in length.
  • the template DNA can be genomic DNA, cDNA plasmid DNA, cosmid DNA, artificial chromosome DNA, synthetic DNA, phasemid DNA, or phagemid DNA.
  • the nucleic acid molecule when dissociated, has minimal cross-hybridization to dissociated template DNA.
  • Also encompassed by the invention is a method for preparing single stranded DNA molecules, comprising: a) fragmenting large or whole genomic template DNA molecules to generate a plurality of fragmented DNA molecules; b) ligating a first universal double stranded adaptor or a second universal adaptor to a first end of each fragmented DNA molecule and a first universal adaptor or second universal adaptor to a second end of each fragmented DNA molecule to produce a mixture of adaptor ligated DNA molecules; c) attaching adaptor ligated DNA molecules comprising a first double stranded universal adaptor and a second double stranded adaptor to a solid support via one strand of the first double stranded universal adaptor; d) washing away adaptor ligated DNA molecules which have not attached to the solid support; e) strand separating those adaptor ligated DNA molecules that are attached to the solid support to release a plurality of single stranded DNA molecules comprising a first single stranded universal
  • the isolating step may comprise attaching the nucleic acid templates to a bead, or encapsulating the nucleic acid template in an emulsion of a water-in-oil emulsion.
  • the nucleic acid template may be encapsulated with a bead that can bind the nucleic acid.
  • the delivering step may comprise delivering the sequestered nucleic acid to a plurality of reaction centers, wherein each reaction center is a well on a picotiter plate.
  • the method can further comprising the step of attaching the isolated single stranded molecules each individually to a solid support.
  • the DNA should be of high quality and free from contaminants such as proteins, nucleases, lipids, and other chemicals (such as residual EDTA from preparation) and salts. It is preferred that genomic DNA should have a 260/280 ratio of 1.8 or higher. If it is desired to sequence the genome of only one organism, then the DNA should be quality checked to ensure that there is no contaminating DNA. For example: a preparation of human DNA may be checked by PCR to ensure that it is not contaminated by bacterial DNA molecules. Another method of checking for contamination is by restriction digestion patterns and especially restriction digestion followed by Southern Blot using suitable probes known to be specific for an organism (e.g., human or mouse) and a second probe known to be specific for a possible contaminating organism (e.g., E. coli ). If it is desired, the DNA should originate from a single clone of the organism (e.g., a colony if from bacteria).
  • DNase I The purpose of the DNase I digestion step is to fragment a large stretch of DNA such as a whole genome or a large portion of a genome into smaller species. This population of smaller-sized DNA species generated from a single DNA template is referred to as a “library”.
  • DNase I is an endonuclease which cleaves double-stranded template DNA. The cleavage characteristics of DNase I allow random digestion of template DNA (i.e., minimal sequence bias) and will result in the predominance of blunt-ended, double-stranded DNA fragments when used in the presence of manganese-based buffers (Melgar and Goldthwait 1968).
  • the digestion of genomic templates by DNase I is dependent on three factors: i) quantity of enzyme used (units); ii) temperature of digestion (° C.); and iii) incubation time (minutes).
  • the DNase I digestion conditions outlined below were optimized to yield DNA libraries in a size range from 50-700 base pairs (bp).
  • DNA was obtained and prepared to a concentration of 0.3 mg/ml in Tris-HCl (10 mM, pH 7-8). A total of 134 ⁇ l of DNA (15 ⁇ g) was needed for this preparation. It is recommended to not use DNA preparations diluted with buffers containing EDTA (i.e., TE, Tris/EDTA). The presence of EDTA is inhibitory to enzyme digestion with DNase I. If the DNA preparation contains EDTA, it is important that the DNA be “salted” out of solution and reconstituted with the appropriate Tris-HCl buffer (10 mM, pH 7-8) or nanopure H 2 O (pH 7-8).
  • Tris-HCl buffer 10 mM, pH 7-8
  • nanopure H 2 O pH 7-8
  • DNase I Buffer comprising 50 ⁇ l Tris pH 7.5 (1M), 10 ⁇ l MnCl 2 (1M), 1 ⁇ l BSA (100 mg/ml), and 39 ⁇ l water was prepared.
  • the digested DNA was purified by using the QiaQuick PCR purification kit. The digestion reaction was then split into four aliquots, and four spin columns were used to purify each aliquot (37.5 ⁇ l per spin column). Each column was eluted with 30 ⁇ l elution buffer (EB) according to the manufacturer's protocol. The eluates were then combined to generate a final reaction volume of 120 ⁇ l.
  • EB elution buffer
  • Pfu polishing is used to increase the amount of blunt-ended species by fill-in (i.e., “blunting”) of 5′ overhangs. Additionally, Pfu DNA polymerase has 3′ ⁇ 5′ exonuclease activity that will result in the removal of single and double nucleotide extensions. Pfu polishing increases the amount of blunt-ended DNA fragments available for adaptor ligation (Costa 1994a, 1994b, 1994c). The following Pfu polishing protocol was used.
  • polishing reaction components were mixed well and incubated at 72° C. for 30 minutes.
  • polishing reaction mixture was then split into four aliquots and purified using QiaQuick PCR purification columns (37.5 ⁇ L on each column). Each column was eluted with 30 ⁇ l buffer EB according to the manufacturer's protocol. The eluates were then combined to generate a final reaction volume of 120 ⁇ L.
  • Step 3 Ligation of Universal Adaptors to Fragmented DNA Library
  • Universal Adaptors are comprised of double-stranded oligonucleotides that contain specific priming regions that afford both PCR amplification and nucleotide sequencing.
  • the Universal Adaptors are designed to include a set of unique PCR priming regions that are 20 base pairs in length located adjacent to a set of unique sequencing priming regions that are 20 base pairs in length, followed by a unique 4-base “key” consisting of one of each deoxyribonucleotide (i.e., A, C, G, T).
  • Each unique Universal Adaptor (termed “Universal Adaptor A” and “Universal Adaptor B”) is forty-four base pairs (44 bp) in length. Universal Adaptors are ligated, using T4 DNA ligase, onto each end of the DNA fragment to generate a total nucleotide addition of 88 bp to each DNA fragment. Different Universal Adaptors are designed specifically for each genomic DNA library preparation and will therefore provide a unique identifier for each organism.
  • Universal Adaptor DNA oligonucleotides are designed with two phosphorothioate linkages at each oligonucleotide end that serve to protect against nuclease activity (Samini, T. D., B. Jolles, and A. Laigle. 2001. Best minimally modified antisense oligonucleotides according to cell nuclease activity. Antisense Nucleic Acid Drug Dev . 11(3):129., the disclosure of which is incorporated in toto herein by reference.). Each oligonucleotide is HPLC-purified to ensure there are no contaminating or spurious DNA oligonucleotide sequences in the final prep.
  • the Universal Adaptors are designed to allow directional ligation to the blunt-ended, fragmented genomic DNA.
  • the PCR priming region contains a 5′ four-base overhang and a blunt-ended 3′ Key region.
  • Directionality is achieved as the blunt-end side of the Universal Adaptor ligates to the blunt-ended DNA fragment while the 5′ overhang of the adaptor cannot ligate to the blunt-ended DNA fragment.
  • a 5′ biotin is added to the Universal Adaptor B to allow subsequent isolation of ssDNA template (Step 8).
  • Each Universal Adaptor is prepared by annealing, in a single tube, the two single-stranded complementary DNA oligonucleotides (i.e., one oligo containing the sense sequence and the second oligo containing the antisense sequence). The following ligation protocol was used.
  • Step 3a Microcon Filtration and Adaptor Construction. Total Preparation Time was Approximately 25 min.
  • the Universal Adaptor ligation reaction requires a 100-fold excess of adaptors.
  • the double-stranded gDNA library is filtered through a Microcon YM-100 filter device.
  • Microcon YM-100 membranes can be used to remove double stranded DNA smaller than 125 bp. Therefore, unbound adaptors (44 bp), as well as adaptor dimers (88 bp) can be removed from the ligated gDNA library population. The following filtration protocol was used:
  • Adaptors were HPLC-purified and modified with phosphorothioate linkages prior to use.
  • Adaptor “A” (10 ⁇ M)
  • the primers were annealed using the ANNEAL program on the Sample Prep Labthermal cycler (see below).
  • Adaptor “B” (10 ⁇ M)
  • 10 ⁇ l of 100 ⁇ M Adaptor B 40 bp, sense
  • 10 ⁇ l of 100 ⁇ M Adaptor B 44 bp, antisense
  • the primers were annealed using the ANNEAL program on the Sample Prep Lab thermal cycler.
  • Adaptor sets could be stored at ⁇ 20° C. until use.
  • Step 4 Gel Electrophoresis and Extraction of Adapted DNA Library
  • the Universal Adaptor ligation protocol produces the following: 1) fragmented DNAs with adaptors on either end; 2) unbound single adaptors; or 3) the formation of adaptor dimers.
  • Agarose gel electrophoresis is used as a method to separate and isolate the adapted DNA library population from the unligated, single adaptors and adaptor dimer populations.
  • the procedure of DNase I digestion of genomic DNA yields a library population that ranges from 50-700 bp (Step 1).
  • the addition of the 88-bp Universal Adaptor set will shift the population to a larger size and will result in a migration profile in the size range of approximately 130-800 bp.
  • Adaptor dimers will migrate at 88 bp and adaptors unligated will migrate at 44 bp. Therefore, genomic DNA libraries in size ranges >200 bp can be physically isolated from the agarose gel and purified using standard gel extraction techniques. Gel isolation of the adapted DNA library will result in the recovery of a library population in a size range that is ⁇ 200 bp (size range of library can be varied depending on application). The following electrophoresis and extraction protocol was used.
  • Step 5 Strand Displacement and Extension of Nicked Double Stranded DNA Library
  • DNA oligonucleotides used for the Universal Adaptors are not phosphorylated, gaps are present at the 3′ junctions of the fragmented gDNAs. These two “gaps” or “nicks” can be filled in by using a strand displacing DNA polymerase.
  • the polymerase recognizes nicks, displaces the nicked strands, and extends the strand in a manner that results in repair of nicks and in the formation of non-nicked double-stranded DNA.
  • the strand displacing enzyme used is the large fragment of Bst DNA polymerase.
  • Step 7 Isolation of Single-Stranded DNA Library using Streptavidin Beads
  • Double-stranded genomic DNA fragment pools will have adaptors bound in the following possible configurations:
  • Genomic DNA species with two Universal Adaptor B sequences with two biotin molecules can bind to the streptavidin-containing beads at both ends.
  • Species with A and B adaptors having only a single biotin molecule can bind to the beads only at the “B” end.
  • the bead-bound double-stranded DNA is treated with a sodium hydroxide solution that serves to disrupt the hydrogen bonding between the complementary DNA strands. If the DNA fragment has biotin on each end (Universal Adaptor B ends), both resulting single strands remain bound to the beads. If the fragment has only a single biotin (Universal Adaptors A and B), then the complementary strand separates from the DNA-bead complex.
  • the resulting single-stranded genomic DNA library is collected from the solution phase and is quantitated, e.g., using pyrophosphate sequencing (PyroSequence) or by using a RNA Pico 6000 LabChip (Agilent, Palo Alto, Calif.).
  • Single-stranded genomic DNA libraries are quantitated by calculating the number of molecules per unit volume.
  • Single-stranded gDNA molecules are then annealed (at a half copy per bead to obtain one effective copy per bead) to 25-30 ⁇ m sepharose beads containing DNA capture primers (PCR primer B).
  • the templates are then amplified using emulsion polymerase chain reaction protocols. Subsequent sequencing may be conducted using known techniques. For isolation of the single stranded library, the following protocol was used.
  • Step 8a Single-Stranded gDNA Quantitation using Pyrophosphate Sequencing. Total Preparation Time was Approximately 1 hr.
  • Step 8b Single-Stranded gDNA Quantitation using RNA Pico 6000 LabChip. Total Preparation Time was Approximately 30 minutes.
  • RNA Pico 6000 LabChip was prepared on the BioAnalyzer according to the manufacturers' guidelines.
  • RNA LabChip ladder (RNA 6000 ladder) was prepared according to manufacturer's (Ambion) directions. Briefly, the RNA LabChip ladder, in solution, was heated to 70° C. for 2 minutes. The solution was chilled on ice for 5 minutes to snap cool the ladder. The solution was briefly centrifuged to clear any condensate from tube walls. The RNA LabChip Ladder was stored on ice and used within one day.
  • the BioAnalyzer software was used to calculate the concentration of each ssDNA library lane (see the Table below and FIG. 8. The average of all three lanes was used to calculate the DNA concentration of the library using the procedure outlined below.
  • the concentration of Library 1 was calculated as 1639 pg/ ⁇ l (Column 5) and the average fragment size was 434 nucleotides (Column 9). These values were obtained from the Agilent 2100 software as described in Steps (a)-(d), above.
  • the average molecular weight (MW) of a ribonucleotide is 328.2 g/mole (Column 10).
  • the MW of the average library fragment (1.42 ⁇ 10 5 g/mole, Column 11) was calculated by multiplying the average fragment length (434) by the average ribonucleotide (328.2).
  • the quantitated library (1639 pg/ ⁇ l) was converted to grams per microliter (1.64 ⁇ 10 ⁇ 9 g/ ⁇ l, Column 12).
  • the number of moles per microliter (1.15 ⁇ 10 ⁇ 14 moles/ ⁇ l, Column 14) was calculated by dividing the grams per microliter (1.64 ⁇ 10 ⁇ 9 g/ ⁇ l, Column 12) by the average molecular weight of the library fragments (1.42 ⁇ 10 5 , Column 11). Finally, the number of molecules per microliter (6.93 ⁇ 10 9 molecules/ ⁇ l, Column 15) was derived by multiplying the number of moles per microliter (1.15 ⁇ 10 ⁇ 14 moles/ ⁇ l, Column 14) by Avogadro's number (6.02 ⁇ 10 23 molecules/mole).
  • the final library concentration was expected to be greater than 1 ⁇ 10 8 molecules/ ⁇ l.
  • a more important factor for library quality was adaptor dimer concentration.
  • the height of the library peak was determined approximately 10 fold greater than the adaptor dimer peak (the first peak after the marker).
  • a library of good quality is expected to have a peak height at least 2 fold greater than the dimer peak.
  • the RNA Pico 6000 LabChip provided estimates within 500% accuracy of the single-stranded gDNA concentration.
  • the recommended input DNA is 2.5 cpb, 1 cpb, 0.5 cpb, and 0.1 cpb. This titration was easily checked using the 4slot bead loading chamber on a 14 ⁇ 43 PTP.
  • Step 9 Dilution and Storage of Single-Stranded gDNA Library
  • the single-stranded gDNA library was eluted and quantitated in Buffer EB. To prevent degradation, the single-stranded gDNA library was stored frozen at ⁇ 20° C. in the presence of EDTA. After quantitation, an equal volume of 10 mM TE was added to the library stock. All subsequent dilutions was in TE. The yield was as follows:
  • single-stranded gDNA library was diluted to 100 million molecules/ ⁇ l in 1 ⁇ Library-Grade Elution Buffer. Aliquots of single-stranded gDNA library were prepared for common use. For this, 200,000 molecules/ ⁇ l were diluted in 1 ⁇ Library-Grade Elution Buffer and 20 ⁇ l aliquots were measured. Single-use library aliquots were stored at ⁇ 20° C.
  • Step 10 Emulsion Polymerase Chain Reaction.
  • the Stop Solution (50 mM EDTA) included 100 ⁇ l of 0.5 M EDTA mixed with 900 ⁇ l of nH 2 O to obtain 1.0 ml of 50 mM EDTA solution.
  • 10 mM dNTPs (10 ⁇ l dCTP (100 mM), 10 ⁇ l DATP (100 mM), 10 ⁇ l dGTP (100 mM), and 10 ⁇ l dTTP (100 mM) were mixed with 60 ⁇ l molecular biology grade water. All four 100 mM nucleotide stocks were thawed on ice.
  • each nucleotide was combined with 60 ⁇ l of nH 2 O to a final volume of 100 ⁇ l, and mixed thoroughly. Next, 1 ml aliquots were dispensed into 1.5 ml microcentrifuge tubes. The stock solutions could be stored at ⁇ 20° C. for one year.
  • the 10 ⁇ Annealing buffer included 200 mM Tris (pH 7.5) and 50 mM magnesium acetate. For this solution, 24.23 g Tris was added to 800 ml nH 2 O and the mixture was adjusted to pH 7.5. To this solution, 10.72 g of magnesium acetate was added and dissolved completely. The solution was brought up to a final volume of 1000 ml and could be stored at 4° C. for 1 month.
  • the 10 ⁇ TE included 100 mM Tris-HCl (pH 7.5) and 50 mM EDTA. These reagents were added together and mixed thoroughly. The solution could be stored at room temperature for 6 months.
  • the universal adaptors are designed to include: 1) a set of unique PCR priming regions that are typically 20 bp in length (located adjacent to (2)); 2) a set of unique sequencing priming regions that are typically 20 bp in length; and 3) optionally followed by a unique discriminating key sequence consisting of at least one of each of the four deoxyribonucleotides (i.e., A, C, G, T).
  • a unique discriminating key sequence consisting of at least one of each of the four deoxyribonucleotides (i.e., A, C, G, T).
  • the single-stranded DNA library is utilized for PCR amplification and subsequent sequencing.
  • Sequencing methodology requires random digestion of a given genome into 150 to 500 base pair fragments, after which two unique bipartite primers (composed of both a PCR and sequencing region) are ligated onto the 5′ and 3′ ends of the fragments (FIG. 5).
  • T m melting temperature
  • the disclosed process utilizes synthetic priming sites that necessitates careful de novo primer design.
  • PCR/LDR work was particularly relevant and focused on designing oligonucleotide “zipcodes”, 24 base primers comprised of six specifically designed tetramers with a similar final T m . (see, Gerry, N. P., et al., Universal DNA microarray method for multiplex detection of low abundance point mutations. Journal of Molecular Biology, 1999. 292: p. 251-262; U.S. Pat. No. 6,506,594).
  • Tetrameric components were chosen based on the following criteria: each tetramer differed from the others by at least two bases, tetramers that induced self-pairing or hairpin formations were excluded, and palindromic (AGCT) or repetitive tetramers (TATA) were omitted as well. Thirty-six of the 256 (4 4 ) possible permutations met the necessary requirements and were then subjected to further restrictions required for acceptable PCR primer design (Table 1).
  • Table 1 shows a matrix demonstrating tetrameric primer component selection based on criteria outlined by Gerry et al. 1999 . J. Mol. Bio . 292: 251-262. Each tetramer was required to differ from all others by at least two bases. The tetramers could not be palindromic or complimentary with any other tetramer. Thirty-six tetramers were selected (bold, underlined); italicized sequences signal palindromic tetramers that were excluded from consideration.
  • PCR primers were designed to meet specifications common to general primer design (see, Rubin, E. and A. A. Levy, A mathematical model and a computerized simulation of PCR using complex templates. Nucleic Acids Res, 1996. 24(18): p. 3538-45; Buck, G. A., et al., Design strategies and performance of custom DNA sequencing primers. Biotechniques, 1999. 27(3): p. 528-36), and the actual selection was conducted by a computer program, MMP. Primers were limited to a length of 20 bases (5 tetramers) for efficient synthesis of the total bipartite PCR/sequencing primer.
  • Each primer contained a two base GC clamp on the 5′ end, and a single GC clamp on the 3′ end (Table 2), and all primers shared similar T m (+/ ⁇ 2° C.) (FIG. 10).
  • No hairpinning within the primer (internal hairpin stem ⁇ G> ⁇ 1.9 kcal/mol) was permitted.
  • Dimerization was also controlled; a 3 base maximum acceptable dimer was allowed, but it could occur in final six 3′ bases, and the maximum allowable ⁇ G for a 3′ dimer was ⁇ 2.0 kcal/mol. Additionally, a penalty was applied to primers in which the 3′ ends were too similar to others in the group, thus preventing cross-hybridization between one primer and the reverse complement of another.
  • Table 2 shows possible permutations of the 36 selected tetrads providing two 5′ and a single 3′ G/C clamp. The internal positions are composed of remaining tetrads. This results in 8 ⁇ 19 ⁇ 19 ⁇ 19 ⁇ 9 permutations, or 493,848 possible combinations.
  • FIG. 10 shows first pass, T m based selection of acceptable primers, reducing field of 493,848 primers to 56,246 candidates with T m of 64 to 66° C.
  • TABLE 3 The probability of perfect sequence matches for primers increases with decreasing match length requirements and increasing size of the genome of interest.
  • the probability of finding a 16 base perfect match is 97% for the sequences in the NCBI database (approximately 100 times larger than the Adenovirus genome).
  • the probability of finding a 17 base perfect match to a 20 base primer is 99% for the sequences in the human genome (3 billion bases).
  • the immobilized product would lack a sequencing primer binding site, and would result in an empty PicoTiter plate (PTP) well. If the CHR out-competed the bead-bound primer, the sequencing primer would still be present, and the only effect would be a shorter insert. Neither result would unduly compromise the sequencing quality. Given the large amount of genomic material used in the sample preparation process (currently 25 ⁇ g, containing 5.29 ⁇ 10 16 copies of the 35 Kb Adenovirus genome), oversampling can be used to provide fragments that lack the complete CHR, and allow standard PCR amplification of the region in question.
  • the purpose of the Nebulization step is to fragment a large stretch of DNA such as a whole genome or a large portion of a genome into smaller molecular species that are amenable to DNA sequencing.
  • This population of smaller-sized DNA species generated from a single DNA template is referred to as a library.
  • Nebulization shears double-stranded template DNA into fragments ranging from 50 to 900 base pairs.
  • the sheared library contains single-stranded ends that are end-repaired by a combination of T4 DNA polymerase, E. coli DNA polymerase I (Klenow fragment), and T4 polynucleotide kinase.
  • Both T4 and Klenow DNA polymerases are used to “fill-in” 3′ recessed ends (5′ overhangs) of DNA via their 5′-3′ polymerase activity.
  • the single-stranded 3′-5′ exonuclease activity of T4 and Klenow polymerases will remove 3′ overhang ends and the kinase activity of T4 polynucleotide kinase will add phosphates to 5′ hydroxyl termini.
  • gDNA genomic DNA
  • 10 mM TE 10 mM Tris, 0.1 mM EDTA, pH 7.6; see reagent list at the end of section.
  • the DNA was analyzed for contamination by measuring the O.D. 260/280 ratio, which was 1.8 or higher.
  • the final gDNA concentration was expected to be approximately 300 ⁇ g/ml.
  • reaction mixture was placed in an ice-cold nebulizer (CIS-US, Bedford, Mass.).
  • the recovered sample was purified using a QIAquick column (Qiagen Inc., Valencia, Calif.) according to manufacturer's directions. The large volume required the column to be loaded several times.
  • the sample was eluted with 30 ⁇ l of Buffer EB (10 mM Tris HCl, pH 8.5; supplied in Qiagen kit) which was pre-warmed at 55° C.
  • Nebulization of DNA templates yields many fragments of DNA with frayed ends. These ends are made blunt and ready for ligation to adaptor fragments by using three enzymes, T4 DNA polymerase, E. coli DNA polymerase (Klenow fragment) and T4 polynucleotide kinase.
  • step 2 The solution of step 1 was mixed well and incubated at 25° C. for 10 minutes in a MJ thermocycler (any accurate incubator may be used).
  • the treated DNA was purified using a QiaQuick column and eluted with 30 ⁇ l of Buffer EB (10 mM Tris HCl, pH 8.5) which was pre-warmed at 55° C.
  • genomic DNA libraries isolated in size ranges ⁇ 250 bp can be physically isolated from the agarose gel and purified using standard gel extraction techniques. Gel isolation of the adapted gDNA library will result in the recovery of a library population in a size range that is ⁇ 250 bp (size range of library can be varied depending on application).
  • the library size range after ligation of adapters is 130 to 980 bp. It should be noted that the procedure may be adapted for isolation of any band size range, such as, for example, 130 to 200 bp, 200 to 400 bp, 250 to 500 bp, 300 to 600 bp, 500 to 700 bp and the like by cutting different regions of the gel. The procedure described below was used to isolated fragments of 250 bp to 500 bp.
  • a 150 ml agarose gel was prepared to include 2% agarose, 1 ⁇ TBE, and 4.5 ⁇ l ethidium bromide (10 mg/ml stock).
  • the ligated DNA was mixed with 10 ⁇ Ready Load Dye and loaded onto the gel.
  • 10 ⁇ l of a 100-bp ladder (0.1 ⁇ g/ ⁇ l) was loaded on two lanes away from the ligation reaction flanking the sample.
  • the gel was electrophoresed at 100 V for 3 hours. When the gel run was complete, the gel was removed from the gel box, transferred to a GelDoc, and covered with plastic wrap.
  • the DNA bands were visualized using the Prep UV light.
  • the gel slices were placed in a 15 ml falcon tube.
  • the agarose-embedded gDNA library was isolated using a Qiagen MinElute Gel Extraction kit. Aliquots of each isolated gDNA library were analyzed using a BioAnalyzer DNA 1000 LabChip to assess the exact distribution of the gDNA library population.
  • PB from the QiaQuick Purification kit
  • 9 ⁇ l of 20% acetic acid were mixed.
  • the beads in 250 ⁇ l Melt Solution were pelleted using a Dynal MPC and the supernatant was carefully removed and transferred to the freshly prepared PB/acetic acid solution.
  • DNA from the 1500 ⁇ l solution was purified using a single MinElute purification spin column. This was performed by loading the sample through the same column twice at 750 ⁇ l per load.
  • the single stranded gDNA library was eluted with 15 ⁇ l of Buffer EB which was pre-warmed at 55° C.
  • Single-stranded gDNA was quantitated using RNA Pico 6000 LabChip as described in Example 1.
  • the single stranded library was quantitated by a second assay to ensure the initial Agilent 2100 quantitation was performed accurately.
  • RiboGreen quantitation was performed as described (ssDNA Quantitation by Fluorometry) to confirm the Agilent 2100 quantitation. If the two estimates differed by more than 3 fold, each analysis was repeated. If the quantitation showed greater than a 3 fold difference between the two procedures, a broader range of template to bead was used.
  • FIG. 9A Typical results from Agilent 2100 DNA 1000 LabChip analysis of 1 ⁇ l of the material following Nebulization and polishing are shown in FIG. 9A. The size range distribution of the majority of the product was expected to fall around 50 to 900 base pairs. The mean size (top of peak) was expected to be approximately 450 bp. Typical results from gel purification of adaptor ligated library fragments are shown in FIG. 9B.
  • reagents listed in the Examples represent standard reagents that are commercially available.
  • Klenow, T4 DNA polymerase, T4 DNA polymerase buffer, T4 PNK, T4 PNK buffer, Quick T4 DNA Ligase, Quick Ligation Buffer, Bst DNA polymerase (Large Fragment) and ThermoPol reaction buffer are available from New England Biolabs (Beverly, Mass.).
  • dNTP mix is available from Pierce (Rockford, Ill.).
  • Agarose, UltraPure TBE, BlueJuice gel loading buffer and Ready-Load 100 bp DNA ladder may be purchased from Invitrogen (Carlsbad, Calif.).
  • Ethidium Bromide and 2-Propanol may be purchased from Fisher (Hampton, N.H.).
  • RNA Ladder may be purchased from Ambion (Austin, Tex.).
  • Other reagents are either commonly known and/or are listed below:
  • Melt Solution Ingredient Quantity Required Vendor Stock Number NaCl (5 M) 200 ⁇ l Invitrogen 24740-011 NaOH (10 N) 125 ⁇ l Fisher SS255-1 molecular biology 9.675 ml Eppendorf 0032-006-205 grade water
  • the Melt Solution included 100 mM NaCl, and 125 mM NaOH. The listed reagents were combined and mixed thoroughly. The solution could be stored at RT for six months.
  • the 2 ⁇ B&W buffer included final concentrations of 10 mM Tris-HCl (pH 7.5), 1 mM EDTA, and 2 M NaCl.
  • the listed reagents were combined by combined and mixed thoroughly. The solution could be stored at RT for 6 months.
  • the 1 ⁇ B&W buffer was prepared by mixing 2 ⁇ B&W buffer with picopure H 2 O, 1:1. The final concentrations was half of that listed the above, i.e., 5 mM Tris-HCl (pH 7.5), 0.5 mM EDTA, and 1 M NaCl.
  • T4 DNA Polymerase Buffer 50 mM NaCl, 10 mM Tris-HCl, 10 mM MgCl 2 , 1 mM dithiothreitol (pH 7.9 @ 25° C.).
  • TE 10 mM Tris, 1 mM EDTA.
  • Nebulization Buffer Ingredient Quantity Required Vendor Stock Number Glycerol 53.1 ml Sigma G5516 molecular biology 42.1 ml Eppendorf 0032-006-205 grade water UltraPure Tris-HCl 3.7 ml Invitrogen 15567-027 (pH 7.5, 1M) EDTA (0.5M) 1.1 ml Sigma M-10228
  • ATP 10 mM: Ingredient Quantity Required Vendor Stock Number ATP (100 mM) 10 ⁇ l Roche 1140965 molecular biology 90 ⁇ l Eppendorf 0032-006-205 grade water
  • the 10 ⁇ Annealing Buffer included 200 mM Tris (pH 7.5) and 50 mM magnesium acetate.
  • 200 ml of Tris was added to 500 ml picopure H 2 O.
  • 10.72 g of magnesium acetate was added to the solution and dissolved completely.
  • the solution was adjusted to a final volume of 1000 ml.
  • the solution could be stored at 4° C. for six months. To avoid the potential for contamination of libraries, the buffer was aliquotted for single or short-term usage.
  • Adaptor “A” (400 ⁇ M): Quantity Ingredient Req. Vendor Stock No. Adaptor A (sense; HPLC- 10.0 ⁇ l IDT custom purified, phosphorothioate linkages, 44 bp, 1000 pmol/ ⁇ l) Adaptor A (antisense; HPLC- 10.0 ⁇ l IDT custom purified, Phosphorothioate linkages, 40 bp, 1000 pmol/ ⁇ l) Annealing buffer (10 ⁇ ) 2.5 ⁇ l 454 Corp. previous table molecular biology grade water 2.5 ⁇ l Eppendorf 0032-006-205
  • Adaptor “B” (400 ⁇ M): Quantity Ingredient Req. Vendor Stock No. Adaptor B (sense; HPLC- 10 ⁇ l IDT Custom purified, phosphorothioate linkages, 40 bp, 1000 pmol/ ⁇ l)) Adaptor B (anti; HPLC-purified, 10 ⁇ l IDT Custom phosphorothioate linkages, 5′Biotinylated, 44 bp, 1000 pmol/ ⁇ l) Annealing buffer (10X) 2.5 ⁇ l 454 Corp. previous table molecular biology grade water 2.5 ⁇ l Eppendorf 0032-006-205
  • Acetic Acid Quantity Ingredient Required Vendor Stock Number acetic acid, glacial 2 ml Fisher A35-500 molecular biology grade water 8 ml Eppendorf 0032-006-205
  • MinElute kit hypertext transfer protocol://world wide web.qiagen.com/literature/handbooks/minelute/1016839_HBMinElute_Prot_Gel.pdf.
  • BioAnalyzer DNA and RNA LabChip Usage (Agilent): hypertext transfer protocol://world wide web.agilent.com/chem/labonachip
  • BioAnalyzer RNA 6000 Ladder (Ambion): hypertext transfer protocol://world wide web.ambion.com/techlib/spec/sp — 7152.pdf

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Clinical Laboratory Science (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Hematology (AREA)
  • Plant Pathology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Optics & Photonics (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Colloid Chemistry (AREA)
US10/767,894 2003-01-29 2004-01-28 Method for preparing single-stranded DNA libraries Abandoned US20040185484A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US10/767,894 US20040185484A1 (en) 2003-01-29 2004-01-28 Method for preparing single-stranded DNA libraries
US12/154,901 US20090011959A1 (en) 2003-01-29 2008-05-27 Method for preparing single-stranded DNA libraries

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US44347103P 2003-01-29 2003-01-29
US46507103P 2003-04-23 2003-04-23
US47660203P 2003-06-06 2003-06-06
US47631303P 2003-06-06 2003-06-06
US47650403P 2003-06-06 2003-06-06
US47659203P 2003-06-06 2003-06-06
US49798503P 2003-08-25 2003-08-25
US10/767,894 US20040185484A1 (en) 2003-01-29 2004-01-28 Method for preparing single-stranded DNA libraries

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/154,901 Division US20090011959A1 (en) 2003-01-29 2008-05-27 Method for preparing single-stranded DNA libraries

Publications (1)

Publication Number Publication Date
US20040185484A1 true US20040185484A1 (en) 2004-09-23

Family

ID=32854649

Family Applications (15)

Application Number Title Priority Date Filing Date
US10/767,779 Active 2024-11-12 US7323305B2 (en) 2003-01-29 2004-01-28 Methods of amplifying and sequencing nucleic acids
US10/768,729 Expired - Fee Related US7244567B2 (en) 2003-01-29 2004-01-28 Double ended sequencing
US10/767,894 Abandoned US20040185484A1 (en) 2003-01-29 2004-01-28 Method for preparing single-stranded DNA libraries
US10/767,899 Active 2025-03-16 US7842457B2 (en) 2003-01-29 2004-01-28 Bead emulsion nucleic acid amplification
US11/788,838 Expired - Lifetime US8790876B2 (en) 2003-01-29 2007-04-20 Methods of amplifying and sequencing nucleic acids
US11/982,095 Expired - Lifetime US8012690B2 (en) 2003-01-29 2007-10-31 Bead emulsion nucleic acid amplification
US12/154,901 Abandoned US20090011959A1 (en) 2003-01-29 2008-05-27 Method for preparing single-stranded DNA libraries
US12/803,362 Expired - Lifetime US8158359B2 (en) 2003-01-29 2010-06-24 Methods of amplifying and sequencing nucleic acids
US13/033,240 Active 2026-01-22 US8748102B2 (en) 2003-01-29 2011-02-23 Bead emulsion nucleic acid amplification
US13/419,241 Abandoned US20120238475A1 (en) 2003-01-29 2012-03-13 Methods of Amplifying and Sequencing Nucleic Acids
US13/618,334 Expired - Lifetime US8765380B2 (en) 2003-01-29 2012-09-14 Bead emulsion nucleic acid amplification
US14/036,398 Abandoned US20140162885A1 (en) 2003-01-29 2013-09-25 Bead Emulsion Nucleic Acid Amplification
US14/518,700 Abandoned US20150099672A1 (en) 2003-01-29 2014-10-20 Bead emulsion nucleic acid amplification
US15/190,886 Expired - Lifetime US10240192B2 (en) 2003-01-29 2016-06-23 Bead emulsion nucleic acid amplification
US16/249,681 Expired - Lifetime US10982274B2 (en) 2003-01-29 2019-01-16 Bead emulsion nucleic acid amplification

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US10/767,779 Active 2024-11-12 US7323305B2 (en) 2003-01-29 2004-01-28 Methods of amplifying and sequencing nucleic acids
US10/768,729 Expired - Fee Related US7244567B2 (en) 2003-01-29 2004-01-28 Double ended sequencing

Family Applications After (12)

Application Number Title Priority Date Filing Date
US10/767,899 Active 2025-03-16 US7842457B2 (en) 2003-01-29 2004-01-28 Bead emulsion nucleic acid amplification
US11/788,838 Expired - Lifetime US8790876B2 (en) 2003-01-29 2007-04-20 Methods of amplifying and sequencing nucleic acids
US11/982,095 Expired - Lifetime US8012690B2 (en) 2003-01-29 2007-10-31 Bead emulsion nucleic acid amplification
US12/154,901 Abandoned US20090011959A1 (en) 2003-01-29 2008-05-27 Method for preparing single-stranded DNA libraries
US12/803,362 Expired - Lifetime US8158359B2 (en) 2003-01-29 2010-06-24 Methods of amplifying and sequencing nucleic acids
US13/033,240 Active 2026-01-22 US8748102B2 (en) 2003-01-29 2011-02-23 Bead emulsion nucleic acid amplification
US13/419,241 Abandoned US20120238475A1 (en) 2003-01-29 2012-03-13 Methods of Amplifying and Sequencing Nucleic Acids
US13/618,334 Expired - Lifetime US8765380B2 (en) 2003-01-29 2012-09-14 Bead emulsion nucleic acid amplification
US14/036,398 Abandoned US20140162885A1 (en) 2003-01-29 2013-09-25 Bead Emulsion Nucleic Acid Amplification
US14/518,700 Abandoned US20150099672A1 (en) 2003-01-29 2014-10-20 Bead emulsion nucleic acid amplification
US15/190,886 Expired - Lifetime US10240192B2 (en) 2003-01-29 2016-06-23 Bead emulsion nucleic acid amplification
US16/249,681 Expired - Lifetime US10982274B2 (en) 2003-01-29 2019-01-16 Bead emulsion nucleic acid amplification

Country Status (10)

Country Link
US (15) US7323305B2 (fr)
EP (8) EP2145955B1 (fr)
JP (9) JP4768598B2 (fr)
CN (2) CN102212614B (fr)
AT (4) ATE461291T1 (fr)
AU (4) AU2004209001B2 (fr)
CA (6) CA2513899C (fr)
DE (4) DE602004036672C5 (fr)
ES (5) ES2396245T3 (fr)
WO (4) WO2004069849A2 (fr)

Cited By (171)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030096268A1 (en) * 2001-07-06 2003-05-22 Michael Weiner Method for isolation of independent, parallel chemical micro-reactions using a porous filter
US20040056018A1 (en) * 2001-09-25 2004-03-25 Beru Ag Method for operating a multi-stage electrical heater comprised of several heating elements
WO2005010145A3 (fr) * 2003-07-05 2005-08-11 Univ Johns Hopkins Procede et compositions de detection et d'enumeration de variations genetiques
US20060110764A1 (en) * 2004-10-25 2006-05-25 Tom Tang Large-scale parallelized DNA sequencing
US20060121470A1 (en) * 2002-08-01 2006-06-08 Henrik Pedersen Multi-step synthesis of templated molecules
US20060269934A1 (en) * 2005-03-16 2006-11-30 Applera Corporation Compositions and methods for clonal amplification and analysis of polynucleotides
US20060292603A1 (en) * 2002-10-30 2006-12-28 Gouliaev Alex H Method for selecting a chemical entity from a tagged library
US20070031865A1 (en) * 2005-07-07 2007-02-08 David Willoughby Novel Process for Construction of a DNA Library
US20070039866A1 (en) * 2005-08-22 2007-02-22 Schroeder Benjamin G Device, system, and method for depositing processed immiscible-fluid-discrete-volumes
US20070117121A1 (en) * 2005-09-16 2007-05-24 Hutchison Stephen K cDNA library preparation
US20070172839A1 (en) * 2006-01-24 2007-07-26 Smith Douglas R Asymmetrical adapters and methods of use thereof
US20070231823A1 (en) * 2006-03-23 2007-10-04 Mckernan Kevin J Directed enrichment of genomic DNA for high-throughput sequencing
US20080132693A1 (en) * 2003-01-29 2008-06-05 Jan Berka Bead emulsion nucleic acid amplification
US20080145898A1 (en) * 2006-12-14 2008-06-19 Applera Corporation Sequencing methods
US20080193983A1 (en) * 2002-12-19 2008-08-14 Nuevolution A/S Quasirandom Structure and Function Guided Synthesis Methods
US20080305957A1 (en) * 2003-09-18 2008-12-11 Thomas Thisted Method for Obtaining Structural Information Concerning an Encoded Molecule and Method for Selecting Compounds
US20090053724A1 (en) * 2007-06-28 2009-02-26 454 Life Sciences Corporation System and method for adaptive reagent control in nucleic acid sequencing
US20090105959A1 (en) * 2007-06-01 2009-04-23 Braverman Michael S System and method for identification of individual samples from a multiplex mixture
US20090203086A1 (en) * 2008-02-06 2009-08-13 454 Life Sciences Corporation System and method for improved signal detection in nucleic acid sequencing
US20090233291A1 (en) * 2005-06-06 2009-09-17 454 Life Sciences Corporation Paired end sequencing
US20090239211A1 (en) * 2004-02-17 2009-09-24 Nuevolution A/S Method For Enrichment Involving Elimination By Mismatch Hybridisation
US7604940B1 (en) 2005-03-16 2009-10-20 Applied Biosystems, Llc Compositions and methods for analyzing isolated polynucleotides
US20090318298A1 (en) * 2006-09-28 2009-12-24 President And Fellows Of Harvard College Methods for Sequencing DNA
US20100016177A1 (en) * 2001-06-20 2010-01-21 Henrik Pedersen Templated molecules and methods for using such molecules
US20100137143A1 (en) * 2008-10-22 2010-06-03 Ion Torrent Systems Incorporated Methods and apparatus for measuring analytes
US20100136557A1 (en) * 2007-06-29 2010-06-03 Sydney Brenner Methods and Compositions for Isolating Nucleic Acid Sequence Variants
US20100143908A1 (en) * 2006-11-15 2010-06-10 Biospherex, Llc, A Limited Liability Company Multitag sequencing ecogenomics analysis-us
USRE41780E1 (en) 2003-03-14 2010-09-28 Lawrence Livermore National Security, Llc Chemical amplification based on fluid partitioning in an immiscible liquid
US20100261189A1 (en) * 2008-10-03 2010-10-14 Roche Molecular Systems, Inc. System and method for detection of HLA Variants
US20100282617A1 (en) * 2006-12-14 2010-11-11 Ion Torrent Systems Incorporated Methods and apparatus for detecting molecular interactions using fet arrays
US20100301398A1 (en) * 2009-05-29 2010-12-02 Ion Torrent Systems Incorporated Methods and apparatus for measuring analytes
US7888034B2 (en) 2008-07-01 2011-02-15 454 Life Sciences Corporation System and method for detection of HIV tropism variants
US20110039303A1 (en) * 2007-02-05 2011-02-17 Stevan Bogdan Jovanovich Microfluidic and nanofluidic devices, systems, and applications
WO2011042189A1 (fr) 2009-10-09 2011-04-14 Roche Diagnostics Gmbh Système et procédé pour la rupture d'émulsion et la récupération d'éléments biologiques
US7948015B2 (en) 2006-12-14 2011-05-24 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
US20110126911A1 (en) * 2009-12-01 2011-06-02 IntegenX Inc., a California Corporation Composite Plastic Articles
US20110177587A1 (en) * 2004-01-28 2011-07-21 454 Corporation Nucleic acid amplification with continuous flow emulsion
US20110217738A1 (en) * 2010-03-03 2011-09-08 Gen9, Inc. Methods and Devices for Nucleic Acid Synthesis
WO2011056872A3 (fr) * 2009-11-03 2011-11-03 Gen9, Inc. Procédés et dispositifs microfluidiques pour la manipulation de gouttelettes dans un ensemble polynucléotidique haute fidélité
WO2011106314A3 (fr) * 2010-02-25 2012-02-23 Advanced Liquid Logic, Inc. Procédé de fabrication de banques d'acide nucléique
US20120135871A1 (en) * 2006-04-04 2012-05-31 Keygene N.V. High throughput detection of molecular markers based on aflp and high through-put sequencing
US8217433B1 (en) 2010-06-30 2012-07-10 Life Technologies Corporation One-transistor pixel array
US8262900B2 (en) 2006-12-14 2012-09-11 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
WO2012130681A1 (fr) 2011-03-25 2012-10-04 Roche Diagnostics Gmbh Système et procédé de détection de variants de l'intégrase du vih
US8388908B2 (en) 2009-06-02 2013-03-05 Integenx Inc. Fluidic devices with diaphragm valves
US8394642B2 (en) 2009-06-05 2013-03-12 Integenx Inc. Universal sample preparation system and use in an integrated analysis system
US8431390B2 (en) 2004-09-15 2013-04-30 Integenx Inc. Systems of sample processing having a macro-micro interface
EP2599877A1 (fr) * 2010-06-30 2013-06-05 BGI Shenzhen Co., Limited Nouvelle méthode de séquençage par pcr et son utilisation dans le génotypage hla
US8470164B2 (en) 2008-06-25 2013-06-25 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
US8476063B2 (en) 2004-09-15 2013-07-02 Integenx Inc. Microfluidic devices
US8512538B2 (en) 2010-05-28 2013-08-20 Integenx Inc. Capillary electrophoresis device
US8552771B1 (en) 2012-05-29 2013-10-08 Life Technologies Corporation System for reducing noise in a chemical sensor array
US20130309668A1 (en) * 2004-03-08 2013-11-21 Rubicon Genomics, Inc. Methods and compositions for generating and amplifying dna libraries for sensitive detection and analysis of dna methylation
US8653567B2 (en) 2010-07-03 2014-02-18 Life Technologies Corporation Chemically sensitive sensor with lightly doped drains
US8673627B2 (en) 2009-05-29 2014-03-18 Life Technologies Corporation Apparatus and methods for performing electrochemical reactions
US8672532B2 (en) 2008-12-31 2014-03-18 Integenx Inc. Microfluidic methods
WO2014043140A1 (fr) * 2012-09-12 2014-03-20 The Regents Of The University Of California Séquençage précis du génome de cellules individuelles par l'amplification et le séquençage d'un seul brin
US8685324B2 (en) 2010-09-24 2014-04-01 Life Technologies Corporation Matched pair transistor circuits
GB2497912B (en) * 2010-10-08 2014-06-04 Harvard College High-throughput single cell barcoding
US8747748B2 (en) 2012-01-19 2014-06-10 Life Technologies Corporation Chemical sensor with conductive cup-shaped sensor surface
US8748165B2 (en) 2008-01-22 2014-06-10 Integenx Inc. Methods for generating short tandem repeat (STR) profiles
US8753812B2 (en) 2004-11-12 2014-06-17 The Board Of Trustees Of The Leland Stanford Junior University Charge perturbation detection method for DNA and other molecules
WO2014068407A3 (fr) * 2012-10-26 2014-06-26 Sysmex Corporation Systèmes d'émulsion et amplification à base d'émulsion d'acide nucléique
US8763642B2 (en) 2010-08-20 2014-07-01 Integenx Inc. Microfluidic devices with mechanically-sealed diaphragm valves
US8776573B2 (en) 2009-05-29 2014-07-15 Life Technologies Corporation Methods and apparatus for measuring analytes
US8808984B2 (en) 2002-03-15 2014-08-19 Neuvolution A/S Method for synthesising templated molecules
US8808986B2 (en) 2008-08-27 2014-08-19 Gen9, Inc. Methods and devices for high fidelity polynucleotide synthesis
US8815512B2 (en) 2005-12-22 2014-08-26 Keygene N.V. Method for high-throughput AFLP-based polymorphism detection
US8821798B2 (en) 2012-01-19 2014-09-02 Life Technologies Corporation Titanium nitride as sensing layer for microwell structure
US8841217B1 (en) 2013-03-13 2014-09-23 Life Technologies Corporation Chemical sensor with protruded sensor surface
US8858782B2 (en) 2010-06-30 2014-10-14 Life Technologies Corporation Ion-sensing charge-accumulation circuits and methods
US8963216B2 (en) 2013-03-13 2015-02-24 Life Technologies Corporation Chemical sensor with sidewall spacer sensor surface
US8962366B2 (en) 2013-01-28 2015-02-24 Life Technologies Corporation Self-aligned well structures for low-noise chemical sensors
EP2840148A1 (fr) 2013-08-23 2015-02-25 F. Hoffmann-La Roche AG Procédé et système pour l'amplification d'acides nucléiques
EP2848698A1 (fr) 2013-08-26 2015-03-18 F. Hoffmann-La Roche AG Système et méthode pour une amplification automatisée dacide nucléique
US9080968B2 (en) 2013-01-04 2015-07-14 Life Technologies Corporation Methods and systems for point of use removal of sacrificial material
US20150197789A1 (en) * 2006-02-08 2015-07-16 Illumina Cambridge Limited End modification to prevent over-representation of fragments
US9096951B2 (en) 2003-02-21 2015-08-04 Nuevolution A/S Method for producing second-generation library
US9109251B2 (en) 2004-06-25 2015-08-18 University Of Hawaii Ultrasensitive biosensors
US9116117B2 (en) 2013-03-15 2015-08-25 Life Technologies Corporation Chemical sensor with sidewall sensor surface
US9121058B2 (en) 2010-08-20 2015-09-01 Integenx Inc. Linear valve arrays
US9128044B2 (en) 2013-03-15 2015-09-08 Life Technologies Corporation Chemical sensors with consistent sensor surface areas
US9217144B2 (en) 2010-01-07 2015-12-22 Gen9, Inc. Assembly of high fidelity polynucleotides
US9216414B2 (en) 2009-11-25 2015-12-22 Gen9, Inc. Microfluidic devices and methods for gene synthesis
US9376716B2 (en) 2005-06-23 2016-06-28 Keygene N.V. Strategies for high throughput identification and detection of polymorphisms
US9422600B2 (en) 2009-11-25 2016-08-23 Gen9, Inc. Methods and apparatuses for chip-based DNA error reduction
WO2016160965A1 (fr) * 2015-03-30 2016-10-06 Rubicon Genomics, Inc. Procédés et compositions permettant la réparation des extrémités de l'adn par de multiples activités enzymatiques
US9464318B2 (en) * 2015-02-11 2016-10-11 Paragon Genomics, Inc. Methods and compositions for reducing non-specific amplification products
US9486757B2 (en) 2009-03-13 2016-11-08 President And Fellows Of Harvard College Scale-up of microfluidic devices
US9513253B2 (en) 2011-07-11 2016-12-06 Advanced Liquid Logic, Inc. Droplet actuators and techniques for droplet-based enzymatic assays
US9574189B2 (en) 2005-12-01 2017-02-21 Nuevolution A/S Enzymatic encoding methods for efficient synthesis of large libraries
US9618475B2 (en) 2010-09-15 2017-04-11 Life Technologies Corporation Methods and apparatus for measuring analytes
US9671363B2 (en) 2013-03-15 2017-06-06 Life Technologies Corporation Chemical sensor with consistent sensor surface areas
EP3175914A1 (fr) * 2004-01-07 2017-06-07 Illumina Cambridge Limited Perfectionnements apportés ou se rapportant à des réseaux moléculaires
US9752176B2 (en) 2011-06-15 2017-09-05 Ginkgo Bioworks, Inc. Methods for preparative in vitro cloning
US9816088B2 (en) 2013-03-15 2017-11-14 Abvitro Llc Single cell bar-coding for antibody discovery
US9823217B2 (en) 2013-03-15 2017-11-21 Life Technologies Corporation Chemical device with thin conductive element
US9835585B2 (en) 2013-03-15 2017-12-05 Life Technologies Corporation Chemical sensor with protruded sensor surface
US9841398B2 (en) 2013-01-08 2017-12-12 Life Technologies Corporation Methods for manufacturing well structures for low-noise chemical sensors
WO2018049260A1 (fr) * 2016-09-09 2018-03-15 Tl Biolabs Corp . Compositions de microréseau réutilisables et procédés
EP3208343A4 (fr) * 2014-10-13 2018-03-21 BGI Shenzhen Co., Limited Procédé de fragmentation d'acide nucléique et combinaison de séquences
US20180080020A1 (en) * 2006-01-11 2018-03-22 Raindance Technologies, Inc. Microfluidic devices and methods of use in the formation and control of nanoreactors
US9951384B2 (en) 2012-01-13 2018-04-24 Data2Bio Genotyping by next-generation sequencing
US9970984B2 (en) 2011-12-01 2018-05-15 Life Technologies Corporation Method and apparatus for identifying defects in a chemical sensor array
US20180148767A1 (en) * 2015-05-29 2018-05-31 Epicentre Technologies Corporation Methods of analyzing nucleic acids
US10077472B2 (en) 2014-12-18 2018-09-18 Life Technologies Corporation High data rate integrated circuit with power management
US10081807B2 (en) 2012-04-24 2018-09-25 Gen9, Inc. Methods for sorting nucleic acids and multiplexed preparative in vitro cloning
CN108588200A (zh) * 2018-05-06 2018-09-28 湖南大地同年生物科技有限公司 一种R-Loop高通量测序文库构建方法
WO2018186930A1 (fr) * 2017-04-06 2018-10-11 MyOmicsDx, Inc Procédé et kit de construction d'une bibliothèque d'acides nucléiques
US10100358B2 (en) 2017-01-10 2018-10-16 Paragon Genomics, Inc. Methods and compositions for reducing redundant molecular barcodes created in primer extension reactions
US10100357B2 (en) 2013-05-09 2018-10-16 Life Technologies Corporation Windowed sequencing
EP3259372A4 (fr) * 2015-02-17 2018-11-07 Complete Genomics, Inc. Séquençage de l'adn à l'aide d'un déplacement de brin régulé
US10192024B2 (en) 2012-05-18 2019-01-29 454 Life Sciences Corporation System and method for generation and use of optimal nucleotide flow orders
US10191071B2 (en) 2013-11-18 2019-01-29 IntegenX, Inc. Cartridges and instruments for sample analysis
US10202608B2 (en) 2006-08-31 2019-02-12 Gen9, Inc. Iterative nucleic acid assembly using activation of vector-encoded traits
US10208332B2 (en) 2014-05-21 2019-02-19 Integenx Inc. Fluidic cartridge with valve mechanism
US10233494B2 (en) 2005-09-29 2019-03-19 Keygene N.V. High throughput screening of populations carrying naturally occurring mutations
US10308931B2 (en) 2012-03-21 2019-06-04 Gen9, Inc. Methods for screening proteins using DNA encoded chemical libraries as templates for enzyme catalysis
CN109853047A (zh) * 2019-04-10 2019-06-07 翌圣生物科技（上海）有限公司 一种基因组dna测序文库快速构建方法及配套试剂盒
US10316364B2 (en) 2005-09-29 2019-06-11 Keygene N.V. Method for identifying the source of an amplicon
US10344336B2 (en) 2015-06-09 2019-07-09 Life Technologies Corporation Methods, systems, compositions, kits, apparatus and computer-readable media for molecular tagging
CN110062809A (zh) * 2016-12-20 2019-07-26 豪夫迈·罗氏有限公司 用于环状共有序列测序的单链环状dna文库
US10379079B2 (en) 2014-12-18 2019-08-13 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
US10421993B2 (en) 2015-02-11 2019-09-24 Paragon Genomics, Inc. Methods and compositions for reducing non-specific amplification products
US10451585B2 (en) 2009-05-29 2019-10-22 Life Technologies Corporation Methods and apparatus for measuring analytes
US10457935B2 (en) 2010-11-12 2019-10-29 Gen9, Inc. Protein arrays and methods of using and making the same
US10458942B2 (en) 2013-06-10 2019-10-29 Life Technologies Corporation Chemical sensor array having multiple sensors per well
US10525467B2 (en) 2011-10-21 2020-01-07 Integenx Inc. Sample preparation, processing and analysis systems
US10590483B2 (en) 2014-09-15 2020-03-17 Abvitro Llc High-throughput nucleotide library sequencing
US10605767B2 (en) 2014-12-18 2020-03-31 Life Technologies Corporation High data rate integrated circuit with transmitter configuration
US10612017B2 (en) 2009-05-29 2020-04-07 Life Technologies Corporation Scaffolded nucleic acid polymer particles and methods of making and using
CN111133135A (zh) * 2017-07-17 2020-05-08 希昆斯生物科学公司 用于高通量测序的快速文库构建
US10690627B2 (en) 2014-10-22 2020-06-23 IntegenX, Inc. Systems and methods for sample preparation, processing and analysis
CN111455469A (zh) * 2020-04-07 2020-07-28 深圳易倍科华生物科技有限公司 一种单链快速建库方法及建库仪器
US10865440B2 (en) 2011-10-21 2020-12-15 IntegenX, Inc. Sample preparation, processing and analysis systems
US10941453B1 (en) 2020-05-20 2021-03-09 Paragon Genomics, Inc. High throughput detection of pathogen RNA in clinical specimens
US10960397B2 (en) 2007-04-19 2021-03-30 President And Fellows Of Harvard College Manipulation of fluids, fluid components and reactions in microfluidic systems
EP2971168B1 (fr) 2013-03-15 2021-05-05 Guardant Health, Inc. Méthodes pour détecter cancer
US11072789B2 (en) 2012-06-25 2021-07-27 Gen9, Inc. Methods for nucleic acid assembly and high throughput sequencing
US11077415B2 (en) 2011-02-11 2021-08-03 Bio-Rad Laboratories, Inc. Methods for forming mixed droplets
US11084014B2 (en) 2010-11-12 2021-08-10 Gen9, Inc. Methods and devices for nucleic acids synthesis
EP3901273A1 (fr) * 2012-08-14 2021-10-27 10X Genomics, Inc. Compositions de microcapsule et procédés
US11168353B2 (en) 2011-02-18 2021-11-09 Bio-Rad Laboratories, Inc. Compositions and methods for molecular labeling
US11174509B2 (en) 2013-12-12 2021-11-16 Bio-Rad Laboratories, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample
US11187702B2 (en) 2003-03-14 2021-11-30 Bio-Rad Laboratories, Inc. Enzyme quantification
US11193121B2 (en) 2013-02-08 2021-12-07 10X Genomics, Inc. Partitioning and processing of analytes and other species
US11231451B2 (en) 2010-06-30 2022-01-25 Life Technologies Corporation Methods and apparatus for testing ISFET arrays
US11254968B2 (en) 2010-02-12 2022-02-22 Bio-Rad Laboratories, Inc. Digital analyte analysis
US11307166B2 (en) 2010-07-01 2022-04-19 Life Technologies Corporation Column ADC
US11339430B2 (en) 2007-07-10 2022-05-24 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
US11351510B2 (en) 2006-05-11 2022-06-07 Bio-Rad Laboratories, Inc. Microfluidic devices
US11359239B2 (en) 2012-08-14 2022-06-14 10X Genomics, Inc. Methods and systems for processing polynucleotides
US11390917B2 (en) 2010-02-12 2022-07-19 Bio-Rad Laboratories, Inc. Digital analyte analysis
US11421274B2 (en) 2012-12-14 2022-08-23 10X Genomics, Inc. Methods and systems for processing polynucleotides
US11434531B2 (en) 2013-12-28 2022-09-06 Guardant Health, Inc. Methods and systems for detecting genetic variants
US11434523B2 (en) 2012-09-04 2022-09-06 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
US11441179B2 (en) 2012-08-14 2022-09-13 10X Genomics, Inc. Methods and systems for processing polynucleotides
US11473138B2 (en) 2012-12-14 2022-10-18 10X Genomics, Inc. Methods and systems for processing polynucleotides
US11511242B2 (en) 2008-07-18 2022-11-29 Bio-Rad Laboratories, Inc. Droplet libraries
US11591637B2 (en) 2012-08-14 2023-02-28 10X Genomics, Inc. Compositions and methods for sample processing
US11629344B2 (en) 2014-06-26 2023-04-18 10X Genomics, Inc. Methods and systems for processing polynucleotides
US11635427B2 (en) 2010-09-30 2023-04-25 Bio-Rad Laboratories, Inc. Sandwich assays in droplets
US11667952B2 (en) 2017-08-24 2023-06-06 Takara Bio Usa, Inc. Methods of producing nucleic acids using oligonucleotides modified by a stimulus
US11680293B1 (en) 2022-04-21 2023-06-20 Paragon Genomics, Inc. Methods and compositions for amplifying DNA and generating DNA sequencing results from target-enriched DNA molecules
US11702662B2 (en) 2011-08-26 2023-07-18 Gen9, Inc. Compositions and methods for high fidelity assembly of nucleic acids
US11786872B2 (en) 2004-10-08 2023-10-17 United Kingdom Research And Innovation Vitro evolution in microfluidic systems
WO2023175040A3 (fr) * 2022-03-15 2023-11-02 Illumina, Inc. Séquençage simultané de brins complémentaires sens et antisens sur des polynucléotides concaténés pour la détection de méthylation
US11819849B2 (en) 2007-02-06 2023-11-21 Brandeis University Manipulation of fluids and reactions in microfluidic systems
US11898193B2 (en) 2011-07-20 2024-02-13 Bio-Rad Laboratories, Inc. Manipulating droplet size
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification
US11913065B2 (en) 2012-09-04 2024-02-27 Guardent Health, Inc. Systems and methods to detect rare mutations and copy number variation

Families Citing this family (972)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7622294B2 (en) 1997-03-14 2009-11-24 Trustees Of Tufts College Methods for detecting target analytes and enzymatic reactions
US20030027126A1 (en) 1997-03-14 2003-02-06 Walt David R. Methods for detecting target analytes and enzymatic reactions
DE69826697T2 (de) 1997-07-07 2006-02-16 Medical Research Council In vitro selektionsmethode
GB9900298D0 (en) * 1999-01-07 1999-02-24 Medical Res Council Optical sorting method
CA2290731A1 (fr) * 1999-11-26 2001-05-26 D. Jed Harrison Appareil et methode de piegeage de reactifs en forme de perles, dans le cadre d'un systeme d'analyse de microfluides
US6432290B1 (en) 1999-11-26 2002-08-13 The Governors Of The University Of Alberta Apparatus and method for trapping bead based reagents within microfluidic analysis systems
ATE455186T1 (de) * 2000-06-26 2010-01-15 Nugen Technologies Inc Methoden und zusammensetzungen zur auf transkription basierenden vervielfältigung von nukleinsäuren
US7846733B2 (en) 2000-06-26 2010-12-07 Nugen Technologies, Inc. Methods and compositions for transcription-based nucleic acid amplification
DE60142709D1 (de) 2000-12-13 2010-09-09 Nugen Technologies Inc Methoden und zusammensetzungen zur generierung einer vielzahl von kopien von nukleinsäuresequenzen und methoden zur detektion derselben
WO2002072772A2 (fr) 2001-03-09 2002-09-19 Nugen Technologies, Inc. Procedes et compositions permettant l'amplification de sequences d'arn
US20030108664A1 (en) * 2001-10-05 2003-06-12 Kodas Toivo T. Methods and compositions for the formation of recessed electrical features on a substrate
WO2003035824A1 (fr) * 2001-10-25 2003-05-01 Bar-Ilan University Processeur de biopuces transparentes interactives pour cellules individuelles
GB0127564D0 (en) * 2001-11-16 2002-01-09 Medical Res Council Emulsion compositions
US20030217923A1 (en) * 2002-05-24 2003-11-27 Harrison D. Jed Apparatus and method for trapping bead based reagents within microfluidic analysis systems
US7595883B1 (en) 2002-09-16 2009-09-29 The Board Of Trustees Of The Leland Stanford Junior University Biological analysis arrangement and approach therefor
US8791053B2 (en) * 2002-09-27 2014-07-29 Mpm-Holding Aps Spatially encoded polymer matrix
KR101216828B1 (ko) * 2002-12-30 2013-01-04 더 리전트 오브 더 유니버시티 오브 캘리포니아 병원균 검출과 분석을 위한 방법과 기구
US7575865B2 (en) * 2003-01-29 2009-08-18 454 Life Sciences Corporation Methods of amplifying and sequencing nucleic acids
CA2555962C (fr) 2003-02-26 2015-10-06 Callida Genomics, Inc. Analyse de reseau d'adn aleatoire par hybridation
IL154677A0 (en) * 2003-02-27 2003-09-17 Univ Bar Ilan A method and apparatus for manipulating an individual cell
GB0307403D0 (en) 2003-03-31 2003-05-07 Medical Res Council Selection by compartmentalised screening
GB0307428D0 (en) 2003-03-31 2003-05-07 Medical Res Council Compartmentalised combinatorial chemistry
US20060078893A1 (en) * 2004-10-12 2006-04-13 Medical Research Council Compartmentalised combinatorial chemistry by microfluidic control
JP2006523465A (ja) 2003-04-14 2006-10-19 ニューゲン テクノロジーズ， インコーポレイテッド ランダムにプライミングされる複合プライマーを用いる大規模増幅
FR2856498B1 (fr) * 2003-06-19 2005-09-30 Goulven Jean Alain Vernois Distribution sous atmosphere controlee
US8597597B2 (en) * 2003-06-26 2013-12-03 Seng Enterprises Ltd. Picoliter well holding device and method of making the same
US9200245B2 (en) 2003-06-26 2015-12-01 Seng Enterprises Ltd. Multiwell plate
US7888110B2 (en) * 2003-06-26 2011-02-15 Seng Enterprises Ltd. Pico liter well holding device and method of making the same
WO2005028110A2 (fr) * 2003-09-19 2005-03-31 Applera Corporation Microplaques utilisees pour effectuer une amplification nucleotidique par cyclage thermique
WO2005054431A2 (fr) * 2003-12-01 2005-06-16 454 Corporation Procede permettant d'isoler des micro-reactions chimiques paralleles independantes au moyen d'un filtre poreux
US7972994B2 (en) 2003-12-17 2011-07-05 Glaxosmithkline Llc Methods for synthesis of encoded libraries
US20050221339A1 (en) 2004-03-31 2005-10-06 Medical Research Council Harvard University Compartmentalised screening by microfluidic control
US7622281B2 (en) 2004-05-20 2009-11-24 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for clonal amplification of nucleic acid
WO2005118773A2 (fr) 2004-05-28 2005-12-15 Wafergen, Inc. Appareil et procedes pour effectuer des analyses multiplex
US7799553B2 (en) 2004-06-01 2010-09-21 The Regents Of The University Of California Microfabricated integrated DNA analysis system
US7264934B2 (en) * 2004-06-10 2007-09-04 Ge Healthcare Bio-Sciences Corp. Rapid parallel nucleic acid analysis
WO2006003664A1 (fr) * 2004-07-07 2006-01-12 Seng Enterprises Ltd. Procede et dispositif d'identification d'une image d'un puits dans une image de composant porteur de puits
EP1781404A2 (fr) * 2004-08-25 2007-05-09 Seng Enterprises Limited Procede et dispositif destines a isoler des cellules
US7485451B2 (en) * 2004-11-18 2009-02-03 Regents Of The University Of California Storage stable compositions of biological materials
BRPI0515777A (pt) * 2004-12-11 2008-08-05 Cytogenix Inc biossìntese isenta de células de ácido nucléico de alta qualidade e usos dos mesmos
US8038964B2 (en) * 2005-01-25 2011-10-18 Seng Enterprises Ltd. Device for studying individual cells
EP2272983A1 (fr) * 2005-02-01 2011-01-12 AB Advanced Genetic Analysis Corporation Réactifs, méthodes et bibliothèques pour séquencage fondé sur des billes
JP2006211984A (ja) * 2005-02-04 2006-08-17 Univ Nagoya エマルジョンを利用した核酸増幅方法、及び核酸増幅反応用キット
US8374887B1 (en) 2005-02-11 2013-02-12 Emily H. Alexander System and method for remotely supervising and verifying pharmacy functions
JP2008529538A (ja) * 2005-02-16 2008-08-07 ジェネティック テクノロジーズ リミテッド 相補性デュプリコンの増幅を含む遺伝子分析方法
EP1861721B1 (fr) * 2005-03-10 2017-05-03 Gen-Probe Incorporated Systemes et procedes permettant d'effectuer des dosages afin de detecter ou de quantifier des analytes dans des echantillons
EP1877576B1 (fr) * 2005-04-12 2013-01-23 454 Life Sciences Corporation Procedes de determination de variantes de sequence utilisant un sequencage des amplicons
US20060228721A1 (en) 2005-04-12 2006-10-12 Leamon John H Methods for determining sequence variants using ultra-deep sequencing
CA2607532C (fr) * 2005-04-29 2013-03-12 The J. Craig Venter Institute Amplification et clonage de molecules d'adn uniques en cercle roulant
NZ564095A (en) * 2005-05-10 2009-06-26 Oregon State Methods of mapping polymorphisms and polymorphism microarrays
WO2007145612A1 (fr) 2005-06-06 2007-12-21 454 Life Sciences Corporation Séquençage d'extrémités appariées
DK1910538T3 (da) 2005-06-09 2011-08-08 Praecis Pharm Inc Fremgangsmåder til syntese af kodede biblioteker
WO2006138284A2 (fr) 2005-06-15 2006-12-28 Callida Genomics, Inc. Analyse d'acides nucleiques a l'aide de melanges aleatoires de fragments non chevauchants
ES2344802T3 (es) * 2005-06-23 2010-09-07 Keygene N.V. Estrategias mejoradas para la secuenciacion de genomas complejos utilizando tecnologias de secuenciacion de alto rendimiento.
GB0514935D0 (en) 2005-07-20 2005-08-24 Solexa Ltd Methods for sequencing a polynucleotide template
GB0514910D0 (en) 2005-07-20 2005-08-24 Solexa Ltd Method for sequencing a polynucleotide template
US10083273B2 (en) * 2005-07-29 2018-09-25 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US11111543B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US11111544B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US9424392B2 (en) 2005-11-26 2016-08-23 Natera, Inc. System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals
US10081839B2 (en) * 2005-07-29 2018-09-25 Natera, Inc System and method for cleaning noisy genetic data and determining chromosome copy number
JP2009505642A (ja) * 2005-08-19 2009-02-12 コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガニゼイション アラクノカンパのルシフェラーゼ
CA2621267A1 (fr) * 2005-09-07 2007-03-15 Nugen Technologies, Inc. Procedure d'amplication d'acide nucleique amelioree
WO2007133831A2 (fr) 2006-02-24 2007-11-22 Callida Genomics, Inc. Séquençage génomique à haut débit sur des puces à adn
EP2546360A1 (fr) 2005-10-07 2013-01-16 Callida Genomics, Inc. Réseaux de molécules simples auto-assemblées et leurs utilisations
US20070141555A1 (en) * 2005-10-11 2007-06-21 Mordechai Deutsch Current damper for the study of cells
PT1948816E (pt) * 2005-10-24 2012-03-19 Univ Johns Hopkins Processos melhorados de focalização
KR100828714B1 (ko) 2005-10-25 2008-05-09 주식회사 엘지화학 리보핵산을 이용한 멀티플렉스 증폭방법
JP2009513135A (ja) * 2005-10-28 2009-04-02 プリーシス・ファーマシューティカルズ・インコーポレイテッド エンコードされたライブラリーを用いて興味のある化合物を同定する方法
GB0522310D0 (en) 2005-11-01 2005-12-07 Solexa Ltd Methods of preparing libraries of template polynucleotides
US8288120B2 (en) * 2005-11-03 2012-10-16 Seng Enterprises Ltd. Method for studying floating, living cells
WO2007056490A2 (fr) * 2005-11-08 2007-05-18 Incom, Inc. Lame porte-objet d’examen par fibres optiques, trousses de lames porte-objet et leurs utilisations
WO2007055568A1 (fr) * 2005-11-14 2007-05-18 Keygene N.V. Procede de tri a haut debit de populations de marquage de transposons et d'identification a grande echelle de sequences paralleles de sites d'insertion
GB0524069D0 (en) 2005-11-25 2006-01-04 Solexa Ltd Preparation of templates for solid phase amplification
US20070128610A1 (en) * 2005-12-02 2007-06-07 Buzby Philip R Sample preparation method and apparatus for nucleic acid sequencing
DK1966394T3 (da) * 2005-12-22 2012-10-29 Keygene Nv Forbedrede strategier til transkriptprofilering under anvendelse af high throughput-sekventeringsteknologier
CA2637974A1 (fr) * 2006-01-19 2007-07-26 The Research Foundation Of State University Of New York Procedes et dispositifs destines a la detection et l'identification de billes codees et de molecules biologiques
WO2007083388A1 (fr) * 2006-01-20 2007-07-26 Toppan Printing Co., Ltd. Cuve de réaction et procédé de réaction d'amplification d'adn
US7749365B2 (en) 2006-02-01 2010-07-06 IntegenX, Inc. Optimized sample injection structures in microfluidic separations
DE102006005287B4 (de) * 2006-02-06 2012-12-27 Siemens Ag Verfahren zum Nachweis von Zielnukleinsäuren
CA2641851A1 (fr) 2006-02-08 2007-08-16 Eric Hans Vermaas Procede de sequencage d'une matrice polynucleotidique
US8301394B2 (en) 2006-02-16 2012-10-30 454 Life Sciences Corporation System and method for correcting primer extension errors in nucleic acid sequence data
US8364417B2 (en) * 2007-02-15 2013-01-29 454 Life Sciences Corporation System and method to correct out of phase errors in DNA sequencing data by use of a recursive algorithm
US11237171B2 (en) 2006-02-21 2022-02-01 Trustees Of Tufts College Methods and arrays for target analyte detection and determination of target analyte concentration in solution
US8492098B2 (en) * 2006-02-21 2013-07-23 The Trustees Of Tufts College Methods and arrays for target analyte detection and determination of reaction components that affect a reaction
SG10201405158QA (en) * 2006-02-24 2014-10-30 Callida Genomics Inc High throughput genome sequencing on dna arrays
US7766033B2 (en) * 2006-03-22 2010-08-03 The Regents Of The University Of California Multiplexed latching valves for microfluidic devices and processors
SG170802A1 (en) 2006-03-31 2011-05-30 Solexa Inc Systems and devices for sequence by synthesis analysis
US8809068B2 (en) 2006-04-18 2014-08-19 Advanced Liquid Logic, Inc. Manipulation of beads in droplets and methods for manipulating droplets
US7439014B2 (en) 2006-04-18 2008-10-21 Advanced Liquid Logic, Inc. Droplet-based surface modification and washing
CN101495654A (zh) * 2006-04-19 2009-07-29 阿普里拉股份有限公司 无凝胶珠基测序的试剂、方法和文库
US10522240B2 (en) 2006-05-03 2019-12-31 Population Bio, Inc. Evaluating genetic disorders
US7702468B2 (en) * 2006-05-03 2010-04-20 Population Diagnostics, Inc. Evaluating genetic disorders
US9562837B2 (en) 2006-05-11 2017-02-07 Raindance Technologies, Inc. Systems for handling microfludic droplets
WO2007136736A2 (fr) * 2006-05-19 2007-11-29 Codon Devices, Inc. Procédés de tri et de synthèse d'acides nucléiques
CA2653321A1 (fr) * 2006-05-26 2007-12-06 Althea Technologies, Inc. Analyse biochimique de cellules partagees
US11001881B2 (en) 2006-08-24 2021-05-11 California Institute Of Technology Methods for detecting analytes
US8614278B2 (en) 2006-06-06 2013-12-24 Dow Corning Corporation Silicone acrylate hybrid composition and method of making same
US8569416B2 (en) 2006-06-06 2013-10-29 Dow Corning Corporation Single phase silicone acrylate formulation
JP2009540052A (ja) * 2006-06-06 2009-11-19 ダウ・コーニング・コーポレイション シリコーンアクリレートハイブリッド組成物およびその製造方法
US20080124707A1 (en) * 2006-06-09 2008-05-29 Agency For Science, Technology And Research Nucleic acid concatenation
EP2548972A1 (fr) 2006-06-14 2013-01-23 Verinata Health, Inc Procédés pour le diagnostic dýanomalies fýtales
US20080009007A1 (en) * 2006-06-16 2008-01-10 Pacific Biosciences Of California, Inc. Controlled initiation of primer extension
EP2038425B1 (fr) 2006-07-12 2010-09-15 Keygene N.V. Cartographie physique à haut débit par aflp
WO2008014485A2 (fr) 2006-07-28 2008-01-31 California Institute Of Technology Ensembles de pcr-q multiplex
US11525156B2 (en) 2006-07-28 2022-12-13 California Institute Of Technology Multiplex Q-PCR arrays
WO2008015396A2 (fr) 2006-07-31 2008-02-07 Solexa Limited Procédé de préparation de bibliothèque évitant la formation de dimères d'adaptateur
EP3536396B1 (fr) 2006-08-07 2022-03-30 The President and Fellows of Harvard College Tensioactifs fluorocarbonés stabilisateurs d'émulsions
US11560588B2 (en) 2006-08-24 2023-01-24 California Institute Of Technology Multiplex Q-PCR arrays
WO2008042067A2 (fr) 2006-09-28 2008-04-10 Illumina, Inc. Compositions et procédés de séquencage nucléotidique
US7754429B2 (en) 2006-10-06 2010-07-13 Illumina Cambridge Limited Method for pair-wise sequencing a plurity of target polynucleotides
WO2008045575A2 (fr) * 2006-10-13 2008-04-17 J. Craig Venter Institute, Inc. Procédé de séquençage
US8841116B2 (en) * 2006-10-25 2014-09-23 The Regents Of The University Of California Inline-injection microdevice and microfabricated integrated DNA analysis system using same
US7910354B2 (en) * 2006-10-27 2011-03-22 Complete Genomics, Inc. Efficient arrays of amplified polynucleotides
US8338109B2 (en) 2006-11-02 2012-12-25 Mayo Foundation For Medical Education And Research Predicting cancer outcome
WO2008055915A2 (fr) * 2006-11-06 2008-05-15 Clondiag Gmbh Dosages
US20090111705A1 (en) 2006-11-09 2009-04-30 Complete Genomics, Inc. Selection of dna adaptor orientation by hybrid capture
US20080242560A1 (en) * 2006-11-21 2008-10-02 Gunderson Kevin L Methods for generating amplified nucleic acid arrays
US7902345B2 (en) 2006-12-05 2011-03-08 Sequenom, Inc. Detection and quantification of biomolecules using mass spectrometry
US7932034B2 (en) * 2006-12-20 2011-04-26 The Board Of Trustees Of The Leland Stanford Junior University Heat and pH measurement for sequencing of DNA
WO2008093098A2 (fr) 2007-02-02 2008-08-07 Illumina Cambridge Limited Procedes pour indexer des echantillons et sequencer de multiples matrices nucleotidiques
US9152150B1 (en) 2007-02-22 2015-10-06 Applied Biosystems, Llc Compositions, systems, and methods for immiscible fluid discrete volume manipulation
US9029085B2 (en) 2007-03-07 2015-05-12 President And Fellows Of Harvard College Assays and other reactions involving droplets
JP2010521156A (ja) 2007-03-16 2010-06-24 ４５４ ライフ サイエンシーズ コーポレイション Ｈｉｖ薬物耐性バリアントの検出のためのシステムおよび方法
US20100151465A1 (en) 2008-03-27 2010-06-17 Jingyue Ju Selective Capture and Release of Analytes
US20080243865A1 (en) * 2007-03-28 2008-10-02 Oracle International Corporation Maintaining global state of distributed transaction managed by an external transaction manager for clustered database systems
US20080239867A1 (en) * 2007-03-28 2008-10-02 Gilbert Donna J Adjustable stir
JP2008245612A (ja) * 2007-03-30 2008-10-16 Hitachi Ltd 試料調製法および装置
US7883265B2 (en) * 2007-06-01 2011-02-08 Applied Biosystems, Llc Devices, systems, and methods for preparing emulsions
WO2009015296A1 (fr) * 2007-07-24 2009-01-29 The Regents Of The University Of California Générateur de gouttelettes microfabriqué
WO2009012984A1 (fr) 2007-07-26 2009-01-29 Roche Diagnostics Gmbh Préparation cible pour le séquençage en parallèle de génomes complexes
JP5020734B2 (ja) * 2007-07-31 2012-09-05 株式会社日立ハイテクノロジーズ 核酸解析方法及び装置
US9404150B2 (en) 2007-08-29 2016-08-02 Sequenom, Inc. Methods and compositions for universal size-specific PCR
EP2201021A4 (fr) 2007-08-29 2012-01-25 Applied Biosystems Llc Procédé de séquençage alternatif d'acide nucléique
EP2191011B1 (fr) * 2007-08-29 2017-03-29 Illumina Cambridge Limited Procédé de séquençage d'une matrice de polynucléotides
CA2734029C (fr) 2007-08-30 2016-03-29 The Trustees Of Tufts College Procedes pour determiner la concentration d'un analyte dans une solution
EP2188027A4 (fr) * 2007-09-11 2011-06-08 Arryx Inc Procédé de liaison et appareil pour trier des objets
JP2010538644A (ja) * 2007-09-13 2010-12-16 アリックス インク 法医学的ｄｎａ分析および医学的診断において対象物を選別するための方法および装置
EP2188660B1 (fr) * 2007-09-13 2018-11-14 GE Healthcare Bio-Sciences Corp. Liquide d'immersion dispersant pour imagerie à résolution élevée et lithographie
US8716190B2 (en) 2007-09-14 2014-05-06 Affymetrix, Inc. Amplification and analysis of selected targets on solid supports
US9388457B2 (en) 2007-09-14 2016-07-12 Affymetrix, Inc. Locus specific amplification using array probes
US20100304378A1 (en) * 2007-09-17 2010-12-02 Universite De Strasbourg Method for Detecting or Quantifying a Truncating Mutation
US20090118129A1 (en) * 2007-09-28 2009-05-07 Pacific Biosciences Of California, Inc. Virtual reads for readlength enhancement
JP2010539982A (ja) * 2007-10-01 2010-12-24 アプライド バイオシステムズ， エルエルシー チェイスライゲーション配列決定法
US20100086914A1 (en) * 2008-10-03 2010-04-08 Roche Molecular Systems, Inc. High resolution, high throughput hla genotyping by clonal sequencing
EP2053132A1 (fr) 2007-10-23 2009-04-29 Roche Diagnostics GmbH Enrichissement et analyse de séquence de régions génomiques
WO2009055597A2 (fr) * 2007-10-25 2009-04-30 Monsanto Technology Llc Procédés d'identification d'une liaison génétique
US9145540B1 (en) 2007-11-15 2015-09-29 Seng Enterprises Ltd. Device for the study of living cells
US8592150B2 (en) 2007-12-05 2013-11-26 Complete Genomics, Inc. Methods and compositions for long fragment read sequencing
US9797010B2 (en) 2007-12-21 2017-10-24 President And Fellows Of Harvard College Systems and methods for nucleic acid sequencing
EP2237887A2 (fr) * 2007-12-26 2010-10-13 Seng Enterprises Ltd. Dispositif pour l'étude de cellules vivantes
US8189186B2 (en) * 2007-12-27 2012-05-29 Lawrence Livermore National Security, Llc. Signal enhancement using a switchable magnetic trap
US20090181390A1 (en) * 2008-01-11 2009-07-16 Signosis, Inc. A California Corporation High throughput detection of micrornas and use for disease diagnosis
WO2009091934A1 (fr) * 2008-01-17 2009-07-23 Sequenom, Inc. Procédés et compositions d'analyse de séquence d'acide nucléique à simple molécule
US7767400B2 (en) * 2008-02-03 2010-08-03 Helicos Biosciences Corporation Paired-end reads in sequencing by synthesis
EP2250283A2 (fr) * 2008-02-12 2010-11-17 Nugen Technologies, Inc. Procédés et composition pour amplification isotherme d'acide nucléique
US20090203531A1 (en) * 2008-02-12 2009-08-13 Nurith Kurn Method for Archiving and Clonal Expansion
CA2717320A1 (fr) * 2008-03-11 2009-09-17 Sequenom, Inc. Tests adn pour determiner le sexe d'un bebe avant sa naissance
AU2009226248B8 (en) 2008-03-17 2014-10-02 Stichting Genetwister Ip Expression-linked gene discovery
US10745740B2 (en) 2008-03-19 2020-08-18 Qiagen Sciences, Llc Sample preparation
GB2470672B (en) * 2008-03-21 2012-09-12 Nugen Technologies Inc Methods of RNA amplification in the presence of DNA
EP3170904B1 (fr) * 2008-03-28 2017-08-16 Pacific Biosciences Of California, Inc. Compositions et procédés pour le séquençage d'acide nucléique
BRPI0911326B1 (pt) * 2008-04-04 2019-11-26 Allopartis Biotechnologies Inc método de seleção para atividade enzimática melhorada em um substrato insolúvel
JP5227062B2 (ja) 2008-04-08 2013-07-03 株式会社日立製作所 Ｄｎａ分析装置
TWI460602B (zh) * 2008-05-16 2014-11-11 Counsyl Inc 廣用的懷孕前篩檢裝置
AU2009253675A1 (en) 2008-05-28 2009-12-03 Genomedx Biosciences, Inc. Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer
US10407731B2 (en) 2008-05-30 2019-09-10 Mayo Foundation For Medical Education And Research Biomarker panels for predicting prostate cancer outcomes
WO2010003132A1 (fr) 2008-07-02 2010-01-07 Illumina Cambridge Ltd. Utilisation de populations de billes dans la fabrication de matrices sur des surfaces
WO2010009426A2 (fr) * 2008-07-17 2010-01-21 Life Technologies Corporation Dispositifs et procédés pour la délivrance de réactif
ES2532153T3 (es) 2008-07-18 2015-03-24 Trovagene, Inc. Métodos para la detección de secuencias de ácidos nucleicos "ultracortos" basados en PCR
US20100035252A1 (en) * 2008-08-08 2010-02-11 Ion Torrent Systems Incorporated Methods for sequencing individual nucleic acids under tension
EP3216874A1 (fr) 2008-09-05 2017-09-13 TOMA Biosciences, Inc. Procédés pour la stratification et l'annotation des options de traitement médicamenteux contre le cancer
US8795961B2 (en) 2008-09-05 2014-08-05 Pacific Biosciences Of California, Inc. Preparations, compositions, and methods for nucleic acid sequencing
US8476013B2 (en) 2008-09-16 2013-07-02 Sequenom, Inc. Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
US8962247B2 (en) 2008-09-16 2015-02-24 Sequenom, Inc. Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses
US20110218123A1 (en) 2008-09-19 2011-09-08 President And Fellows Of Harvard College Creation of libraries of droplets and related species
WO2010039189A2 (fr) * 2008-09-23 2010-04-08 Helicos Biosciences Corporation Procédés de séquençage d’acides nucléiques dégradés ou modifiés
US20100075862A1 (en) * 2008-09-23 2010-03-25 Quanterix Corporation High sensitivity determination of the concentration of analyte molecules or particles in a fluid sample
US8663920B2 (en) 2011-07-29 2014-03-04 Bio-Rad Laboratories, Inc. Library characterization by digital assay
US9417190B2 (en) 2008-09-23 2016-08-16 Bio-Rad Laboratories, Inc. Calibrations and controls for droplet-based assays
US9132394B2 (en) 2008-09-23 2015-09-15 Bio-Rad Laboratories, Inc. System for detection of spaced droplets
US20100075439A1 (en) * 2008-09-23 2010-03-25 Quanterix Corporation Ultra-sensitive detection of molecules by capture-and-release using reducing agents followed by quantification
US8951939B2 (en) 2011-07-12 2015-02-10 Bio-Rad Laboratories, Inc. Digital assays with multiplexed detection of two or more targets in the same optical channel
US9492797B2 (en) 2008-09-23 2016-11-15 Bio-Rad Laboratories, Inc. System for detection of spaced droplets
US9598725B2 (en) 2010-03-02 2017-03-21 Bio-Rad Laboratories, Inc. Emulsion chemistry for encapsulated droplets
US9156010B2 (en) 2008-09-23 2015-10-13 Bio-Rad Laboratories, Inc. Droplet-based assay system
US11130128B2 (en) 2008-09-23 2021-09-28 Bio-Rad Laboratories, Inc. Detection method for a target nucleic acid
US8222047B2 (en) * 2008-09-23 2012-07-17 Quanterix Corporation Ultra-sensitive detection of molecules on single molecule arrays
US9764322B2 (en) 2008-09-23 2017-09-19 Bio-Rad Laboratories, Inc. System for generating droplets with pressure monitoring
US8633015B2 (en) 2008-09-23 2014-01-21 Bio-Rad Laboratories, Inc. Flow-based thermocycling system with thermoelectric cooler
US9399215B2 (en) 2012-04-13 2016-07-26 Bio-Rad Laboratories, Inc. Sample holder with a well having a wicking promoter
WO2011120020A1 (fr) 2010-03-25 2011-09-29 Quantalife, Inc. Système de transport de gouttelettes à des fins de détection
US8709762B2 (en) 2010-03-02 2014-04-29 Bio-Rad Laboratories, Inc. System for hot-start amplification via a multiple emulsion
US10512910B2 (en) 2008-09-23 2019-12-24 Bio-Rad Laboratories, Inc. Droplet-based analysis method
US20100087325A1 (en) * 2008-10-07 2010-04-08 Illumina, Inc. Biological sample temperature control system and method
US8541207B2 (en) 2008-10-22 2013-09-24 Illumina, Inc. Preservation of information related to genomic DNA methylation
US9080211B2 (en) 2008-10-24 2015-07-14 Epicentre Technologies Corporation Transposon end compositions and methods for modifying nucleic acids
ES2515065T3 (es) 2008-10-24 2014-10-29 Epicentre Technologies Corporation Composiciones de extremo del transposón y métodos para modificar ácidos nucleicos
US8877436B2 (en) * 2008-10-27 2014-11-04 Qiagen Gaithersburg, Inc. Fast results hybrid capture assay on an automated platform
US8486865B2 (en) 2008-11-03 2013-07-16 The Regents Of The University Of California Methods for detecting modification resistant nucleic acids
JP2010110262A (ja) * 2008-11-06 2010-05-20 Hitachi Maxell Ltd ウェルプレートを用いた核酸増幅法
US9506119B2 (en) 2008-11-07 2016-11-29 Adaptive Biotechnologies Corp. Method of sequence determination using sequence tags
US9394567B2 (en) 2008-11-07 2016-07-19 Adaptive Biotechnologies Corporation Detection and quantification of sample contamination in immune repertoire analysis
US8748103B2 (en) 2008-11-07 2014-06-10 Sequenta, Inc. Monitoring health and disease status using clonotype profiles
US8628927B2 (en) 2008-11-07 2014-01-14 Sequenta, Inc. Monitoring health and disease status using clonotype profiles
US9528160B2 (en) 2008-11-07 2016-12-27 Adaptive Biotechnolgies Corp. Rare clonotypes and uses thereof
US9365901B2 (en) 2008-11-07 2016-06-14 Adaptive Biotechnologies Corp. Monitoring immunoglobulin heavy chain evolution in B-cell acute lymphoblastic leukemia
SG195652A1 (en) 2008-11-07 2013-12-30 Sequenta Inc Methods of monitoring conditions by sequence analysis
US10236078B2 (en) 2008-11-17 2019-03-19 Veracyte, Inc. Methods for processing or analyzing a sample of thyroid tissue
US9495515B1 (en) 2009-12-09 2016-11-15 Veracyte, Inc. Algorithms for disease diagnostics
GB2512153B (en) 2008-11-17 2014-11-12 Veracyte Inc Methods and compositions of molecular profiling for disease diagnostics
US8674175B2 (en) 2008-12-05 2014-03-18 Keygene N.V. Farnesene synthase
EP3150724A1 (fr) 2008-12-19 2017-04-05 President and Fellows of Harvard College Séquençage d'acide nucléique assisté par particules
WO2010075188A2 (fr) 2008-12-23 2010-07-01 Illumina Inc. Libération multibase pour lectures longues dans le séquençage par des protocoles de synthèse
ES2403312T3 (es) 2009-01-13 2013-05-17 Keygene N.V. Nuevas estrategias para la secuenciación del genoma
US20100179074A1 (en) * 2009-01-15 2010-07-15 Honeywell International Inc. Methods and apparatus for fluid delivery and removal of micron scale structures
HUE029424T2 (en) 2009-01-15 2017-02-28 Adaptive Biotechnologies Corp Adaptive immunity profiling and a method for producing monoclonal antibodies
CN102333891A (zh) * 2009-01-20 2012-01-25 利兰·斯坦福青年大学托管委员会 用于药靶诊断、预后和鉴别的单细胞基因表达
US20100331204A1 (en) 2009-02-13 2010-12-30 Jeff Jeddeloh Methods and systems for enrichment of target genomic sequences
JP5457222B2 (ja) 2009-02-25 2014-04-02 エフ．ホフマン−ラ ロシュ アーゲー 小型化ハイスループット核酸分析
US9347092B2 (en) 2009-02-25 2016-05-24 Roche Molecular System, Inc. Solid support for high-throughput nucleic acid analysis
US9074258B2 (en) 2009-03-04 2015-07-07 Genomedx Biosciences Inc. Compositions and methods for classifying thyroid nodule disease
WO2010107946A2 (fr) * 2009-03-18 2010-09-23 Sequenom, Inc. Utilisation d'endonucléases thermostables pour générer des molécules rapporteuses
EP2411148B1 (fr) 2009-03-23 2018-02-21 Raindance Technologies, Inc. Manipulation de gouttelettes microfluidiques
GB0904957D0 (en) 2009-03-23 2009-05-06 Univ Erasmus Medical Ct Tumour gene profile
GB0904934D0 (en) 2009-03-23 2009-05-06 Geneseqe As Method and apparatus for detecting molecules
WO2010115100A1 (fr) 2009-04-03 2010-10-07 L&C Diagment, Inc. Procédés et systèmes de détection multiplex d'acide nucléique
WO2010117456A2 (fr) * 2009-04-08 2010-10-14 Applied Biosystems, Llc Enrichissement sur colonne de billes de pcr comprenant des amplicons insérés
JP2012529918A (ja) 2009-04-19 2012-11-29 セルマティックス， インコーポレイテッド 不妊症および／または卵の質を評価するための方法および装置
US9090663B2 (en) * 2009-04-21 2015-07-28 The Trustees Of Columbia University In The City Of New York Systems and methods for the capture and separation of microparticles
AU2010242073C1 (en) 2009-04-30 2015-12-24 Good Start Genetics, Inc. Methods and compositions for evaluating genetic markers
EP2248914A1 (fr) 2009-05-05 2010-11-10 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Utilisation d'endonucléases à restriction de classe IIB dans des applications de séquençage de 2ème génération
EP3360978A3 (fr) 2009-05-07 2018-09-26 Veracyte, Inc. Procédés pour le diagnostic d'affections thyroïdiennes
US8003329B2 (en) * 2009-05-12 2011-08-23 Becton Dickinson & Company Molecular counting by color-coded micelles
EP3663750B1 (fr) 2009-05-29 2021-11-03 Life Technologies Corporation Particules de polymère d'acide nucléique échafaudées et procédés de fabrication et d'utilisation
US9524369B2 (en) 2009-06-15 2016-12-20 Complete Genomics, Inc. Processing and analysis of complex nucleic acid sequence data
JP2012531202A (ja) 2009-06-25 2012-12-10 フレッド ハチンソン キャンサー リサーチ センター 適応免疫を測定する方法
WO2011002319A2 (fr) * 2009-07-02 2011-01-06 Zygem Corporation Limited Blocage, extraction et détection combinés d'acide nucléique dans un réceptacle de réaction unique
JP5099455B2 (ja) * 2009-07-16 2012-12-19 独立行政法人科学技術振興機構 エマルジョンを用いたｒｎａの選択的増幅法
US8825412B2 (en) 2010-05-18 2014-09-02 Natera, Inc. Methods for non-invasive prenatal ploidy calling
EP2456892B1 (fr) * 2009-07-24 2014-10-01 Illumina, Inc. Procédé de séquençage d'une matrice polynucléotidique
JP5795313B2 (ja) * 2009-07-29 2015-10-14 パイロベット ピーティーイー エルティーディーＰｙｒｏｂｅｔｔ Ｐｔｅ Ｌｔｄ アッセイを行うための方法及び装置
WO2011014811A1 (fr) * 2009-07-31 2011-02-03 Ibis Biosciences, Inc. Amorces de capture et supports solides liés à une séquence de capture pour tests diagnostiques moléculaires
EP2470669B1 (fr) 2009-08-25 2014-06-18 Illumina, Inc. Procédés de sélection et d amplification de polynucléotides
JP5869482B2 (ja) 2009-09-02 2016-02-24 プレジデント アンド フェローズ オブ ハーバード カレッジ ジェッティングおよび他の技術を使用して生成された多重エマルジョン
EP2473618B1 (fr) 2009-09-02 2015-03-04 Bio-Rad Laboratories, Inc. Système de mélange de fluides par coalescence d'émulsions multiples
US10072287B2 (en) 2009-09-10 2018-09-11 Centrillion Technology Holdings Corporation Methods of targeted sequencing
US10174368B2 (en) 2009-09-10 2019-01-08 Centrillion Technology Holdings Corporation Methods and systems for sequencing long nucleic acids
WO2011041485A1 (fr) 2009-09-30 2011-04-07 Gene Security Network, Inc. Méthode non invasive de détermination d'une ploïdie prénatale
US10520500B2 (en) 2009-10-09 2019-12-31 Abdeslam El Harrak Labelled silica-based nanomaterial with enhanced properties and uses thereof
AU2010315580B2 (en) 2009-10-27 2014-11-06 President And Fellows Of Harvard College Droplet creation techniques
EP2494353B1 (fr) 2009-10-30 2017-09-27 Illumina Inc. Dispositif comprenant une pluralité de microrécipients codés et une pluralité de compartiments et un procédé de lecture d'une pluralité de microrécipients codés
EP2494069B1 (fr) 2009-10-30 2013-10-02 Roche Diagniostics GmbH Procédé de détection des aberrations chromosomiques équilibrées
CN102712954A (zh) 2009-11-06 2012-10-03 小利兰·斯坦福大学托管委员会 器官移植患者移植排斥的非侵入性诊断
ES2542426T3 (es) * 2009-11-16 2015-08-05 Genomictree, Inc. Método de genotipado
EP2504448B1 (fr) * 2009-11-25 2016-10-19 Bio-Rad Laboratories, Inc. Procédés et compositions destinés à détecter un matériel génétique
US10446272B2 (en) 2009-12-09 2019-10-15 Veracyte, Inc. Methods and compositions for classification of samples
WO2011071382A1 (fr) 2009-12-10 2011-06-16 Keygene N.V. Profilage polymorphique du génome entier
CN102656279A (zh) 2009-12-17 2012-09-05 凯津公司 基于全基因组测序的限制性酶
CN102791880A (zh) 2009-12-18 2012-11-21 凯津公司 改进的大突变分析
US9926593B2 (en) 2009-12-22 2018-03-27 Sequenom, Inc. Processes and kits for identifying aneuploidy
EP2517025B1 (fr) 2009-12-23 2019-11-27 Bio-Rad Laboratories, Inc. Procédés pour réduire l'échange de molécules entre des gouttelettes
ES2704701T3 (es) 2010-01-19 2019-03-19 Verinata Health Inc Nuevo protocolo de preparación de bibliotecas de secuenciación
US20120100548A1 (en) 2010-10-26 2012-04-26 Verinata Health, Inc. Method for determining copy number variations
PL2531880T3 (pl) 2010-02-01 2017-09-29 Illumina Inc. Sposoby ogniskowania oraz układy optyczne i zespoły optyczne realizujące te sposoby
US20110195457A1 (en) * 2010-02-09 2011-08-11 General Electric Company Isothermal amplification of nucleic acid using primers comprising a randomized sequence and specific primers and uses thereof
US9366632B2 (en) 2010-02-12 2016-06-14 Raindance Technologies, Inc. Digital analyte analysis
US10351905B2 (en) 2010-02-12 2019-07-16 Bio-Rad Laboratories, Inc. Digital analyte analysis
WO2011103421A1 (fr) 2010-02-18 2011-08-25 Shuber Anthony P Compositions et méthodes pour le traitement du cancer
US20110262903A1 (en) 2010-02-26 2011-10-27 Life Technologies Corporation Modified Proteins and Methods of Making and Using Same
US8415171B2 (en) * 2010-03-01 2013-04-09 Quanterix Corporation Methods and systems for extending dynamic range in assays for the detection of molecules or particles
US8236574B2 (en) 2010-03-01 2012-08-07 Quanterix Corporation Ultra-sensitive detection of molecules or particles using beads or other capture objects
WO2011109379A1 (fr) 2010-03-01 2011-09-09 Quanterix Corporation Procédés et systèmes pour étendre la plage dynamique dans des dosages pour la détection de molécules ou de particules
US9678068B2 (en) * 2010-03-01 2017-06-13 Quanterix Corporation Ultra-sensitive detection of molecules using dual detection methods
CN202281746U (zh) 2010-03-06 2012-06-20 伊鲁米那股份有限公司 检测来自样品光信号的测定设备及其光学组件和光学系统
US20110311963A1 (en) * 2010-03-16 2011-12-22 Life Technologies Corporation Method and Apparatus for Addressable Flow Cells in Single Molecule Sequencing
EP2550351A4 (fr) 2010-03-25 2014-07-09 Quantalife Inc Système de détection pour analyses à base de gouttelettes
EP2550528B1 (fr) 2010-03-25 2019-09-11 Bio-Rad Laboratories, Inc. Génération de gouttelettes pour dosages sur gouttelettes
US8951940B2 (en) 2010-04-01 2015-02-10 Illumina, Inc. Solid-phase clonal amplification and related methods
PT2556171E (pt) 2010-04-05 2015-12-21 Prognosys Biosciences Inc Ensaios biológicos codificados espacialmente
US10787701B2 (en) 2010-04-05 2020-09-29 Prognosys Biosciences, Inc. Spatially encoded biological assays
US20190300945A1 (en) 2010-04-05 2019-10-03 Prognosys Biosciences, Inc. Spatially Encoded Biological Assays
SI2558577T1 (sl) 2010-04-16 2019-05-31 Nuevolution A/S Bifunkcionalni kompleksi in metode za pripravo in uporabo takšnih kompleksov
US20110269194A1 (en) * 2010-04-20 2011-11-03 Swift Biosciences, Inc. Materials and methods for nucleic acid fractionation by solid phase entrapment and enzyme-mediated detachment
WO2011135041A1 (fr) 2010-04-30 2011-11-03 Roche Diagnostics Gmbh Système et procédé de purification et d'utilisation de la pyrophosphatase inorganique provenant d'aquifex aeolicus
US9930297B2 (en) * 2010-04-30 2018-03-27 Becton, Dickinson And Company System and method for acquiring images of medication preparations
EP2388337B1 (fr) 2010-04-30 2014-07-02 Nxp B.V. Dispositif de détection et son procédé de fabrication
EP2566985A4 (fr) * 2010-05-06 2014-08-06 Ibis Biosciences Inc Systèmes intégrés de préparation d'échantillons et mélanges d'enzymes stabilisées
DK2567226T3 (en) 2010-05-06 2016-10-10 Adaptive Biotechnologies Corp Monitoring the health and disease status using klonotypeprofiler
WO2011140433A2 (fr) 2010-05-07 2011-11-10 The Board Of Trustees Of The Leland Stanford Junior University Mesure et comparaison de diversité immunitaire par séquençage à haut débit
WO2011143194A2 (fr) 2010-05-10 2011-11-17 Life Technologies Corporation Système et procédé de traitement d'un échantillon biologique
WO2011143361A2 (fr) 2010-05-11 2011-11-17 Veracyte, Inc. Méthodes et compositions utilisées dans le cadre du diagnostic de maladies
US11322224B2 (en) 2010-05-18 2022-05-03 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US20190010543A1 (en) 2010-05-18 2019-01-10 Natera, Inc. Methods for simultaneous amplification of target loci
US11408031B2 (en) 2010-05-18 2022-08-09 Natera, Inc. Methods for non-invasive prenatal paternity testing
US11326208B2 (en) 2010-05-18 2022-05-10 Natera, Inc. Methods for nested PCR amplification of cell-free DNA
US11332785B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11939634B2 (en) 2010-05-18 2024-03-26 Natera, Inc. Methods for simultaneous amplification of target loci
US9677118B2 (en) 2014-04-21 2017-06-13 Natera, Inc. Methods for simultaneous amplification of target loci
US11332793B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for simultaneous amplification of target loci
US10316362B2 (en) 2010-05-18 2019-06-11 Natera, Inc. Methods for simultaneous amplification of target loci
US11339429B2 (en) 2010-05-18 2022-05-24 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US20110287432A1 (en) 2010-05-21 2011-11-24 454 Life Science Corporation System and method for tailoring nucleotide concentration to enzymatic efficiencies in dna sequencing technologies
US20120035062A1 (en) 2010-06-11 2012-02-09 Life Technologies Corporation Alternative nucleotide flows in sequencing-by-synthesis methods
US9353412B2 (en) 2010-06-18 2016-05-31 Illumina, Inc. Conformational probes and methods for sequencing nucleic acids
US9650629B2 (en) * 2010-07-07 2017-05-16 Roche Molecular Systems, Inc. Clonal pre-amplification in emulsion
WO2012008831A1 (fr) 2010-07-13 2012-01-19 Keygene N.V. Génération simplifiée de cartes physiques de novo à partir de banques de clones
CN105964312A (zh) 2010-07-22 2016-09-28 基因细胞生物系统有限公司 复合液体池
CN103392182B (zh) 2010-08-02 2017-07-04 众有生物有限公司 用于发现遗传疾病中致病突变的系统和方法
US20120034603A1 (en) 2010-08-06 2012-02-09 Tandem Diagnostics, Inc. Ligation-based detection of genetic variants
US10533223B2 (en) 2010-08-06 2020-01-14 Ariosa Diagnostics, Inc. Detection of target nucleic acids using hybridization
US11203786B2 (en) 2010-08-06 2021-12-21 Ariosa Diagnostics, Inc. Detection of target nucleic acids using hybridization
US20130040375A1 (en) 2011-08-08 2013-02-14 Tandem Diagnotics, Inc. Assay systems for genetic analysis
US11031095B2 (en) 2010-08-06 2021-06-08 Ariosa Diagnostics, Inc. Assay systems for determination of fetal copy number variation
US8700338B2 (en) 2011-01-25 2014-04-15 Ariosa Diagnosis, Inc. Risk calculation for evaluation of fetal aneuploidy
US20130261003A1 (en) 2010-08-06 2013-10-03 Ariosa Diagnostics, In. Ligation-based detection of genetic variants
US10167508B2 (en) 2010-08-06 2019-01-01 Ariosa Diagnostics, Inc. Detection of genetic abnormalities
US20140342940A1 (en) 2011-01-25 2014-11-20 Ariosa Diagnostics, Inc. Detection of Target Nucleic Acids using Hybridization
JP5917519B2 (ja) 2010-09-10 2016-05-18 バイオ−ラッド ラボラトリーズ インコーポレーティッド クロマチン分析のためのｄｎａのサイズ選択
EP3572528A1 (fr) 2010-09-24 2019-11-27 The Board of Trustees of the Leland Stanford Junior University Capture directe, amplification et séquençage d'adn cible à l'aide d'amorces immobilisées
US20120077716A1 (en) 2010-09-29 2012-03-29 454 Life Sciences Corporation System and method for producing functionally distinct nucleic acid library ends through use of deoxyinosine
US8759038B2 (en) 2010-09-29 2014-06-24 Illumina Cambridge Limited Compositions and methods for sequencing nucleic acids
GB201016484D0 (en) 2010-09-30 2010-11-17 Geneseque As Method
US9399217B2 (en) 2010-10-04 2016-07-26 Genapsys, Inc. Chamber free nanoreactor system
US9187783B2 (en) 2010-10-04 2015-11-17 Genapsys, Inc. Systems and methods for automated reusable parallel biological reactions
US9184099B2 (en) 2010-10-04 2015-11-10 The Board Of Trustees Of The Leland Stanford Junior University Biosensor devices, systems and methods therefor
US20120322665A1 (en) 2010-10-08 2012-12-20 454 Life Sciences Corporation System and method for detection of hiv-1 clades and recombinants of the reverse transcriptase and protease regions
US9689012B2 (en) 2010-10-12 2017-06-27 Cornell University Method of dual-adapter recombination for efficient concatenation of multiple DNA fragments in shuffled or specified arrangements
US20150225792A1 (en) 2014-01-17 2015-08-13 Northwestern University Compositions and methods for identifying depressive disorders
US10233501B2 (en) 2010-10-19 2019-03-19 Northwestern University Biomarkers predictive of predisposition to depression and response to treatment
US10093981B2 (en) 2010-10-19 2018-10-09 Northwestern University Compositions and methods for identifying depressive disorders
US20150218639A1 (en) 2014-01-17 2015-08-06 Northwestern University Biomarkers predictive of predisposition to depression and response to treatment
EP2633069B1 (fr) 2010-10-26 2015-07-01 Illumina, Inc. Procédés de séquençage
EP3141614B1 (fr) 2010-10-27 2018-11-28 Life Technologies Corporation Modèle prédictif destiné à être utilisé dans le séquençage par synthèse
US9387476B2 (en) 2010-10-27 2016-07-12 Illumina, Inc. Flow cells for biological or chemical analysis
US10273540B2 (en) 2010-10-27 2019-04-30 Life Technologies Corporation Methods and apparatuses for estimating parameters in a predictive model for use in sequencing-by-synthesis
WO2012058096A1 (fr) * 2010-10-27 2012-05-03 Illumina, Inc. Microdispositifs et cartouches de biocapteurs pour analyse biologique ou chimique et systèmes et procédés associés
EP4016086A1 (fr) 2010-11-01 2022-06-22 Bio-Rad Laboratories, Inc. Système de formation d'émulsions
WO2012074855A2 (fr) 2010-11-22 2012-06-07 The Regents Of The University Of California Procédés d'identification d'un transcrit cellulaire naissant d'arn
EP2646573A1 (fr) 2010-12-01 2013-10-09 MorphoSys AG Détection simultanée de biomolécules dans des cellules uniques
EP3709303A1 (fr) 2010-12-14 2020-09-16 Life Technologies Corporation Systèmes et procédés permettant la surveillance de la qualité d'exécution de séquençage du temps d'exécution
ES2770342T3 (es) 2010-12-22 2020-07-01 Natera Inc Procedimientos para pruebas prenatales no invasivas de paternidad
US9163281B2 (en) 2010-12-23 2015-10-20 Good Start Genetics, Inc. Methods for maintaining the integrity and identification of a nucleic acid template in a multiplex sequencing reaction
US9594870B2 (en) 2010-12-29 2017-03-14 Life Technologies Corporation Time-warped background signal for sequencing-by-synthesis operations
US20130060482A1 (en) 2010-12-30 2013-03-07 Life Technologies Corporation Methods, systems, and computer readable media for making base calls in nucleic acid sequencing
US10241075B2 (en) 2010-12-30 2019-03-26 Life Technologies Corporation Methods, systems, and computer readable media for nucleic acid sequencing
KR20210131432A (ko) 2010-12-30 2021-11-02 파운데이션 메디신 인코포레이티드 종양 샘플의 다유전자 분석의 최적화
WO2012092455A2 (fr) 2010-12-30 2012-07-05 Life Technologies Corporation Modèles pour analyser des données issues d'opérations de séquençage par synthèse
US8951781B2 (en) 2011-01-10 2015-02-10 Illumina, Inc. Systems, methods, and apparatuses to image a sample for biological or chemical analysis
US20130005591A1 (en) * 2011-01-13 2013-01-03 Halgen Corporation Method for parallel amplification of nucleic acids
CA2823815A1 (fr) 2011-01-14 2012-07-19 Keygene N.V. Genotypage fonde sur des sequences aleatoires a extremites appariees
WO2012100194A1 (fr) 2011-01-20 2012-07-26 Ibis Biosciences, Inc. Transducteur microfluidique
US10131947B2 (en) 2011-01-25 2018-11-20 Ariosa Diagnostics, Inc. Noninvasive detection of fetal aneuploidy in egg donor pregnancies
US8756020B2 (en) 2011-01-25 2014-06-17 Ariosa Diagnostics, Inc. Enhanced risk probabilities using biomolecule estimations
US11270781B2 (en) 2011-01-25 2022-03-08 Ariosa Diagnostics, Inc. Statistical analysis for non-invasive sex chromosome aneuploidy determination
US9994897B2 (en) 2013-03-08 2018-06-12 Ariosa Diagnostics, Inc. Non-invasive fetal sex determination
US9952237B2 (en) 2011-01-28 2018-04-24 Quanterix Corporation Systems, devices, and methods for ultra-sensitive detection of molecules or particles
US10144950B2 (en) 2011-01-31 2018-12-04 Roche Sequencing Solutions, Inc. Methods of identifying multiple epitopes in cells
US20130316358A1 (en) 2011-01-31 2013-11-28 Yeda Research And Development Co. Ltd. Methods of diagnosing disease using overlap extension pcr
WO2012108920A1 (fr) 2011-02-09 2012-08-16 Natera, Inc Procédés de classification de ploïdie prénatale non invasive
WO2012129187A1 (fr) 2011-03-18 2012-09-27 Bio-Rad Laboratories, Inc. Essais numériques multiplexés avec utilisation combinée de signaux
US20120252682A1 (en) 2011-04-01 2012-10-04 Maples Corporate Services Limited Methods and systems for sequencing nucleic acids
WO2012139125A2 (fr) 2011-04-07 2012-10-11 Life Technologies Corporation Système et procédés de fabrication et de traitement d'émulsions
US9121047B2 (en) 2011-04-07 2015-09-01 Life Technologies Corporation System and methods for making and processing emulsions
EP3878975A1 (fr) 2011-04-08 2021-09-15 Life Technologies Corporation Ordonnancements d'écoulement de réactif de protection de phase pour utilisation dans un séquençage-par-synthèse
WO2012142301A2 (fr) 2011-04-12 2012-10-18 Quanterix Corporation Procédé de détermination d'un protocole de traitement et/ou d'un pronostic de rétablissement d'un patient à la suite d'un traumatisme cérébral
GB201106254D0 (en) 2011-04-13 2011-05-25 Frisen Jonas Method and product
ES2625288T3 (es) 2011-04-15 2017-07-19 The Johns Hopkins University Sistema de secuenciación segura
AU2012249759A1 (en) 2011-04-25 2013-11-07 Bio-Rad Laboratories, Inc. Methods and compositions for nucleic acid analysis
CA2834218C (fr) 2011-04-29 2021-02-16 Sequenom, Inc. Quantification d'une minorite d'especes d'acide nucleique utilisant des oligonucleotides inhibiteurs
US9487825B2 (en) 2011-05-13 2016-11-08 Mount Sinai School Of Medicine Pooled adapter strategy for reducing bias in small RNA characterization
SG10201605049QA (en) * 2011-05-20 2016-07-28 Fluidigm Corp Nucleic acid encoding reactions
EP2714254B1 (fr) 2011-05-23 2017-09-06 President and Fellows of Harvard College Génération d'émulsions et, notamment, d'émulsions multiples
US9926596B2 (en) 2011-05-27 2018-03-27 Genapsys, Inc. Systems and methods for genetic and biological analysis
US8585973B2 (en) 2011-05-27 2013-11-19 The Board Of Trustees Of The Leland Stanford Junior University Nano-sensor array
EP2714928B1 (fr) * 2011-05-27 2017-08-02 Life Technologies Corporation Procédés de manipulation de biomolécules
US8841071B2 (en) 2011-06-02 2014-09-23 Raindance Technologies, Inc. Sample multiplexing
US9598473B2 (en) 2011-06-10 2017-03-21 Keygene N.V. Trichome-specific transcription factor modulating terpene biosynthesis
CN103732744A (zh) 2011-06-15 2014-04-16 Gen9股份有限公司 制备性体外克隆的方法
DK2729580T3 (en) 2011-07-08 2015-12-14 Keygene Nv SEQUENCE BASED genotyping BASED ON OLIGONUKLEOTIDLIGERINGSASSAYS
US8920751B2 (en) 2011-07-08 2014-12-30 Life Technologies Corporation Automated enrichment for nucleic acid sequencing
WO2013019714A1 (fr) 2011-07-29 2013-02-07 The Trustees Of Columbia University In The City Of New York Capteur d'affinité mems pour surveillance ininterrompue de substances à analyser
WO2013022778A1 (fr) 2011-08-05 2013-02-14 Ibis Biosciences, Inc. Séquençage d'acide nucléique par une détection électrochimique
EP4324935A3 (fr) 2011-08-18 2024-05-08 Life Technologies Corporation Procédés, systèmes et supports lisibles par ordinateur pour effectuer des appels de base dans le séquençage d'acides nucléiques
EP3564261A1 (fr) 2011-08-23 2019-11-06 Foundation Medicine, Inc. Molécules de fusion kif5b-ret et leurs utilisations
US10704164B2 (en) 2011-08-31 2020-07-07 Life Technologies Corporation Methods, systems, computer readable media, and kits for sample identification
US8712697B2 (en) 2011-09-07 2014-04-29 Ariosa Diagnostics, Inc. Determination of copy number variations using binomial probability calculations
GB2496016B (en) 2011-09-09 2016-03-16 Univ Leland Stanford Junior Methods for obtaining a sequence
US10385475B2 (en) 2011-09-12 2019-08-20 Adaptive Biotechnologies Corp. Random array sequencing of low-complexity libraries
EP2758552A4 (fr) * 2011-09-23 2015-09-09 Univ Columbia Isolement et enrichissement en acides nucléiques sur puce
DK3623481T3 (da) 2011-09-23 2021-11-15 Illumina Inc Sammensætninger til nukleinsyresekventering
US10152569B2 (en) 2011-09-26 2018-12-11 Gen-Probe Incorporated Algorithms for sequence determinations
US10378051B2 (en) 2011-09-29 2019-08-13 Illumina Cambridge Limited Continuous extension and deblocking in reactions for nucleic acids synthesis and sequencing
DE102011054101A1 (de) 2011-09-30 2013-04-04 Albert-Ludwigs-Universität Freiburg Verfahren zur räumlichen Anordnung von Probenfragmenten zur Amplifikation und Immobilisierung für weitere Derivatisierungen
US11008611B2 (en) 2011-09-30 2021-05-18 Unm Rainforest Innovations Double gate ion sensitive field effect transistor
US10221454B2 (en) 2011-10-10 2019-03-05 The Hospital For Sick Children Methods and compositions for screening and treating developmental disorders
CN102329876B (zh) * 2011-10-14 2014-04-02 深圳华大基因科技有限公司 一种测定待检测样本中疾病相关核酸分子的核苷酸序列的方法
WO2013055995A2 (fr) 2011-10-14 2013-04-18 President And Fellows Of Harvard College Séquençage par assemblage structurel
CA2852665A1 (fr) 2011-10-17 2013-04-25 Good Start Genetics, Inc. Methodes d'identification de mutations associees a des maladies
US9206418B2 (en) 2011-10-19 2015-12-08 Nugen Technologies, Inc. Compositions and methods for directional nucleic acid amplification and sequencing
EP2768982A4 (fr) 2011-10-21 2015-06-03 Adaptive Biotechnologies Corp Quantification de génomes de cellules immunitaires adaptatives dans un mélange complexe de cellules
DE102011085473A1 (de) 2011-10-28 2013-05-02 Albert-Ludwigs-Universität Freiburg Verfahren zur Identifikation von Aptameren
US11180807B2 (en) 2011-11-04 2021-11-23 Population Bio, Inc. Methods for detecting a genetic variation in attractin-like 1 (ATRNL1) gene in subject with Parkinson's disease
EP2776962A4 (fr) 2011-11-07 2015-12-02 Ingenuity Systems Inc Procédés et systèmes pour l'identification de variants génomiques causals
AU2012336040B2 (en) 2011-11-07 2015-12-10 Illumina, Inc. Integrated sequencing apparatuses and methods of use
GB201120711D0 (en) 2011-12-01 2012-01-11 Univ Erasmus Medical Ct Method for classifying tumour cells
JP6193252B2 (ja) 2011-12-01 2017-09-06 ジナプシス インコーポレイテッド 高効率電子配列決定及び検出のためのシステム並びに方法
WO2013085918A1 (fr) * 2011-12-05 2013-06-13 The Regents Of The University Of California Procédés et compositions pour générer des fragments d'acides polynucléiques
EP2788509B1 (fr) 2011-12-09 2018-07-11 Adaptive Biotechnologies Corporation Diagnostic des malignités lymphoïdes et détection de maladie résiduelle minimale
KR101830778B1 (ko) 2011-12-09 2018-02-22 삼성전자주식회사 발열 입자를 포함하는 오일 층을 이용하는 핵산 증폭 장치 및 방법
EP2788499B1 (fr) 2011-12-09 2016-01-13 Illumina, Inc. Base de numération étendue pour étiquettes polymères
US9499865B2 (en) 2011-12-13 2016-11-22 Adaptive Biotechnologies Corp. Detection and measurement of tissue-infiltrating lymphocytes
US10513737B2 (en) 2011-12-13 2019-12-24 Decipher Biosciences, Inc. Cancer diagnostics using non-coding transcripts
US20130189679A1 (en) 2011-12-20 2013-07-25 The Regents Of The University Of Michigan Pseudogenes and uses thereof
WO2013096838A2 (fr) 2011-12-22 2013-06-27 Ibis Biosciences, Inc. Systèmes et procédés d'isolation d'acides nucléiques
US11021737B2 (en) 2011-12-22 2021-06-01 President And Fellows Of Harvard College Compositions and methods for analyte detection
US10150993B2 (en) 2011-12-22 2018-12-11 Ibis Biosciences, Inc. Macromolecule positioning by electrical potential
ES2953308T3 (es) 2011-12-22 2023-11-10 Harvard College Composiciones y métodos para la detección de analitos
WO2013096799A1 (fr) 2011-12-22 2013-06-27 Ibis Biosciences, Inc. Systèmes et procédés d'isolement d'acides nucléiques à partir d'échantillons cellulaires
US9823246B2 (en) 2011-12-28 2017-11-21 The Board Of Trustees Of The Leland Stanford Junior University Fluorescence enhancing plasmonic nanoscopic gold films and assays based thereon
US9506113B2 (en) 2011-12-28 2016-11-29 Ibis Biosciences, Inc. Nucleic acid ligation systems and methods
WO2013102081A2 (fr) 2011-12-29 2013-07-04 Ibis Biosciences, Inc. Distribution de macromolécule à des nanopuits
US9222115B2 (en) 2011-12-30 2015-12-29 Abbott Molecular, Inc. Channels with cross-sectional thermal gradients
WO2013104990A1 (fr) 2012-01-09 2013-07-18 Oslo Universitetssykehus Hf Procédés et biomarqueurs pour l'analyse d'un cancer colorectal
US9777269B2 (en) 2012-01-25 2017-10-03 Gencell Biosystems Ltd. Biomolecule isolation
CA2862552A1 (fr) 2012-01-26 2013-08-01 Nugen Technologies, Inc. Compositions et procedes pour l'enrichissement en sequence d'acide nucleique ciblee et la generation d'une banque a efficacite elevee
US9701959B2 (en) 2012-02-02 2017-07-11 Invenra Inc. High throughput screen for biologically active polypeptides
US8597882B2 (en) 2012-02-03 2013-12-03 Pyrobett Pte. Ltd. Method and apparatus for conducting an assay
WO2013117595A2 (fr) * 2012-02-07 2013-08-15 Illumina Cambridge Limited Enrichissement et amplification ciblés d'acides nucléiques sur un support
CA2863887C (fr) 2012-02-09 2023-01-03 Population Diagnostics, Inc. Methode de selection de biomarqueurs de variation de l'adn genomique basse frequence pour le trouble envahissant du developpement (ted) ou letrouble envahissant du developpement non specifie ailleurs (ted_nos)
CN104220876A (zh) 2012-02-21 2014-12-17 奥斯陆大学医院 用于宫颈癌的检测和预后的方法和生物标志物
US20130217023A1 (en) 2012-02-22 2013-08-22 454 Life Sciences Corporation System And Method For Generation And Use Of Compact Clonally Amplified Products
ES2930180T3 (es) 2012-03-02 2022-12-07 Sequenom Inc Métodos para enriquecer ácido nucleico canceroso a partir de una muestra biológica
EP2823060B1 (fr) 2012-03-05 2018-02-14 Adaptive Biotechnologies Corporation Détermination de chaînes appariées de récepteurs immuns à partir de sous-unités présentant une fréquence correspondante
IN2014DN08312A (fr) 2012-03-06 2015-05-15 Univ Oslo Hf
NO2694769T3 (fr) 2012-03-06 2018-03-03
US20130261984A1 (en) 2012-03-30 2013-10-03 Illumina, Inc. Methods and systems for determining fetal chromosomal abnormalities
US9193996B2 (en) 2012-04-03 2015-11-24 Illumina, Inc. Integrated optoelectronic read head and fluidic cartridge useful for nucleic acid sequencing
US9732387B2 (en) 2012-04-03 2017-08-15 The Regents Of The University Of Michigan Biomarker associated with irritable bowel syndrome and Crohn's disease
US8209130B1 (en) 2012-04-04 2012-06-26 Good Start Genetics, Inc. Sequence assembly
US8812422B2 (en) 2012-04-09 2014-08-19 Good Start Genetics, Inc. Variant database
US20130274148A1 (en) 2012-04-11 2013-10-17 Illumina, Inc. Portable genetic detection and analysis system and method
CN107435070A (zh) * 2012-04-12 2017-12-05 维里纳塔健康公司 拷贝数变异的检测和分类
US10227635B2 (en) 2012-04-16 2019-03-12 Molecular Loop Biosolutions, Llc Capture reactions
CN104471075B (zh) 2012-04-19 2018-06-22 生命技术公司 核酸扩增
EP3095879B1 (fr) 2012-04-19 2018-09-19 Life Technologies Corporation Amplification d'acides nucléiques
WO2013163210A1 (fr) * 2012-04-23 2013-10-31 Philip Alexander Rolfe Procédé et système pour la détection d'un organisme
WO2013165594A1 (fr) * 2012-04-30 2013-11-07 Life Technologies Corporation Modules et procédé d'étalonnage pour un système de préparation robotisé d'échantillons de polynucléotidiques
US20150133310A1 (en) 2012-05-02 2015-05-14 Ibis Biosciences, Inc. Nucleic acid sequencing systems and methods
DK2831276T3 (da) 2012-05-08 2016-08-01 Adaptive Biotechnologies Corp Sammensætninger og fremgangsmåde til at måle og kalibrere amplifikations-bias i multipleks-PCR-reaktioner
US9646132B2 (en) 2012-05-11 2017-05-09 Life Technologies Corporation Models for analyzing data from sequencing-by-synthesis operations
US10289800B2 (en) 2012-05-21 2019-05-14 Ariosa Diagnostics, Inc. Processes for calculating phased fetal genomic sequences
WO2013177220A1 (fr) * 2012-05-21 2013-11-28 The Scripps Research Institute Procédés de préparation d'un échantillon
US9920361B2 (en) 2012-05-21 2018-03-20 Sequenom, Inc. Methods and compositions for analyzing nucleic acid
CN102766574B (zh) * 2012-05-24 2013-12-25 中国科学院北京基因组研究所 用于dna测序仪的反应仓
EP2856177B1 (fr) * 2012-05-25 2020-11-18 The University of North Carolina At Chapel Hill Dispositifs microfluidiques, supports solides pour réactifs et procédés associés
WO2013184754A2 (fr) 2012-06-05 2013-12-12 President And Fellows Of Harvard College Séquençage spatial d'acides nucléiques à l'aide de sondes d'origami d'adn
US9012022B2 (en) 2012-06-08 2015-04-21 Illumina, Inc. Polymer coatings
US8895249B2 (en) 2012-06-15 2014-11-25 Illumina, Inc. Kinetic exclusion amplification of nucleic acid libraries
CN104619894B (zh) 2012-06-18 2017-06-06 纽亘技术公司 用于非期望核酸序列的阴性选择的组合物和方法
WO2014005076A2 (fr) 2012-06-29 2014-01-03 The Regents Of The University Of Michigan Procédés et biomarqueurs pour la détection de troubles rénaux
WO2014008448A1 (fr) 2012-07-03 2014-01-09 Sloan Kettering Institute For Cancer Research Évaluation quantitative de la reconstitution du répertoire des cellules t chez l'homme après une greffe allogénique de cellules souches hématopoïétiques
US20150011396A1 (en) 2012-07-09 2015-01-08 Benjamin G. Schroeder Methods for creating directional bisulfite-converted nucleic acid libraries for next generation sequencing
EP2872648B1 (fr) 2012-07-13 2019-09-04 Sequenom, Inc. Procédés et compositions pour l'enrichissement basé sur la méthylation d'un échantillon maternel en acide nucléique foetal, utiles pour les diagnostics prénatals non invasifs
US9092401B2 (en) 2012-10-31 2015-07-28 Counsyl, Inc. System and methods for detecting genetic variation
GB201212775D0 (en) 2012-07-18 2012-08-29 Dna Electronics Ltd Sensing apparatus and method
US9977861B2 (en) 2012-07-18 2018-05-22 Illumina Cambridge Limited Methods and systems for determining haplotypes and phasing of haplotypes
CA2878280A1 (fr) 2012-07-19 2014-01-23 Ariosa Diagnostics, Inc. Detection a base de ligature sequentielle multiplexe de variants genetiques
CA2877493C (fr) * 2012-07-24 2020-08-25 Natera, Inc. Procedes de pcr hautement multiplex et compositions
US8673972B2 (en) 2012-08-03 2014-03-18 Foundation Medicine, Inc. Human papilloma virus as predictor of cancer prognosis
JP6525872B2 (ja) 2012-08-08 2019-06-05 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 細胞中の複数のエピトープを同定するためのダイナミックレンジを高めること
AU2013302867A1 (en) 2012-08-13 2015-02-26 The Regents Of The University Of California Methods and systems for detecting biological components
US9951386B2 (en) 2014-06-26 2018-04-24 10X Genomics, Inc. Methods and systems for processing polynucleotides
US20140378345A1 (en) * 2012-08-14 2014-12-25 10X Technologies, Inc. Compositions and methods for sample processing
US20140378322A1 (en) * 2012-08-14 2014-12-25 10X Technologies, Inc. Compositions and methods for sample processing
US20150005199A1 (en) * 2012-08-14 2015-01-01 10X Technologies, Inc. Compositions and methods for sample processing
US9567631B2 (en) 2012-12-14 2017-02-14 10X Genomics, Inc. Methods and systems for processing polynucleotides
US10221442B2 (en) 2012-08-14 2019-03-05 10X Genomics, Inc. Compositions and methods for sample processing
US10752949B2 (en) 2012-08-14 2020-08-25 10X Genomics, Inc. Methods and systems for processing polynucleotides
US10273541B2 (en) 2012-08-14 2019-04-30 10X Genomics, Inc. Methods and systems for processing polynucleotides
US20150005200A1 (en) * 2012-08-14 2015-01-01 10X Technologies, Inc. Compositions and methods for sample processing
DK3435084T3 (da) 2012-08-16 2023-05-30 Mayo Found Medical Education & Res Prostatakræftprognose under anvendelse af biomarkører
NL2017959B1 (en) 2016-12-08 2018-06-19 Illumina Inc Cartridge assembly
EP2895620B1 (fr) 2012-09-11 2017-08-02 Life Technologies Corporation Amplification d'acides nucléiques
WO2014043143A1 (fr) 2012-09-11 2014-03-20 Life Technologies Corporation Amplification d'acides nucléiques
DK2895621T3 (da) 2012-09-14 2020-11-30 Population Bio Inc Fremgangsmåder og sammensætning til diagnosticering, prognose og behandling af neurologiske tilstande
US10233495B2 (en) 2012-09-27 2019-03-19 The Hospital For Sick Children Methods and compositions for screening and treating developmental disorders
ES2749118T3 (es) 2012-10-01 2020-03-19 Adaptive Biotechnologies Corp Evaluación de la inmunocompetencia por la diversidad de los receptores de inmunidad adaptativa y caracterización de la clonalidad
US10329608B2 (en) 2012-10-10 2019-06-25 Life Technologies Corporation Methods, systems, and computer readable media for repeat sequencing
US9177098B2 (en) 2012-10-17 2015-11-03 Celmatix Inc. Systems and methods for determining the probability of a pregnancy at a selected point in time
US10162800B2 (en) 2012-10-17 2018-12-25 Celmatix Inc. Systems and methods for determining the probability of a pregnancy at a selected point in time
WO2015160439A2 (fr) 2014-04-17 2015-10-22 Adaptive Biotechnologies Corporation Quantification de génomes de cellules de l'immunité acquise dans un mélange complexe de cellules
US9651539B2 (en) 2012-10-28 2017-05-16 Quantapore, Inc. Reducing background fluorescence in MEMS materials by low energy ion beam treatment
AU2013338393B2 (en) 2012-10-29 2017-05-11 The Johns Hopkins University Papanicolaou test for ovarian and endometrial cancers
EP2914621B1 (fr) 2012-11-05 2023-06-07 Foundation Medicine, Inc. Nouvelles molécules de fusion de ntrk1 et leurs utilisations
US9776182B2 (en) 2012-11-27 2017-10-03 Gencell Biosystems Ltd. Handling liquid samples
CN105189780A (zh) * 2012-12-03 2015-12-23 以琳生物药物有限公司 核酸制备和分析的组合物和方法
US9836577B2 (en) 2012-12-14 2017-12-05 Celmatix, Inc. Methods and devices for assessing risk of female infertility
EP2746405B1 (fr) 2012-12-23 2015-11-04 HS Diagnomics GmbH Procédés et ensembles d'amorces de séquençage de PCR à haut rendement
WO2014113502A1 (fr) 2013-01-15 2014-07-24 Quanterix Corporation Détection de l'adn ou de l'arn au moyen de matrices de molécules simples et d'autres techniques
US9128861B2 (en) 2013-01-17 2015-09-08 Personalis, Inc. Methods and systems for genetic analysis
WO2014113729A2 (fr) 2013-01-18 2014-07-24 Foundation Mecicine, Inc. Méthodes de traitement du cholangiocarcinome
WO2014116729A2 (fr) 2013-01-22 2014-07-31 The Board Of Trustees Of The Leland Stanford Junior University Haplotypage de loci hla par séquençage ultra-profond à l'aveugle
CA3209385A1 (fr) 2013-02-01 2014-08-07 The Regents Of The University Of California Procedes pour assemblage du genome et phasage d'haplotype
US9411930B2 (en) 2013-02-01 2016-08-09 The Regents Of The University Of California Methods for genome assembly and haplotype phasing
US9512422B2 (en) 2013-02-26 2016-12-06 Illumina, Inc. Gel patterned surfaces
ES2662598T3 (es) 2013-03-08 2018-04-09 F. Hoffmann-La Roche Ag Análisis de sangre para la detección de mutaciones de EGFR
EP3578666A1 (fr) * 2013-03-12 2019-12-11 President and Fellows of Harvard College Procédé de génération d'une matrice contenant un acide nucléique tridimensionnel
EP2971169A4 (fr) 2013-03-13 2016-10-26 Abbott Molecular Inc Systèmes et méthodes permettant d'isoler les acides nucléiques
WO2014164716A1 (fr) * 2013-03-13 2014-10-09 President And Fellows Of Harvard College Procédés d'élongation de l'adn
US11060145B2 (en) 2013-03-13 2021-07-13 Sequenom, Inc. Methods and compositions for identifying presence or absence of hypermethylation or hypomethylation locus
US8778609B1 (en) 2013-03-14 2014-07-15 Good Start Genetics, Inc. Methods for analyzing nucleic acids
US20140287946A1 (en) 2013-03-14 2014-09-25 Ibis Biosciences, Inc. Nucleic acid control panels
JP2016512437A (ja) 2013-03-14 2016-04-28 アボツト・モレキユラー・インコーポレイテツド 多重メチル化特異的増幅システムおよび方法
US9146248B2 (en) 2013-03-14 2015-09-29 Intelligent Bio-Systems, Inc. Apparatus and methods for purging flow cells in nucleic acid sequencing instruments
US20140296080A1 (en) 2013-03-14 2014-10-02 Life Technologies Corporation Methods, Systems, and Computer Readable Media for Evaluating Variant Likelihood
WO2014151764A2 (fr) 2013-03-15 2014-09-25 Veracyte, Inc. Procédés et compositions pour classification d'échantillons
US9591268B2 (en) 2013-03-15 2017-03-07 Qiagen Waltham, Inc. Flow cell alignment methods and systems
CN105358709B (zh) 2013-03-15 2018-12-07 雅培分子公司 用于检测基因组拷贝数变化的系统和方法
US9822408B2 (en) * 2013-03-15 2017-11-21 Nugen Technologies, Inc. Sequential sequencing
US10767221B2 (en) 2013-03-15 2020-09-08 Illumina, Inc. Enzyme-linked nucleotides
US9809852B2 (en) 2013-03-15 2017-11-07 Genapsys, Inc. Systems and methods for biological analysis
WO2014144822A2 (fr) 2013-03-15 2014-09-18 Immumetrix, Inc. Procédés et compositions d'étiquetage et d'analyse d'échantillons
EP2971152B1 (fr) 2013-03-15 2018-08-01 The Board Of Trustees Of The Leland Stanford Junior University Identification et utilisation de marqueurs tumoraux acides nucléiques circulants
ES2716094T3 (es) 2013-03-15 2019-06-10 Ibis Biosciences Inc Métodos para analizar la contaminación en la secuenciación del ADN
US11976329B2 (en) 2013-03-15 2024-05-07 Veracyte, Inc. Methods and systems for detecting usual interstitial pneumonia
US9708658B2 (en) * 2013-03-19 2017-07-18 New England Biolabs, Inc. Enrichment of target sequences
US11859171B2 (en) 2013-04-17 2024-01-02 Agency For Science, Technology And Research Method for generating extended sequence reads
JP6433982B2 (ja) * 2013-04-19 2018-12-05 シーメンス・ヘルスケア・ダイアグノスティックス・インコーポレーテッドＳｉｅｍｅｎｓ Ｈｅａｌｔｈｃａｒｅ Ｄｉａｇｎｏｓｔｉｃｓ Ｉｎｃ． 無接触微小滴ディスペンサおよび方法
RU2578009C2 (ru) * 2013-05-08 2016-03-20 Закрытое акционерное общество "ЕВРОГЕН" Способ идентификации нативных пар фрагментов днк или рнк, присутствующих в одних и тех же живых клетках
US10160995B2 (en) * 2013-05-13 2018-12-25 Qiagen Waltham, Inc. Analyte enrichment methods and compositions
EP3004385B1 (fr) 2013-05-24 2018-11-28 Quantapore Inc. Analyse d'acides nucléiques basés sur des nanopores avec une détection par fret mixte
WO2014197377A2 (fr) 2013-06-03 2014-12-11 Good Start Genetics, Inc. Procédés et systèmes pour stocker des données de lecture de séquence
EP3603679B1 (fr) 2013-06-04 2022-08-10 President and Fellows of Harvard College Régulation transcriptionnelle guidée par arn
US10526640B2 (en) 2013-06-19 2020-01-07 Industry-Academic Cooperation Foundation, Yonsei University Methods for retrieving sequence-verified nucleic acid fragments and apparatuses for amplifying sequence verified nucleic acid fragments
KR101648252B1 (ko) * 2014-01-28 2016-08-16 연세대학교 산학협력단 염기서열 확인 과정에서 분리된 핵산 단편들을 회수하는 방법
CN105849275B (zh) 2013-06-25 2020-03-17 普罗格诺西斯生物科学公司 检测样品中生物靶标的空间分布的方法和系统
US9708657B2 (en) * 2013-07-01 2017-07-18 Adaptive Biotechnologies Corp. Method for generating clonotype profiles using sequence tags
EP3919624A3 (fr) 2013-07-01 2021-12-29 Illumina, Inc. Fonctionnalisation de surface exempte de catalyseurs et greffage de polymères
ES2719579T3 (es) 2013-07-03 2019-07-11 Illumina Inc Sistema para secuenciación por síntesis ortogonal
US9926597B2 (en) 2013-07-26 2018-03-27 Life Technologies Corporation Control nucleic acid sequences for use in sequencing-by-synthesis and methods for designing the same
JP6656733B2 (ja) 2013-08-05 2020-03-04 ツイスト バイオサイエンス コーポレーション 新規合成した遺伝子ライブラリ
FI3030645T3 (fi) 2013-08-08 2023-02-10 Fluidijärjestelmä reagenssien toimittamiseen virtauskennoon
US20150051117A1 (en) * 2013-08-16 2015-02-19 President And Fellows Of Harvard College Assembly of Nucleic Acid Sequences in Emulsions
US20160199832A1 (en) 2013-08-30 2016-07-14 Advanced Liquid Logic France Sas Manipulation of droplets on hydrophilic or variegated-hydrophilic surfaces
WO2015031689A1 (fr) 2013-08-30 2015-03-05 Personalis, Inc. Méthodes et systèmes d'analyse génomique
US10395758B2 (en) 2013-08-30 2019-08-27 10X Genomics, Inc. Sequencing methods
CA2959978A1 (fr) * 2013-09-24 2015-04-02 The Regents Of The University Of California Capteurs et systemes de capteurs encapsules pour biodosages et diagnostics et leurs procedes de fabrication et d'utilisation
US10577655B2 (en) 2013-09-27 2020-03-03 Natera, Inc. Cell free DNA diagnostic testing standards
US10262755B2 (en) 2014-04-21 2019-04-16 Natera, Inc. Detecting cancer mutations and aneuploidy in chromosomal segments
WO2015051275A1 (fr) 2013-10-03 2015-04-09 Personalis, Inc. Procédés d'analyse de génotypes
JP6532456B2 (ja) 2013-10-04 2019-06-19 ライフ テクノロジーズ コーポレーション 終止化学を用いる配列決定における整相効果（ｐｈａｓｉｎｇ ｅｆｆｅｃｔｓ）をモデル化するための方法及びシステム
EP3572527B1 (fr) 2013-10-17 2021-05-26 Illumina, Inc. Procédés et compositions pour préparer des bibliothèques d'acides nucléiques
US10851414B2 (en) 2013-10-18 2020-12-01 Good Start Genetics, Inc. Methods for determining carrier status
US11041203B2 (en) 2013-10-18 2021-06-22 Molecular Loop Biosolutions, Inc. Methods for assessing a genomic region of a subject
US9897986B2 (en) 2013-10-29 2018-02-20 Regal Beloit America, Inc. System and method for enabling a motor controller to communicate using multiple different communication protocols
CN103540672B (zh) * 2013-10-29 2015-04-08 中国科学技术大学 一种亲和核酸分子的快速鉴定和分离方法
WO2015069798A1 (fr) * 2013-11-05 2015-05-14 The Regents Of The University Of California Typage médico-légal par microsatellites d'une cellule isolée présente dans des gouttelettes microfluidiques
CN105829589B (zh) 2013-11-07 2021-02-02 小利兰·斯坦福大学理事会 用于分析人体微生物组及其组分的无细胞核酸
WO2015069634A1 (fr) 2013-11-08 2015-05-14 President And Fellows Of Harvard College Microparticules, procédés pour leur préparation et leur utilisation
WO2015073332A1 (fr) 2013-11-12 2015-05-21 Life Technologies Corporation Système et procédé de rupture d'une émulsion
EP3511422B1 (fr) 2013-11-12 2022-12-28 Population Bio, Inc. Procédés et compositions de diagnostic, pronostic et traitement de l'endométriose
CN104630202A (zh) * 2013-11-13 2015-05-20 北京大学 一种能够减小微量核酸物质整体扩增时产生偏倚的扩增方法
WO2015073711A1 (fr) 2013-11-13 2015-05-21 Nugen Technologies, Inc. Compositions et procédés pour l'identification d'une lecture de séquençage en double
EP3077543B1 (fr) 2013-12-05 2019-09-25 Centrillion Technology Holdings Corporation Fabrication de réseaux structurés
EP3077545B1 (fr) 2013-12-05 2020-09-16 Centrillion Technology Holdings Corporation Procédés de séquençage d'acides nucléiques
US10385335B2 (en) 2013-12-05 2019-08-20 Centrillion Technology Holdings Corporation Modified surfaces
AU2014364180B2 (en) 2013-12-09 2021-03-04 Illumina, Inc. Methods and compositions for targeted nucleic acid sequencing
US11091758B2 (en) 2013-12-11 2021-08-17 The Regents Of The University Of California Methods for labeling DNAa fragments to reconstruct physical linkage and phase
EP3080300B1 (fr) 2013-12-11 2020-09-02 Genapsys Inc. Systèmes et procédés d'analyse et d'informatique biologiques
WO2015089438A1 (fr) 2013-12-13 2015-06-18 Northwestern University Biomarqueurs pour les états de stress post-traumatique
US9824068B2 (en) 2013-12-16 2017-11-21 10X Genomics, Inc. Methods and apparatus for sorting data
US10768181B2 (en) 2013-12-17 2020-09-08 The Brigham And Women's Hospital, Inc. Detection of an antibody against a pathogen
US11193176B2 (en) 2013-12-31 2021-12-07 Bio-Rad Laboratories, Inc. Method for detecting and quantifying latent retroviral RNA species
WO2015103225A1 (fr) 2013-12-31 2015-07-09 Illumina, Inc. Cuve à circulation adressable utilisant des électrodes à motif
WO2015107430A2 (fr) 2014-01-16 2015-07-23 Oslo Universitetssykehus Hf Méthodes et biomarqueurs pour la détection et le pronostic du cancer du col de l'utérus
US9587268B2 (en) 2014-01-29 2017-03-07 Agilent Technologies Inc. Fast hybridization for next generation sequencing target enrichment
US9387451B2 (en) 2014-02-03 2016-07-12 International Business Machines Corporation Flow cell array and uses thereof
EP3105326A4 (fr) 2014-02-10 2018-01-10 Gencell Biosystems Limited Dispositif de préparation de banque d'acides nucléiques médiée par des cellules à liquides composites (clc), et ses procédés d'utilisation
US9745614B2 (en) 2014-02-28 2017-08-29 Nugen Technologies, Inc. Reduced representation bisulfite sequencing with diversity adaptors
WO2015134787A2 (fr) 2014-03-05 2015-09-11 Adaptive Biotechnologies Corporation Procédés dans lesquels on utilise des molécules synthétiques contenant des randomères
EP3736344A1 (fr) 2014-03-13 2020-11-11 Sequenom, Inc. Méthodes et procédés d'évaluation non invasive de variations génétiques
WO2015141649A1 (fr) * 2014-03-20 2015-09-24 ユニバーサル・バイオ・リサーチ株式会社 Dispositif d'automatisation de l'amplification d'acide nucléique et dispositif d'automatisation de l'analyse d'une amplification d'acide nucléique
US11060139B2 (en) 2014-03-28 2021-07-13 Centrillion Technology Holdings Corporation Methods for sequencing nucleic acids
US10066265B2 (en) 2014-04-01 2018-09-04 Adaptive Biotechnologies Corp. Determining antigen-specific t-cells
US11390921B2 (en) 2014-04-01 2022-07-19 Adaptive Biotechnologies Corporation Determining WT-1 specific T cells and WT-1 specific T cell receptors (TCRs)
US20150284715A1 (en) * 2014-04-07 2015-10-08 Qiagen Gmbh Enrichment Methods
CN106413896B (zh) 2014-04-10 2019-07-05 10X基因组学有限公司 用于封装和分割试剂的流体装置、系统和方法及其应用
WO2015161054A2 (fr) 2014-04-18 2015-10-22 Genapsys, Inc. Procédés et systèmes pour l'amplification d'acide nucléique
EP3957749A1 (fr) 2014-04-21 2022-02-23 Natera, Inc. Détection de mutations spécifiques d'un tumeur dans les biopsies par séquençage exome entier et dans les échantillons acellulaires
US11053548B2 (en) 2014-05-12 2021-07-06 Good Start Genetics, Inc. Methods for detecting aneuploidy
US10760109B2 (en) 2014-06-06 2020-09-01 The Regents Of The University Of Michigan Compositions and methods for characterizing and diagnosing periodontal disease
WO2015191877A1 (fr) * 2014-06-11 2015-12-17 Life Technologies Corporation Systèmes et procédés d'enrichissement d'un substrat
EP3155127B1 (fr) * 2014-06-13 2020-07-22 Life Technologies Corporation Amplification multiplex d'acides nucléiques
CN105392902B (zh) 2014-06-24 2021-10-29 生物辐射实验室股份有限公司 数字式pcr条码化
CN110211637B (zh) 2014-06-26 2023-10-27 10X基因组学有限公司 核酸序列装配的方法和系统
EP3160654A4 (fr) 2014-06-27 2017-11-15 The Regents of The University of California Tri activé par pcr (pas)
MX2016017136A (es) 2014-06-27 2017-05-10 Abbott Lab Composiciones y metodos para detectar pegivirus 2 de humano (hpgv-2).
WO2016007839A1 (fr) 2014-07-11 2016-01-14 President And Fellows Of Harvard College Méthodes de marquage et de détection à haut rendement de caractéristiques biologiques in situ à l'aide de microscopie
CA2954895A1 (fr) 2014-07-17 2016-01-21 Celmatix Inc. Procedes et systemes pour evaluer l'infertilite et des pathologies apparentees
EP3578668B1 (fr) 2014-07-24 2020-12-30 Abbott Molecular Inc. Procédés pour la détection et l'analyse de mycobacterium tuberculosis
US10526641B2 (en) 2014-08-01 2020-01-07 Dovetail Genomics, Llc Tagging nucleic acids for sequence assembly
WO2016022696A1 (fr) 2014-08-05 2016-02-11 The Trustees Of Columbia University In The City Of New York Procédé d'isolement d'aptamères pour détecter une maladie résiduelle minimale
US10102337B2 (en) 2014-08-06 2018-10-16 Nugen Technologies, Inc. Digital measurements from targeted sequencing
GB201413929D0 (en) 2014-08-06 2014-09-17 Geneseque As Method
CA2956812C (fr) 2014-08-11 2023-04-11 Luminex Corporation Sondes pour une discrimination de fusion et un multiplexage ameliores dans des analyses d'acides nucleiques
GB2543728B (en) 2014-08-12 2019-04-17 Nextgen Jane Inc Medical kit and method for processing a biological sample
US10435685B2 (en) * 2014-08-19 2019-10-08 Pacific Biosciences Of California, Inc. Compositions and methods for enrichment of nucleic acids
EP3183577B1 (fr) 2014-08-21 2020-08-19 Illumina Cambridge Limited Fonctionnalisation de surface réversible
WO2016036403A1 (fr) 2014-09-05 2016-03-10 Population Diagnostics Inc. Méthodes et compositions destinées à inhiber et à traiter des états neurologiques
CA3180239A1 (fr) 2014-09-08 2016-03-17 Becton, Dickinson And Company Plateau ameliore pour malaxage pharmaceutique
US11408024B2 (en) 2014-09-10 2022-08-09 Molecular Loop Biosciences, Inc. Methods for selectively suppressing non-target sequences
CN105400864B (zh) * 2014-09-12 2020-04-14 深圳华大基因股份有限公司 用于基于血液样品构建测序文库的方法及其在确定胎儿遗传异常中的用途
CN106715713B (zh) * 2014-09-12 2020-11-03 深圳华大智造科技有限公司 试剂盒及其在核酸测序中的用途
EP3192869B1 (fr) * 2014-09-12 2019-03-27 MGI Tech Co., Ltd. Oligonucléotide isolé et son utilisation dans le séquençage d'acide nucléique
US10550428B2 (en) 2014-09-17 2020-02-04 Ibis Biosciences, Inc. Sequencing by synthesis using pulse read optics
CN107002121B (zh) 2014-09-18 2020-11-13 亿明达股份有限公司 用于分析核酸测序数据的方法和系统
JP2017536087A (ja) 2014-09-24 2017-12-07 グッド スタート ジェネティクス， インコーポレイテッド 遺伝子アッセイのロバストネスを増大させるためのプロセス制御
CA2963604C (fr) 2014-10-10 2023-02-14 Quantapore, Inc. Analyse de polymeres, a base de nanopore, a l'aide de marqueurs fluorescents a desactivation mutuelle
WO2016060974A1 (fr) 2014-10-13 2016-04-21 Life Technologies Corporation Procédés, systèmes, et supports lisibles par ordinateur pour appel de bases accéléré
EP3209419A4 (fr) 2014-10-22 2018-10-03 The Regents of The University of California Imprimante à microgouttelettes haute définition
CN107002126B (zh) * 2014-10-24 2021-05-25 昆塔波尔公司 使用纳米结构阵列的聚合物的高效光学分析
US20160122817A1 (en) 2014-10-29 2016-05-05 10X Genomics, Inc. Methods and compositions for targeted nucleic acid sequencing
CA2966201A1 (fr) 2014-10-29 2016-05-06 Adaptive Biotechnologies Corp. Detection simultanee hautement multiplexee d'acides nucleiques codant pour des heterodimeres de recepteurs de l'immunite adaptative apparies a partir de nombreux echantillons
EP4026913A1 (fr) 2014-10-30 2022-07-13 Personalis, Inc. Procédés d'utilisation du mosaïcisme dans des acides nucléiques prélevés de façon distale par rapport à leur origine
CN114805710B (zh) 2014-10-31 2023-11-17 伊鲁米纳剑桥有限公司 聚合物以及dna共聚物涂层
JP6812797B2 (ja) * 2014-11-04 2021-01-13 凸版印刷株式会社 核酸導入方法、核酸検出方法、生体成分解析方法、生体成分定量用アレイデバイス、及び生体成分解析キット
EP3770274A1 (fr) 2014-11-05 2021-01-27 Veracyte, Inc. Systèmes et procédés de diagnostic de la fibrose pulmonaire idiopathique sur des biopsies transbronchiques à l'aide de l'apprentissage automatique et de données de transcription dimensionnelle élevée
CN111024936A (zh) 2014-11-05 2020-04-17 纳迈达斯生物科技中心 用于增强成像的金属复合物
CN107250358B (zh) 2014-11-05 2021-03-30 伊卢米纳剑桥有限公司 在样品制备和测序期间使用铁载体螯合剂减少dna损伤
US9975122B2 (en) 2014-11-05 2018-05-22 10X Genomics, Inc. Instrument systems for integrated sample processing
US10246701B2 (en) 2014-11-14 2019-04-02 Adaptive Biotechnologies Corp. Multiplexed digital quantitation of rearranged lymphoid receptors in a complex mixture
US11789906B2 (en) 2014-11-19 2023-10-17 Arc Bio, Llc Systems and methods for genomic manipulations and analysis
WO2016081549A1 (fr) 2014-11-20 2016-05-26 Ampliwise Inc. Compositions, méthodes, systèmes et kits d'amplification et d'analyse d'acides nucléiques
US10233490B2 (en) 2014-11-21 2019-03-19 Metabiotech Corporation Methods for assembling and reading nucleic acid sequences from mixed populations
US11066705B2 (en) 2014-11-25 2021-07-20 Adaptive Biotechnologies Corporation Characterization of adaptive immune response to vaccination or infection using immune repertoire sequencing
EP3227464B1 (fr) 2014-12-05 2022-04-20 Foundation Medicine, Inc. Analyse multigénique de prélèvements tumoraux
US20160177386A1 (en) 2014-12-18 2016-06-23 Life Technologies Corporation Calibration panels and methods for designing the same
US20180016631A1 (en) 2014-12-24 2018-01-18 Keygene N.V. Backbone mediated mate pair sequencing
US10066259B2 (en) 2015-01-06 2018-09-04 Good Start Genetics, Inc. Screening for structural variants
CN112126675B (zh) 2015-01-12 2022-09-09 10X基因组学有限公司 用于制备核酸测序文库的方法和系统以及用其制备的文库
SG11201705425SA (en) 2015-01-13 2017-08-30 10X Genomics Inc Systems and methods for visualizing structural variation and phasing information
GB201501012D0 (en) * 2015-01-21 2015-03-04 Base4 Innovation Ltd Improved droplet sequencing apparatus and method
WO2016122582A1 (fr) * 2015-01-30 2016-08-04 Hewlett Packard Enterprise Development Lp Projection préservant la relation entre des objets numériques
WO2016125236A1 (fr) 2015-02-02 2016-08-11 株式会社日立ハイテクノロジーズ Dispositif d'analyse par fluorescence multicolore
US10646869B2 (en) * 2015-02-03 2020-05-12 Hitachi, Ltd. Flow cell device for single cell analysis, and single cell analysis device
US10669304B2 (en) 2015-02-04 2020-06-02 Twist Bioscience Corporation Methods and devices for de novo oligonucleic acid assembly
WO2016126987A1 (fr) 2015-02-04 2016-08-11 Twist Bioscience Corporation Compositions et méthodes d'assemblage de gène synthétique
EP3253479B1 (fr) 2015-02-04 2022-09-21 The Regents of The University of California Séquençage d'acides nucléiques contenus dans des entités individuelles par barcoding
CA2975529A1 (fr) 2015-02-09 2016-08-18 10X Genomics, Inc. Systemes et procedes pour determiner la variation structurale et la mise en phase au moyen de donnees d'appel de variant
WO2016134034A1 (fr) 2015-02-17 2016-08-25 Dovetail Genomics Llc Assemblage de séquences d'acide nucléique
CN107407685B (zh) 2015-02-20 2021-08-03 宝生物工程（美国)有限公司 快速精确分配、可视化和分析单个细胞的方法
KR20170119710A (ko) 2015-02-24 2017-10-27 10엑스 제노믹스, 인크. 표적화된 핵산 서열 커버리지 방법
EP4286516A3 (fr) 2015-02-24 2024-03-06 10X Genomics, Inc. Procédés et systèmes de traitement de cloisonnement
AU2016222788B2 (en) 2015-02-24 2022-03-31 Adaptive Biotechnologies Corp. Methods for diagnosing infectious disease and determining HLA status using immune repertoire sequencing
CN107614096A (zh) 2015-03-13 2018-01-19 哈佛学院院长及董事 使用扩增测定细胞
CA2979850C (fr) 2015-03-24 2020-07-21 Illumina, Inc. Procedes, ensembles de support, et systemes pour l'imagerie d'echantillons pour une analyse biologique ou chimique
US11807896B2 (en) 2015-03-26 2023-11-07 Dovetail Genomics, Llc Physical linkage preservation in DNA storage
US20160287152A1 (en) * 2015-03-30 2016-10-06 Verily Life Sciences Llc Functionalized Nanoparticles, Methods and In Vivo Diagnostic System
AU2016242967B2 (en) 2015-04-01 2021-07-01 Adaptive Biotechnologies Corp. Method of identifying human compatible T cell receptors specific for an antigenic target
CA2980769A1 (fr) 2015-04-02 2016-10-06 The Jackson Laboratory Procede pour detecter des variations genomiques a l'aide de banques de paires d'appariement circularisees et d'un sequencage aleatoire
EP3530752B1 (fr) 2015-04-10 2021-03-24 Spatial Transcriptomics AB Analyse de plusieurs acides nucléiques spatialement différenciés de spécimens biologiques
WO2016172377A1 (fr) 2015-04-21 2016-10-27 Twist Bioscience Corporation Dispositifs et procédés pour la synthèse de banques d'acides oligonucléiques
EP3091026B1 (fr) 2015-05-08 2019-02-20 Centrillion Technology Holdings Corporation Terminateurs réversibles à liaison disulfure
WO2016183106A1 (fr) 2015-05-11 2016-11-17 Natera, Inc. Procédés et compositions pour la détermination de la ploïdie
DK3294911T3 (da) 2015-05-11 2020-11-16 Illumina Inc Platform til opdagelse og analyse af terapeutiske midler
CN107969138B (zh) 2015-05-14 2022-04-12 生命科技公司 条形码序列和有关系统与方法
EP3527672B1 (fr) 2015-06-09 2022-10-05 Centrillion Technology Holdings Corporation Matrices aux oligonucleotides pour la séquençage d'acides nucléiques
WO2017007753A1 (fr) 2015-07-07 2017-01-12 Illumina, Inc. Formation de motifs en surface sélective par nanoimpression
CN108350452B (zh) 2015-07-14 2022-07-19 雅培分子公司 使用铜-钛氧化物纯化核酸
WO2017011565A1 (fr) 2015-07-14 2017-01-19 Abbott Molecular Inc. Compositions et méthodes d'identification de tuberculose résistante aux médicaments
ES2945607T3 (es) 2015-07-17 2023-07-04 Illumina Inc Láminas de polímero para aplicaciones de secuenciación
US10150994B2 (en) 2015-07-22 2018-12-11 Qiagen Waltham, Inc. Modular flow cells and methods of sequencing
BR112017023418A2 (pt) 2015-07-30 2018-07-24 Illumina, Inc. desbloqueio ortogonal de nucleotídeos
EP3332034A4 (fr) 2015-08-06 2019-01-02 Arc Bio, LLC Systèmes et procédés d'analyse génomique
WO2017027653A1 (fr) 2015-08-11 2017-02-16 The Johns Hopkins University Analyse du fluide d'un kyste ovarien
US10976334B2 (en) 2015-08-24 2021-04-13 Illumina, Inc. In-line pressure accumulator and flow-control system for biological or chemical assays
CN107921432A (zh) 2015-09-02 2018-04-17 伊卢米纳剑桥有限公司 改善流控系统中的液滴操作的系统和方法
US10647981B1 (en) 2015-09-08 2020-05-12 Bio-Rad Laboratories, Inc. Nucleic acid library generation methods and compositions
US9938572B1 (en) 2015-09-08 2018-04-10 Raindance Technologies, Inc. System and method for forming an emulsion
JP6982362B2 (ja) 2015-09-18 2021-12-17 ツイスト バイオサイエンス コーポレーション オリゴ核酸変異体ライブラリーとその合成
CN108698012A (zh) 2015-09-22 2018-10-23 特韦斯特生物科学公司 用于核酸合成的柔性基底
US10465232B1 (en) 2015-10-08 2019-11-05 Trace Genomics, Inc. Methods for quantifying efficiency of nucleic acid extraction and detection
CN108289797B (zh) 2015-10-13 2022-01-28 哈佛学院院长及董事 用于制备和使用凝胶微球的系统和方法
SG11201803289VA (en) 2015-10-19 2018-05-30 Dovetail Genomics Llc Methods for genome assembly, haplotype phasing, and target independent nucleic acid detection
WO2017079406A1 (fr) 2015-11-03 2017-05-11 President And Fellows Of Harvard College Procédé et appareil pour imagerie volumétrique d'une matrice tridimensionnelle contenant des acides nucléiques
US11371094B2 (en) 2015-11-19 2022-06-28 10X Genomics, Inc. Systems and methods for nucleic acid processing using degenerate nucleotides
US9895673B2 (en) 2015-12-01 2018-02-20 Twist Bioscience Corporation Functionalized surfaces and preparation thereof
WO2017096110A1 (fr) * 2015-12-04 2017-06-08 Siemens Healthcare Diagnostics Inc. Procédé et dispositif pour optimiser le processus d'identification de pathogènes
SG11201804086VA (en) 2015-12-04 2018-06-28 10X Genomics Inc Methods and compositions for nucleic acid analysis
US10730030B2 (en) 2016-01-08 2020-08-04 Bio-Rad Laboratories, Inc. Multiple beads per droplet resolution
AU2017207259B2 (en) 2016-01-11 2019-06-27 Illumina Singapore Pte Ltd Detection apparatus having a microfluorometer, a fluidic system, and a flow cell latch clamp module
CN108495938B (zh) * 2016-01-12 2023-07-14 生物辐射实验室股份有限公司 利用相位移区块合成条码化序列及其用途
WO2017123758A1 (fr) 2016-01-12 2017-07-20 Seqwell, Inc. Compositions et méthodes pour le séquençage d'acides nucléiques
KR102641264B1 (ko) 2016-01-22 2024-02-26 퍼듀 리서치 파운데이션 하전된 질량 표지 시스템
JP6685138B2 (ja) 2016-01-27 2020-04-22 シスメックス株式会社 核酸増幅の精度管理方法、精度管理用試薬およびその試薬キット
EP3848457A1 (fr) 2016-02-08 2021-07-14 Rgene, Inc. Compositions de ligase multiples, systèmes et procédés
JP6735348B2 (ja) 2016-02-11 2020-08-05 １０エックス ジェノミクス， インコーポレイテッド 全ゲノム配列データのデノボアセンブリのためのシステム、方法及び媒体
JP2017143783A (ja) * 2016-02-17 2017-08-24 国立大学法人 筑波大学 並列反応用懸濁液、並列反応方法、スクリーニング方法および検査方法
KR20180116377A (ko) 2016-02-23 2018-10-24 더브테일 제노믹스 엘엘씨 게놈 어셈블리를 위한 페이징된 판독 세트의 생성 및 반수체형 페이징
WO2017155858A1 (fr) 2016-03-07 2017-09-14 Insilixa, Inc. Identification de séquence d'acide nucléique à l'aide d'une extension de base unique cyclique en phase solide
US20190062827A1 (en) 2016-03-14 2019-02-28 RGENE, Inc. HYPER-THERMOSTABLE LYSINE-MUTANT ssDNA/RNA LIGASES
CA3016077A1 (fr) 2016-03-22 2017-09-28 Counsyl, Inc. Criblage combinatoire d'adn
EP4198146A3 (fr) 2016-03-25 2023-08-23 Karius, Inc. Procédé utilisant des spike-ins d'acides nucléiques synthétiques
CN108463287B (zh) 2016-03-28 2021-01-15 亿明达股份有限公司 多平面微阵列
WO2017180909A1 (fr) 2016-04-13 2017-10-19 Nextgen Jane, Inc. Dispositifs, systèmes et procédés de collecte et de conservation d'échantillon
US11355328B2 (en) 2016-04-13 2022-06-07 Purdue Research Foundation Systems and methods for isolating a target ion in an ion trap using a dual frequency waveform
ITUA20162640A1 (it) * 2016-04-15 2017-10-15 Menarini Silicon Biosystems Spa Metodo e kit per la generazione di librerie di dna per sequenziamento massivo parallelo
CA3210120C (fr) 2016-04-25 2024-04-09 President And Fellows Of Harvard College Procedes de reaction en chaine d'hybridation pour la detection moleculaire in situ
CN105821482B (zh) * 2016-04-29 2018-04-10 李星军 一种生化微反应体系、高通量测序的建库仪及应用
US10077459B2 (en) 2016-05-04 2018-09-18 General Electric Company Cell-free protein expression using rolling circle amplification product
US10619205B2 (en) 2016-05-06 2020-04-14 Life Technologies Corporation Combinatorial barcode sequences, and related systems and methods
EP3455356B1 (fr) 2016-05-13 2021-08-04 Dovetail Genomics LLC Récupération d'informations de liaison de longue portée à partir d'échantillons conservés
WO2017197338A1 (fr) 2016-05-13 2017-11-16 10X Genomics, Inc. Systèmes microfluidiques et procédés d'utilisation
US10900076B2 (en) 2016-05-18 2021-01-26 Illumina, Inc. Self assembled patterning using patterned hydrophobic surfaces
US11299783B2 (en) 2016-05-27 2022-04-12 Personalis, Inc. Methods and systems for genetic analysis
EP3469078B1 (fr) 2016-06-10 2024-03-27 Life Technologies Corporation Procédés et compositions d'amplification d'acide nucléique
EP3469097B1 (fr) * 2016-06-14 2020-02-19 Base4 Innovation Limited Procédé de séparation d'un polynucléotide modifié
WO2018013509A1 (fr) 2016-07-11 2018-01-18 Arizona Board Of Regents On Behalf Of The University Of Arizona Compositions et méthodes pour diagnostiquer et traiter des arythmies
WO2018017884A1 (fr) 2016-07-20 2018-01-25 Genapsys, Inc. Systèmes et procédés de séquençage d'acides nucléiques
JP7075394B2 (ja) 2016-07-21 2022-05-25 タカラ バイオ ユーエスエー， インコーポレイテッド マルチウェルデバイスを用いたマルチｚ撮像及び分注
WO2018031691A1 (fr) 2016-08-10 2018-02-15 The Regents Of The University Of California Amplification à déplacement multiple et pcr combinées dans une microgouttelette d'émulsion
EP3500082A1 (fr) 2016-08-22 2019-06-26 Biolumic Limited Système, dispositif et méthodes de traitement de semences
GB2568444A (en) 2016-08-22 2019-05-15 Twist Bioscience Corp De novo synthesized nucleic acid libraries
WO2018039490A1 (fr) 2016-08-24 2018-03-01 Genomedx Biosciences, Inc. Utilisation de signatures génomiques en vue d'une prédiction de la réactivité de patients atteints d'un cancer de la prostate à une radiothérapie postopératoire
EP3507364A4 (fr) 2016-08-31 2020-05-20 President and Fellows of Harvard College Procédés de génération de bibliothèques de séquences d'acides nucléiques pour la détection par séquençage fluorescent in situ
WO2018045186A1 (fr) 2016-08-31 2018-03-08 President And Fellows Of Harvard College Procédés de combinaison de la détection de biomolécules dans un dosage unique à l'aide d'un séquençage fluorescent in situ
WO2018039969A1 (fr) * 2016-08-31 2018-03-08 President And Fellows Of Harvard College Procédés d'amplification numérique du génome entier
WO2018045162A1 (fr) 2016-09-01 2018-03-08 Biogen Ma Inc. Biomarqueurs prédictifs de la sclérose en plaques progressive primaire et leurs utilisations
US10428325B1 (en) 2016-09-21 2019-10-01 Adaptive Biotechnologies Corporation Identification of antigen-specific B cell receptors
KR102217487B1 (ko) 2016-09-21 2021-02-23 트위스트 바이오사이언스 코포레이션 핵산 기반 데이터 저장
WO2018064226A1 (fr) 2016-09-27 2018-04-05 uBiome, Inc. Procédé et système de préparation et de séquençage de banque à base de crispr
WO2018064116A1 (fr) 2016-09-28 2018-04-05 Illumina, Inc. Procédés et systèmes de traitement de données
US11485996B2 (en) 2016-10-04 2022-11-01 Natera, Inc. Methods for characterizing copy number variation using proximity-litigation sequencing
US10190155B2 (en) 2016-10-14 2019-01-29 Nugen Technologies, Inc. Molecular tag attachment and transfer
IL290157B2 (en) 2016-10-14 2023-09-01 Illumina Inc cartridge kit
US11725232B2 (en) 2016-10-31 2023-08-15 The Hong Kong University Of Science And Technology Compositions, methods and kits for detection of genetic variants for alzheimer's disease
US10255990B2 (en) 2016-11-11 2019-04-09 uBiome, Inc. Method and system for fragment assembly and sequence identification
US10011870B2 (en) 2016-12-07 2018-07-03 Natera, Inc. Compositions and methods for identifying nucleic acid molecules
CN110366613A (zh) 2016-12-16 2019-10-22 特韦斯特生物科学公司 免疫突触的变体文库及其合成
WO2018118971A1 (fr) 2016-12-19 2018-06-28 Bio-Rad Laboratories, Inc. Adn marqué ayant une contiguïté préservée de marquage par gouttelettes
CA3047328A1 (fr) 2016-12-21 2018-06-28 The Regents Of The University Of California Sequencage genomique de cellules uniques a l'aide de gouttelettes a base d'hydrogel
US10011872B1 (en) 2016-12-22 2018-07-03 10X Genomics, Inc. Methods and systems for processing polynucleotides
US10815525B2 (en) 2016-12-22 2020-10-27 10X Genomics, Inc. Methods and systems for processing polynucleotides
US10550429B2 (en) 2016-12-22 2020-02-04 10X Genomics, Inc. Methods and systems for processing polynucleotides
EP3564387A4 (fr) 2016-12-27 2020-10-07 EGI Tech (Shen Zhen) Co., Limited Procédé de séquençage à base de colorant fluorescent unique
KR102349259B1 (ko) * 2017-01-04 2022-01-07 엠쥐아이 테크 컴퍼니 엘티디. 친화성 시약을 이용한 핵산 시퀀싱
GB201704754D0 (en) 2017-01-05 2017-05-10 Illumina Inc Kinetic exclusion amplification of nucleic acid libraries
EP3571322B9 (fr) 2017-01-20 2023-10-04 VERACYTE SD, Inc. Sous-typage moléculaire, pronostic et traitement du cancer de la vessie
WO2018140966A1 (fr) 2017-01-30 2018-08-02 10X Genomics, Inc. Procédés et systèmes de codage à barres de cellules individuelles sur la base de gouttelettes
GB201701688D0 (en) 2017-02-01 2017-03-15 Illumia Inc System and method with fiducials in non-recliner layouts
GB201701689D0 (en) 2017-02-01 2017-03-15 Illumia Inc System and method with fiducials of non-closed shapes
GB201701686D0 (en) 2017-02-01 2017-03-15 Illunina Inc System & method with fiducials having offset layouts
US10240205B2 (en) 2017-02-03 2019-03-26 Population Bio, Inc. Methods for assessing risk of developing a viral disease using a genetic test
US10995333B2 (en) 2017-02-06 2021-05-04 10X Genomics, Inc. Systems and methods for nucleic acid preparation
EP3585889A1 (fr) 2017-02-21 2020-01-01 Natera, Inc. Compositions, procédés, et kits d'isolement d'acides nucléiques
CA3054303A1 (fr) 2017-02-22 2018-08-30 Twist Bioscience Corporation Stockage de donnees reposant sur un acide nucleique
EP4218738A1 (fr) 2017-02-24 2023-08-02 The Regents of The University of California Structures de particules-gouttes et procédé pour les préparer et les utiliser
GB201703049D0 (en) * 2017-02-24 2017-04-12 Univ I Tromsø - Norges Arktiske Univ Single-strand binding protein
JP6931540B2 (ja) 2017-02-27 2021-09-08 シスメックス株式会社 検体処理チップを用いた送液方法、検体処理チップの送液装置
CA3055925A1 (fr) 2017-03-09 2018-09-13 Decipher Biosciences, Inc. Sous-typage du cancer de la prostate pour predire la reponse a une therapie hormonale
WO2018170169A1 (fr) 2017-03-15 2018-09-20 Twist Bioscience Corporation Banques de variants de la synapse immunologique et leur synthèse
WO2018175399A1 (fr) 2017-03-24 2018-09-27 Bio-Rad Laboratories, Inc. Amorces universelles en épingle à cheveux
US10737267B2 (en) 2017-04-04 2020-08-11 Omniome, Inc. Fluidic apparatus and methods useful for chemical and biological reactions
EP3610034B1 (fr) 2017-04-12 2022-06-08 Karius, Inc. Systèmes, procédés et compositions de préparation d'échantillon
US11185568B2 (en) 2017-04-14 2021-11-30 President And Fellows Of Harvard College Methods for generation of cell-derived microfilament network
US20210371918A1 (en) 2017-04-18 2021-12-02 Dovetail Genomics, Llc Nucleic acid characteristics as guides for sequence assembly
US10161003B2 (en) 2017-04-25 2018-12-25 Omniome, Inc. Methods and apparatus that increase sequencing-by-binding efficiency
JP2018183097A (ja) * 2017-04-26 2018-11-22 株式会社エンプラス 細胞由来の解析用液滴の単離方法、および細胞の解析方法
CA3062716A1 (fr) 2017-05-12 2018-11-15 Decipher Biosciences, Inc. Signatures genetiques pour predire une metastase du cancer de la prostate et identifier la virulence d'une tumeur
CN106957842B (zh) * 2017-05-15 2020-05-22 青岛安德贝生命科技有限公司 Bac克隆dna的提取方法
WO2018213774A1 (fr) 2017-05-19 2018-11-22 10X Genomics, Inc. Systèmes et procédés d'analyse d'ensembles de données
US10844372B2 (en) 2017-05-26 2020-11-24 10X Genomics, Inc. Single cell analysis of transposase accessible chromatin
EP4230746A3 (fr) 2017-05-26 2023-11-01 10X Genomics, Inc. Analyse de cellule unique de chromatine accessible par transposase
US20200362397A1 (en) * 2017-05-31 2020-11-19 Centrillion Technology Holdings Corporation Oligonucleotide probe array with electronic detection system
CN110997711A (zh) 2017-06-08 2020-04-10 布里格姆妇女医院 用于鉴定表位的方法和组合物
CA3066744A1 (fr) 2017-06-12 2018-12-20 Twist Bioscience Corporation Methodes d'assemblage d'acides nucleiques sans joint
WO2018231864A1 (fr) 2017-06-12 2018-12-20 Twist Bioscience Corporation Méthodes d'assemblage d'acides nucléiques continus
US11001885B2 (en) * 2017-06-13 2021-05-11 Personal Genomics Taiwan, Inc. Apparatus for single molecular sequencing and method of sequencing nucleic acid molecules
US11186862B2 (en) 2017-06-20 2021-11-30 Bio-Rad Laboratories, Inc. MDA using bead oligonucleotide
CA3068273A1 (fr) 2017-06-21 2018-12-27 Bluedot Llc Systemes et procedes d'identification d'acides nucleiques dans un echantillon
US11217329B1 (en) 2017-06-23 2022-01-04 Veracyte, Inc. Methods and systems for determining biological sample integrity
SG11202000964UA (en) 2017-08-15 2020-02-27 Omniome Inc Scanning apparatus and methods useful for detection of chemical and biological analytes
WO2019038594A2 (fr) 2017-08-21 2019-02-28 Biolumic Limited Plantes transgéniques à la croissance élevée et à la rusticité élevée
SG11202002194UA (en) 2017-09-11 2020-04-29 Twist Bioscience Corp Gpcr binding proteins and synthesis thereof
JP2020536051A (ja) 2017-09-20 2020-12-10 リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． 腫瘍が高いパッセンジャー遺伝子変異量を担持する患者の免疫療法剤
SG11202002516WA (en) 2017-09-21 2020-04-29 Genapsys Inc Systems and methods for nucleic acid sequencing
WO2019060716A1 (fr) 2017-09-25 2019-03-28 Freenome Holdings, Inc. Méthodes et systèmes d'extraction d'échantillon
CN111372574A (zh) * 2017-09-29 2020-07-03 加利福尼亚大学董事会 单分散乳液的制备方法
US10837047B2 (en) 2017-10-04 2020-11-17 10X Genomics, Inc. Compositions, methods, and systems for bead formation using improved polymers
CN111787930A (zh) 2017-10-06 2020-10-16 芝加哥大学 针对癌症特异性抗原对t淋巴细胞的筛选
US10501739B2 (en) 2017-10-18 2019-12-10 Mission Bio, Inc. Method, systems and apparatus for single cell analysis
WO2019079593A1 (fr) 2017-10-19 2019-04-25 Omniome, Inc. Réduction du bruit de fond et stabilisation de complexes simultanées dans des flux de travaux de dosage par liaison
WO2019079769A1 (fr) 2017-10-20 2019-04-25 Twist Bioscience Corporation Nano-puits chauffés pour la synthèse de polynucléotides
US11099202B2 (en) 2017-10-20 2021-08-24 Tecan Genomics, Inc. Reagent delivery system
WO2019084043A1 (fr) 2017-10-26 2019-05-02 10X Genomics, Inc. Méthodes et systèmes de préparation d'acide nucléique et d'analyse de chromatine
CN111479631B (zh) 2017-10-27 2022-02-22 10X基因组学有限公司 用于样品制备和分析的方法和系统
CN111295443B (zh) 2017-11-02 2024-04-16 生物辐射实验室股份有限公司 基于转座酶的基因组分析
SG11201913654QA (en) 2017-11-15 2020-01-30 10X Genomics Inc Functionalized gel beads
US10829815B2 (en) 2017-11-17 2020-11-10 10X Genomics, Inc. Methods and systems for associating physical and genetic properties of biological particles
WO2019103967A1 (fr) 2017-11-22 2019-05-31 The Regents Of The University Of Michigan Compositions et méthodes pour traiter le cancer
JP2021503969A (ja) 2017-11-29 2021-02-15 エックスゲノムズ コーポレーション 出現（ｅｍｅｒｇｅｎｃｅ）による核酸のシーケンシング
US11254980B1 (en) 2017-11-29 2022-02-22 Adaptive Biotechnologies Corporation Methods of profiling targeted polynucleotides while mitigating sequencing depth requirements
US11427867B2 (en) 2017-11-29 2022-08-30 Xgenomes Corp. Sequencing by emergence
WO2019108851A1 (fr) 2017-11-30 2019-06-06 10X Genomics, Inc. Systèmes et procédés de préparation et d'analyse d'acides nucléiques
JP2021509024A (ja) 2018-01-02 2021-03-18 ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン 多数の液滴の捕捉
US10936953B2 (en) 2018-01-04 2021-03-02 Twist Bioscience Corporation DNA-based digital information storage with sidewall electrodes
US20190237163A1 (en) 2018-01-12 2019-08-01 Life Technologies Corporation Methods for flow space quality score prediction by neural networks
EP4324962A3 (fr) 2018-01-31 2024-05-08 Bio-Rad Laboratories, Inc. Procédés et compositions pour déconvolutionner des codes à barres de partition
US20200370096A1 (en) 2018-01-31 2020-11-26 Dovetail Genomics, Llc Sample prep for dna linkage recovery
EP3752832A1 (fr) 2018-02-12 2020-12-23 10X Genomics, Inc. Procédés de caractérisation d'analytes multiples à partir de cellules individuelles ou de populations cellulaires
CN110184325A (zh) * 2018-02-22 2019-08-30 张家港万众一芯生物科技有限公司 基于微孔阵列芯片的单分子文库pcr扩增的基因测序方法
US11639928B2 (en) 2018-02-22 2023-05-02 10X Genomics, Inc. Methods and systems for characterizing analytes from individual cells or cell populations
CN112368397A (zh) * 2018-03-13 2021-02-12 萨摩尔股份有限公司 用于单分子测序的方法
WO2019195346A1 (fr) 2018-04-02 2019-10-10 Progenity, Inc. Procédés, systèmes et compositions de comptage de molécules d'acide nucléique
CN112262218A (zh) 2018-04-06 2021-01-22 10X基因组学有限公司 用于单细胞处理中的质量控制的系统和方法
EP3553182A1 (fr) 2018-04-11 2019-10-16 Université de Bourgogne Méthode de détection d'anomalies génétiques somatiques, combinaison de sondes de capture et d'un kit de détection
CA3097583A1 (fr) 2018-04-19 2019-10-24 Omniome, Inc. Amelioration de la precision d'appels de base dans des procedes de sequencage d'acide nucleique
CA3098296A1 (fr) 2018-04-26 2019-10-31 Omniome, Inc. Procedes et compositions destines a stabiliser des complexes acide nucleique-nucleotide-polymerase
US20210239700A1 (en) 2018-05-04 2021-08-05 Abbott Laboratories Hbv diagnostic, prognostic, and therapeutic methods and products
WO2019222706A1 (fr) 2018-05-18 2019-11-21 Twist Bioscience Corporation Polynucléotides, réactifs, et procédés d'hybridation d'acides nucléiques
EP3802874A1 (fr) 2018-05-31 2021-04-14 Omniome, Inc. Augmentation du rapport signal/bruit lors du séquençage d'acides nucléiques
US11814750B2 (en) 2018-05-31 2023-11-14 Personalis, Inc. Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples
US10801064B2 (en) 2018-05-31 2020-10-13 Personalis, Inc. Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples
US11180794B2 (en) 2018-05-31 2021-11-23 Omniome, Inc. Methods and compositions for capping nucleic acids
US11932899B2 (en) 2018-06-07 2024-03-19 10X Genomics, Inc. Methods and systems for characterizing nucleic acid molecules
US11703427B2 (en) 2018-06-25 2023-07-18 10X Genomics, Inc. Methods and systems for cell and bead processing
US11525159B2 (en) 2018-07-03 2022-12-13 Natera, Inc. Methods for detection of donor-derived cell-free DNA
AU2019312152A1 (en) 2018-07-24 2021-02-18 Pacific Biosciences Of California, Inc. Serial formation of ternary complex species
US20200032335A1 (en) 2018-07-27 2020-01-30 10X Genomics, Inc. Systems and methods for metabolome analysis
EP3836967A4 (fr) 2018-07-30 2022-06-15 ReadCoor, LLC Procédés et systèmes de traitement ou d'analyse d'échantillons
HRP20221504T1 (hr) 2018-08-08 2023-03-31 Pml Screening, Llc Postupci procjene rizika od razvoja progresivne multifokalne leukoencefalopatije uzrokovane john cunningham virusom pomoću genetskog testiranja
WO2020041293A1 (fr) 2018-08-20 2020-02-27 Bio-Rad Laboratories, Inc. Génération de séquences nucléotidiques par co-localisation de billes à code-barres dans des partitions
US11519033B2 (en) 2018-08-28 2022-12-06 10X Genomics, Inc. Method for transposase-mediated spatial tagging and analyzing genomic DNA in a biological sample
US20220048940A1 (en) 2018-09-28 2022-02-17 Centrillion Technology Holdings Corporation Disulfide-linked reversible terminators
AU2019364418A1 (en) 2018-10-25 2021-04-22 Illumina, Inc. Methods and compositions for identifying ligands on arrays using indexes and barcodes
WO2020101795A1 (fr) 2018-11-15 2020-05-22 Omniome, Inc. Détection électronique de structure d'acide nucléique
EP3887545A4 (fr) * 2018-11-29 2022-08-24 XGenomes Corp. Séquencage par coalescence
GB2585608B (en) 2018-12-04 2021-11-03 Omniome Inc Mixed-phase fluids for nucleic acid sequencing and other analytical assays
CA3121805A1 (fr) 2018-12-07 2020-06-11 Octant, Inc. Systemes de criblage d'interactions proteine-proteine
US11459607B1 (en) 2018-12-10 2022-10-04 10X Genomics, Inc. Systems and methods for processing-nucleic acid molecules from a single cell using sequential co-partitioning and composite barcodes
WO2020120442A2 (fr) 2018-12-13 2020-06-18 Dna Script Synthèse d'oligonucléotides directe sur des cellules et des biomolécules
SG11202012558VA (en) 2018-12-19 2021-01-28 Illumina Inc Methods for improving polynucleotide cluster clonality priority
US11041199B2 (en) 2018-12-20 2021-06-22 Omniome, Inc. Temperature control for analysis of nucleic acids and other analytes
US11358137B2 (en) 2018-12-26 2022-06-14 Industrial Technology Research Institute Tubular structure for producing droplets and method for producing droplets
CN109738469A (zh) * 2018-12-29 2019-05-10 赛纳生物科技(北京)有限公司 一种fop表面微坑镀膜的致密性检测方法
US20220081714A1 (en) 2019-01-04 2022-03-17 Northwestern University Storing temporal data into dna
US11926867B2 (en) 2019-01-06 2024-03-12 10X Genomics, Inc. Generating capture probes for spatial analysis
US11649485B2 (en) 2019-01-06 2023-05-16 10X Genomics, Inc. Generating capture probes for spatial analysis
US11845983B1 (en) 2019-01-09 2023-12-19 10X Genomics, Inc. Methods and systems for multiplexing of droplet based assays
EP3908678A1 (fr) 2019-01-10 2021-11-17 Iovance Biotherapeutics, Inc. Système et procédés de surveillance de la clonalité et de la persistance d'une thérapie cellulaire adoptive
MX2021009482A (es) * 2019-02-11 2021-11-12 Ultima Genomics Inc Metodos para el analisis de acidos nucleicos.
US11467153B2 (en) 2019-02-12 2022-10-11 10X Genomics, Inc. Methods for processing nucleic acid molecules
US11851683B1 (en) 2019-02-12 2023-12-26 10X Genomics, Inc. Methods and systems for selective analysis of cellular samples
SG11202108788TA (en) 2019-02-12 2021-09-29 10X Genomics Inc Methods for processing nucleic acid molecules
EP3924513B1 (fr) 2019-02-14 2023-04-12 Pacific Biosciences of California, Inc. Atténuation d'impacts défavorables de systèmes de détection sur des acides nucléiques et d'autres analytes biologiques
CN113613787B (zh) 2019-02-20 2023-06-13 加利福尼亚太平洋生物科学股份有限公司 用于检测化学和生物分析物的扫描装置和方法
US11655499B1 (en) 2019-02-25 2023-05-23 10X Genomics, Inc. Detection of sequence elements in nucleic acid molecules
SG11202109322TA (en) 2019-02-26 2021-09-29 Twist Bioscience Corp Variant nucleic acid libraries for glp1 receptor
JP2022522668A (ja) 2019-02-26 2022-04-20 ツイスト バイオサイエンス コーポレーション 抗体を最適化するための変異体核酸ライブラリ
WO2020185791A1 (fr) 2019-03-11 2020-09-17 10X Genomics, Inc. Systèmes et procédés de traitement de billes marquées optiquement
EP3937780A4 (fr) 2019-03-14 2022-12-07 InSilixa, Inc. Procédés et systèmes pour une détection à base de fluorescence résolue en temps
NL2023316B1 (en) 2019-03-21 2020-09-28 Illumina Inc Artificial intelligence-based sequencing
WO2020191387A1 (fr) 2019-03-21 2020-09-24 Illumina, Inc. Appel de base à base d'intelligence artificielle
NL2023312B1 (en) 2019-03-21 2020-09-28 Illumina Inc Artificial intelligence-based base calling
NL2023311B9 (en) 2019-03-21 2021-03-12 Illumina Inc Artificial intelligence-based generation of sequencing metadata
US11210554B2 (en) 2019-03-21 2021-12-28 Illumina, Inc. Artificial intelligence-based generation of sequencing metadata
NL2023310B1 (en) 2019-03-21 2020-09-28 Illumina Inc Training data generation for artificial intelligence-based sequencing
NL2023314B1 (en) 2019-03-21 2020-09-28 Illumina Inc Artificial intelligence-based quality scoring
WO2020206170A1 (fr) 2019-04-02 2020-10-08 Progenity, Inc. Procédés, systèmes et compositions de comptage de molécules d'acide nucléique
US11989216B2 (en) 2019-04-09 2024-05-21 University Of Washington Systems and methods for providing similarity-based retrieval of information stored in DNA
MX2021003760A (es) 2019-04-29 2021-09-21 Illumina Inc Identificacion y analisis de muestras microbianas por incubacion rapida y enriquecimiento de acido nucleico.
WO2020227382A1 (fr) * 2019-05-08 2020-11-12 Qiagen Sciences, Llc Procédés et compositions de séquençage séquentiel
US11593649B2 (en) 2019-05-16 2023-02-28 Illumina, Inc. Base calling using convolutions
AU2020280104A1 (en) 2019-05-22 2022-01-20 Mission Bio, Inc. Method and apparatus for simultaneous targeted sequencing of DNA, RNA and protein
AU2020283935A1 (en) 2019-05-28 2021-12-23 Octant, Inc. Transcriptional relay system
EP3976820A1 (fr) 2019-05-30 2022-04-06 10X Genomics, Inc. Procédés de détection de l'hétérogénéité spatiale d'un échantillon biologique
WO2020252186A1 (fr) 2019-06-11 2020-12-17 Omniome, Inc. Détection de mise au point étalonnée
AU2020298294A1 (en) 2019-06-21 2022-02-17 Twist Bioscience Corporation Barcode-based nucleic acid sequence assembly
WO2021003255A1 (fr) 2019-07-01 2021-01-07 Mission Bio Procédé et appareil pour normaliser des lectures quantitatives dans des expériences à cellule unique
WO2021011803A1 (fr) 2019-07-16 2021-01-21 Omniome, Inc. Acides nucléiques synthétiques ayant des structures non naturelles
US10656368B1 (en) 2019-07-24 2020-05-19 Omniome, Inc. Method and system for biological imaging using a wide field objective lens
CN110499361B (zh) * 2019-07-31 2022-11-25 齐鲁工业大学 一种末端碱基流式荧光测序微球的制备方法及应用
US20230178182A1 (en) 2019-08-19 2023-06-08 Green Cross Genome Corporation Method for detecting chromosomal abnormality by using information about distance between nucleic acid fragments
TW202124406A (zh) 2019-09-10 2021-07-01 美商歐姆尼歐美公司 核苷酸之可逆修飾
BR112021026562A2 (pt) 2019-09-20 2022-11-29 Illumina Inc Métodos e composições para identificar ligantes em arranjos com o uso de índices e códigos de barras
CN114829626A (zh) 2019-10-10 2022-07-29 1859公司 用于微流体筛选的方法和系统
CN114599795A (zh) * 2019-10-18 2022-06-07 加利福尼亚太平洋生物科学股份有限公司 用于对核酸加帽的方法和组合物
CN114556480A (zh) 2019-11-07 2022-05-27 欧森纳治疗股份有限公司 肿瘤微环境的分类
WO2021091611A1 (fr) 2019-11-08 2021-05-14 10X Genomics, Inc. Agents de capture d'analytes marqués spatialement pour le multiplexage d'analytes
EP4025711A2 (fr) 2019-11-08 2022-07-13 10X Genomics, Inc. Amélioration de la spécificité de la liaison d'un analyte
CN110951852B (zh) * 2019-11-25 2022-11-25 齐鲁工业大学 单碱基连续延伸流式靶向测序法
US20230028790A1 (en) 2019-11-29 2023-01-26 GC Genome Corporation Artificial intelligence-based chromosomal abnormality detection method
SG11202106899SA (en) 2019-12-23 2021-09-29 10X Genomics Inc Methods for spatial analysis using rna-templated ligation
JP2023511279A (ja) 2020-01-13 2023-03-17 フルーエント バイオサイエンシーズ インコーポレイテッド 単一細胞シーケンシング
US11827936B2 (en) 2020-01-13 2023-11-28 Fluent Biosciences Inc. Methods and systems for single cell gene profiling
CA3167729A1 (fr) 2020-01-13 2021-07-22 Fluent Biosciences Inc. Criblage de medicament par emulsion
US11702693B2 (en) 2020-01-21 2023-07-18 10X Genomics, Inc. Methods for printing cells and generating arrays of barcoded cells
US11732299B2 (en) 2020-01-21 2023-08-22 10X Genomics, Inc. Spatial assays with perturbed cells
US11821035B1 (en) 2020-01-29 2023-11-21 10X Genomics, Inc. Compositions and methods of making gene expression libraries
WO2021152586A1 (fr) 2020-01-30 2021-08-05 Yeda Research And Development Co. Ltd. Procédés d'analyse du microbiome, du profil d'immunoglobuline et de l'état physiologique
US11898205B2 (en) 2020-02-03 2024-02-13 10X Genomics, Inc. Increasing capture efficiency of spatial assays
WO2021158511A1 (fr) 2020-02-04 2021-08-12 Omniome, Inc. Cuves à circulation et procédés pour leur fabrication et leur utilisation
US11732300B2 (en) 2020-02-05 2023-08-22 10X Genomics, Inc. Increasing efficiency of spatial analysis in a biological sample
US11835462B2 (en) 2020-02-11 2023-12-05 10X Genomics, Inc. Methods and compositions for partitioning a biological sample
WO2021163637A1 (fr) 2020-02-13 2021-08-19 Zymergen Inc. Bibliothèque métagénomique et plateforme de découverte de produit naturel
US20210265018A1 (en) 2020-02-20 2021-08-26 Illumina, Inc. Knowledge Distillation and Gradient Pruning-Based Compression of Artificial Intelligence-Based Base Caller
US11891654B2 (en) 2020-02-24 2024-02-06 10X Genomics, Inc. Methods of making gene expression libraries
US11926863B1 (en) 2020-02-27 2024-03-12 10X Genomics, Inc. Solid state single cell method for analyzing fixed biological cells
US11768175B1 (en) 2020-03-04 2023-09-26 10X Genomics, Inc. Electrophoretic methods for spatial analysis
EP4121016A1 (fr) 2020-03-16 2023-01-25 Fluent Biosciences Inc. Analyse multi-omique dans des gouttelettes monodispersées
WO2021214766A1 (fr) 2020-04-21 2021-10-28 Yeda Research And Development Co. Ltd. Procédés de diagnostic d'infections virales et vaccins associés
EP4242325A3 (fr) 2020-04-22 2023-10-04 10X Genomics, Inc. Procédés d'analyse spatiale utilisant un appauvrissement d'arn ciblée
US20230183798A1 (en) 2020-05-05 2023-06-15 Pacific Biosciences Of California, Inc. Compositions and methods for modifying polymerase-nucleic acid complexes
US11188778B1 (en) 2020-05-05 2021-11-30 Illumina, Inc. Equalization-based image processing and spatial crosstalk attenuator
US20230203592A1 (en) 2020-05-05 2023-06-29 Akershus Universitetssykehus Hf Compositions and methods for characterizing bowel cancer
US11851700B1 (en) 2020-05-13 2023-12-26 10X Genomics, Inc. Methods, kits, and compositions for processing extracellular molecules
EP4153775A1 (fr) 2020-05-22 2023-03-29 10X Genomics, Inc. Mesure spatio-temporelle simultanée de l'expression génique et de l'activité cellulaire
EP4153776A1 (fr) 2020-05-22 2023-03-29 10X Genomics, Inc. Analyse spatiale pour détecter des variants de séquence
WO2021242834A1 (fr) 2020-05-26 2021-12-02 10X Genomics, Inc. Procédé de réinitialisation d'un réseau
IL298097A (en) 2020-05-27 2023-01-01 Genetic Tech Limited Methods for assessing the risk of the development of an acute reaction to infection with the corona virus
EP4025692A2 (fr) 2020-06-02 2022-07-13 10X Genomics, Inc. Procédés de banques d'acides nucléiques
CN116249785A (zh) 2020-06-02 2023-06-09 10X基因组学有限公司 用于抗原-受体的空间转录组学
WO2021252499A1 (fr) 2020-06-08 2021-12-16 10X Genomics, Inc. Méthodes de détermination de marge chirurgicale et méthodes d'utilisation associées
EP4165207A1 (fr) 2020-06-10 2023-04-19 10X Genomics, Inc. Procédés de détermination d'un emplacement d'un analyte dans un échantillon biologique
AU2021294334A1 (en) 2020-06-25 2023-02-02 10X Genomics, Inc. Spatial analysis of DNA methylation
US11761038B1 (en) 2020-07-06 2023-09-19 10X Genomics, Inc. Methods for identifying a location of an RNA in a biological sample
US11981960B1 (en) 2020-07-06 2024-05-14 10X Genomics, Inc. Spatial analysis utilizing degradable hydrogels
EP4179113A1 (fr) 2020-07-08 2023-05-17 F. Hoffmann-La Roche AG Déplétion ciblée de molécules de bibliothèque non cibles à l'aide d'amorces poison pendant la capture cible de bibliothèques de séquençage de nouvelle génération
US11981958B1 (en) 2020-08-20 2024-05-14 10X Genomics, Inc. Methods for spatial analysis using DNA capture
US11926822B1 (en) 2020-09-23 2024-03-12 10X Genomics, Inc. Three-dimensional spatial analysis
CA3200519A1 (fr) * 2020-11-03 2022-05-12 Fluent Biosciences Inc. Procedes et systemes pour la detection de microbes pathogenes chez un patient
US11827935B1 (en) 2020-11-19 2023-11-28 10X Genomics, Inc. Methods for spatial analysis using rolling circle amplification and detection probes
KR20220074088A (ko) 2020-11-27 2022-06-03 주식회사 지씨지놈 인공지능 기반 암 진단 및 암 종 예측방법
AU2021409136A1 (en) 2020-12-21 2023-06-29 10X Genomics, Inc. Methods, compositions, and systems for capturing probes and/or barcodes
CN116997411A (zh) 2021-01-13 2023-11-03 加利福尼亚太平洋生物科学股份有限公司 使用胶体组装的表面结构化
WO2022174054A1 (fr) 2021-02-13 2022-08-18 The General Hospital Corporation Procédés et compositions pour la détection de macromolécules in situ et utilisations correspondantes
AU2022227563A1 (en) 2021-02-23 2023-08-24 10X Genomics, Inc. Probe-based analysis of nucleic acids and proteins
WO2022198068A1 (fr) 2021-03-18 2022-09-22 10X Genomics, Inc. Capture multiplex de gène et expression de protéines à partir d'un échantillon biologique
EP4314327A1 (fr) 2021-03-22 2024-02-07 Illumina Cambridge Limited Procédés d'amélioration de la clonalité de groupes d'acides nucléiques
WO2022208171A1 (fr) 2021-03-31 2022-10-06 UCL Business Ltd. Procédés de détection d'analytes
US20220336052A1 (en) * 2021-04-19 2022-10-20 University Of Utah Research Foundation Systems and methods for facilitating rapid genome sequence analysis
KR20220160806A (ko) 2021-05-28 2022-12-06 주식회사 지씨지놈 세포유리 핵산단편 말단 서열 모티프 빈도 및 크기를 이용한 암 진단 및 암 종 예측방법
WO2022265994A1 (fr) 2021-06-15 2022-12-22 Illumina, Inc. Fonctionnalisation de surface exempte d'hydrogel pour séquençage
US11236388B1 (en) 2021-06-17 2022-02-01 Element Biosciences, Inc. Compositions and methods for pairwise sequencing
US11859241B2 (en) 2021-06-17 2024-01-02 Element Biosciences, Inc. Compositions and methods for pairwise sequencing
CN113174388B (zh) * 2021-06-28 2021-09-10 中国农业大学 一种功能核酸纳米杆与功能核酸纳米花的制备及形貌转换方法
US11455487B1 (en) 2021-10-26 2022-09-27 Illumina Software, Inc. Intensity extraction and crosstalk attenuation using interpolation and adaptation for base calling
KR20240031968A (ko) 2021-07-19 2024-03-08 일루미나, 인코포레이티드 염기 호출에 대한 보간 및 적응을 갖는 강도 추출
GB202110479D0 (en) 2021-07-21 2021-09-01 Dnae Diagnostics Ltd Compositions, kits and methods for sequencing target polynucleotides
GB202110485D0 (en) 2021-07-21 2021-09-01 Dnae Diagnostics Ltd Compositions, kits and methods for sequencing target polynucleotides
WO2023002203A1 (fr) 2021-07-21 2023-01-26 Dnae Diagnostics Limited Procédé et système comprenant une cartouche pour le séquençage de polynucléotides cibles
US20230116852A1 (en) 2021-07-23 2023-04-13 Illumina, Inc. Methods for preparing substrate surface for dna sequencing
WO2023034489A1 (fr) 2021-09-01 2023-03-09 10X Genomics, Inc. Procédés, compositions et kits pour bloquer une sonde de capture sur un réseau spatial
WO2023049215A1 (fr) 2021-09-22 2023-03-30 Illumina, Inc. Appel de base basé sur l'état compressé
CA3234961A1 (fr) 2021-10-20 2023-04-27 Illumina, Inc. Procedes de capture d'adn de banque pour le sequencage
WO2023081300A2 (fr) * 2021-11-03 2023-05-11 Abbott Laboratories Systèmes et méthodes pour l'analyse d'échantillons
US20230348957A1 (en) 2021-12-07 2023-11-02 Luminex Corporation Methods and compositions for nucleic acid analysis
WO2023114190A1 (fr) * 2021-12-13 2023-06-22 Cz Biohub Sf, Inc. Établissement de profils épigénomiques unicellulaires à l'aide de la fluidique et des hydrogels
US20230215515A1 (en) 2021-12-23 2023-07-06 Illumina Software, Inc. Facilitating secure execution of external workflows for genomic sequencing diagnostics
WO2023122363A1 (fr) 2021-12-23 2023-06-29 Illumina Software, Inc. Résumés dynamiques d'état graphique pour séquençage de nucléotides
WO2023129764A1 (fr) 2021-12-29 2023-07-06 Illumina Software, Inc. Permutation automatique des versions de modèle d'analyse de variants pour les applications d'analyse génomique
WO2023135485A1 (fr) 2022-01-13 2023-07-20 Oslo Universitetssykehus Hf Marqueurs du cancer de la prostate et leurs utilisations
WO2023141154A1 (fr) 2022-01-20 2023-07-27 Illumina Cambridge Limited Procédés de détection de méthylcytosine et d'hydroxyméthylcytosine par séquençage
WO2023152568A2 (fr) 2022-02-10 2023-08-17 Oslo Universitetssykehus Hf Compositions et méthodes de caractérisation du cancer du poumon
WO2023183937A1 (fr) 2022-03-25 2023-09-28 Illumina, Inc. Appel de bases séquence par séquence
CN114592023B (zh) * 2022-03-31 2023-03-24 杭州优玛达生物科技有限公司 一种细胞裂解自组装多肽复合物、自组装方法、自组装多肽制剂及应用
EP4253550A1 (fr) 2022-04-01 2023-10-04 GenCC GmbH 6 Co. KG Procédé de fabrication d'un système de transport viral, d'un vecteur ou de tout système de transport et complexes crispr spécifiques au cancer
US20230392201A1 (en) 2022-06-06 2023-12-07 Element Biosciences, Inc. Methods for assembling and reading nucleic acid sequences from mixed populations
WO2023239917A1 (fr) 2022-06-09 2023-12-14 Illumina, Inc. Dépendance d'appel de bases envers l'inclinaison de cellule de flux
WO2024050450A1 (fr) 2022-08-31 2024-03-07 Gigamune, Inc. Vecteurs enveloppés modifiés et leurs procédés d'utilisation
US20240133892A1 (en) 2022-09-27 2024-04-25 Nautilus Subsidiary, Inc. Polypeptide capture, in situ fragmentation and identification

Citations (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5506100A (en) * 1990-10-11 1996-04-09 Indiana University Foundation Process and apparatus for fragmenting biomaterials
US5508169A (en) * 1990-04-06 1996-04-16 Queen's University At Kingston Indexing linkers
US5610010A (en) * 1990-10-11 1997-03-11 Indiana University Foundation Process and apparatus for fragmenting biomaterials
US5629158A (en) * 1989-03-22 1997-05-13 Cemu Bitecknik Ab Solid phase diagnosis of medical conditions
US5728524A (en) * 1992-07-13 1998-03-17 Medical Research Counsil Process for categorizing nucleotide sequence populations
US5814444A (en) * 1995-06-07 1998-09-29 University Of Washington Methods for making and using single-chromosome amplfication libraries
US5863722A (en) * 1994-10-13 1999-01-26 Lynx Therapeutics, Inc. Method of sorting polynucleotides
US5989892A (en) * 1995-06-14 1999-11-23 Tonen Corporation Microorganisms, demulsifiers and processes for breaking an emulsion
US5994068A (en) * 1997-03-11 1999-11-30 Wisconsin Alumni Research Foundation Nucleic acid indexing
US6004783A (en) * 1994-03-18 1999-12-21 The General Hospital Corporation Cleaved amplified RFLP detection methods
US6023540A (en) * 1997-03-14 2000-02-08 Trustees Of Tufts College Fiber optic sensor with encoded microspheres
US6060245A (en) * 1996-12-13 2000-05-09 Stratagene Methods and adaptors for generating specific nucleic acid populations
US6184012B1 (en) * 1996-04-25 2001-02-06 Medical Research Council Isolation of enzymes
US6270966B1 (en) * 1996-02-09 2001-08-07 The United States Of America As Represented By The Department Of Health And Human Services Restriction display (RD-PCR) of differentially expressed mRNAs
US6274320B1 (en) * 1999-09-16 2001-08-14 Curagen Corporation Method of sequencing a nucleic acid
US6287825B1 (en) * 1998-09-18 2001-09-11 Molecular Staging Inc. Methods for reducing the complexity of DNA sequences
US6468748B1 (en) * 1996-03-04 2002-10-22 Sequenom, Inc. Methods of screening nucleic acids using volatile salts in mass spectrometry
US6475736B1 (en) * 2000-05-23 2002-11-05 Variagenics, Inc. Methods for genetic analysis of DNA using biased amplification of polymorphic sites
US6489103B1 (en) * 1997-07-07 2002-12-03 Medical Research Council In vitro sorting method

Family Cites Families (216)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4175054A (en) 1976-11-11 1979-11-20 Petrolite Corporation Use of hydrocarbon polymers in demulsification
US5821058A (en) * 1984-01-16 1998-10-13 California Institute Of Technology Automated DNA sequencing technique
US5171534A (en) * 1984-01-16 1992-12-15 California Institute Of Technology Automated DNA sequencing technique
US4965188A (en) * 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4801529A (en) 1985-06-18 1989-01-31 Brandeis University Methods for isolating mutant microoganisms using microcapsules coated with indicator material
US4863849A (en) 1985-07-18 1989-09-05 New York Medical College Automatable process for sequencing nucleotide
US4811218A (en) * 1986-06-02 1989-03-07 Applied Biosystems, Inc. Real time scanning electrophoresis apparatus for DNA sequencing
US5252494A (en) * 1986-06-25 1993-10-12 Trustees Of Tufts College Fiber optic sensors, apparatus, and detection methods using controlled release polymers and reagent formulations held within a polymeric reaction matrix
US5143853A (en) * 1986-06-25 1992-09-01 Trustees Of Tufts College Absorbance modulated fluorescence detection methods and sensors
US5254477A (en) * 1986-06-25 1993-10-19 Trustees Of Tufts College Flourescence intramolecular energy transfer conjugate compositions and detection methods
US4822746A (en) * 1986-06-25 1989-04-18 Trustees Of Tufts College Radiative and non-radiative energy transfer and absorbance modulated fluorescence detection methods and sensors
US4994372A (en) * 1987-01-14 1991-02-19 President And Fellows Of Harvard College DNA sequencing
US5525464A (en) * 1987-04-01 1996-06-11 Hyseq, Inc. Method of sequencing by hybridization of oligonucleotide probes
IL86724A (en) 1987-06-19 1995-01-24 Siska Diagnostics Inc Methods and kits for amplification and testing of nucleic acid sequences
JP2846018B2 (ja) 1988-01-21 1999-01-13 ジェネンテク，インコーポレイテッド 核酸配列の増幅および検出
CA1340807C (fr) 1988-02-24 1999-11-02 Lawrence T. Malek Procede d'amplification d'une sequence d'acide nucleique
GB8810400D0 (en) 1988-05-03 1988-06-08 Southern E Analysing polynucleotide sequences
SE8801070D0 (sv) 1988-03-23 1988-03-23 Pharmacia Ab Method for immobilizing a dna sequence on a solid support
US4971903A (en) * 1988-03-25 1990-11-20 Edward Hyman Pyrophosphate-based method and apparatus for sequencing nucleic acids
JPH03503845A (ja) 1988-04-22 1991-08-29 マサチユセツツ・インスチチユート・オブ・テクノロジー 微小滴を形成しそして使用する方法
US5225332A (en) 1988-04-22 1993-07-06 Massachusetts Institute Of Technology Process for manipulation of non-aqueous surrounded microdroplets
US6054270A (en) * 1988-05-03 2000-04-25 Oxford Gene Technology Limited Analying polynucleotide sequences
US5700637A (en) * 1988-05-03 1997-12-23 Isis Innovation Limited Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays
GB8822228D0 (en) * 1988-09-21 1988-10-26 Southern E M Support-bound oligonucleotides
US5512439A (en) * 1988-11-21 1996-04-30 Dynal As Oligonucleotide-linked magnetic particles and uses thereof
US4938876A (en) 1989-03-02 1990-07-03 Ohsol Ernest O Method for separating oil and water emulsions
EP0392546A3 (fr) 1989-04-14 1991-09-11 Ro Institut Za Molekularnu Genetiku I Geneticko Inzenjerstvo Procédé pour déterminer le contenu complet ou partiel de séquences très courtes dans des échantillons de particules discrètes de dimensions microscopiques par hybridation avec des sondes oligonucléotidiques
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5871928A (en) * 1989-06-07 1999-02-16 Fodor; Stephen P. A. Methods for nucleic acid analysis
US5744101A (en) * 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US5800992A (en) 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US5302509A (en) * 1989-08-14 1994-04-12 Beckman Instruments, Inc. Method for sequencing polynucleotides
US5545522A (en) * 1989-09-22 1996-08-13 Van Gelder; Russell N. Process for amplifying a target polynucleotide sequence using a single primer-promoter complex
KR0185192B1 (ko) 1989-10-05 1999-04-01 제임스 더블유. 데이비 신규의 유전자 및 폴리펩티드의 무세포 합성 및 분리
WO1991012342A1 (fr) * 1990-02-16 1991-08-22 F. Hoffmann-La Roche Ag Ameliorations apportees a la specificite et a l'applicabilite de la reaction en chaine de polymerases
JPH04223A (ja) * 1990-04-16 1992-01-06 Toshiba Corp 無線電話装置、その充電方法および無線電話充電システム
US5244636A (en) * 1991-01-25 1993-09-14 Trustees Of Tufts College Imaging fiber optic array sensors, apparatus, and methods for concurrently detecting multiple analytes of interest in a fluid sample
US5320814A (en) * 1991-01-25 1994-06-14 Trustees Of Tufts College Fiber optic array sensors, apparatus, and methods for concurrently visualizing and chemically detecting multiple analytes of interest in a fluid sample
US5250264A (en) * 1991-01-25 1993-10-05 Trustees Of Tufts College Method of making imaging fiber optic sensors to concurrently detect multiple analytes of interest in a fluid sample
US5114984A (en) * 1991-04-26 1992-05-19 Olin Corporation Process for producing an antimicrobially effective polyurethane
WO1993003151A1 (fr) † 1991-08-10 1993-02-18 Medical Research Council Traitement de populations de cellules
US5474796A (en) 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
WO1993005183A1 (fr) * 1991-09-09 1993-03-18 Baylor College Of Medicine Procede et dispositif pour la determination rapide du sequençage d'adn ou d'arn au moyen d'une methode de sequençage par addition de base
WO1993006239A1 (fr) * 1991-09-24 1993-04-01 Keygene N.V. Amplification selective de fragments de restriction: procede general de dactyloscopie genetique
US5270170A (en) 1991-10-16 1993-12-14 Affymax Technologies N.V. Peptide library and screening method
EP0916396B1 (fr) * 1991-11-22 2005-04-13 Affymetrix, Inc. (a Delaware Corporation) Stratégies associées pour la synthèse de polymères
US5445971A (en) * 1992-03-20 1995-08-29 Abbott Laboratories Magnetically assisted binding assays using magnetically labeled binding members
GB9208733D0 (en) 1992-04-22 1992-06-10 Medical Res Council Dna sequencing method
GB9210176D0 (en) * 1992-05-12 1992-06-24 Cemu Bioteknik Ab Chemical method
DE4223169C1 (de) 1992-07-10 1993-11-25 Ferring Arzneimittel Gmbh Verfahren zur Mikroverkapselung wasserlöslicher Wirkstoffe
US6114114A (en) * 1992-07-17 2000-09-05 Incyte Pharmaceuticals, Inc. Comparative gene transcript analysis
RU2048522C1 (ru) 1992-10-14 1995-11-20 Институт белка РАН Способ размножения нуклеиновых кислот, способ их экспрессии и среда для их осуществления
US5436143A (en) * 1992-12-23 1995-07-25 Hyman; Edward D. Method for enzymatic synthesis of oligonucleotides
IL104384A (en) 1993-01-13 1996-11-14 Yeda Res & Dev Method for screening catalytic non-enzyme polypeptides and proteins
US5298741A (en) * 1993-01-13 1994-03-29 Trustees Of Tufts College Thin film fiber optic sensor array and apparatus for concurrent viewing and chemical sensing of a sample
CA2155186A1 (fr) 1993-02-01 1994-08-18 Kevin M. Ulmer Methodes et appareil pour le sequencage de l'adn
US5436149A (en) 1993-02-19 1995-07-25 Barnes; Wayne M. Thermostable DNA polymerase with enhanced thermostability and enhanced length and efficiency of primer extension
US5714320A (en) 1993-04-15 1998-02-03 University Of Rochester Rolling circle synthesis of oligonucleotides and amplification of select randomized circular oligonucleotides
AU6707194A (en) 1993-04-19 1994-11-08 Medisorb Technologies International L.P. Encapsulation of nucleic acids with conjugates that facilitate and target cellular uptake and gene expression
AU6815894A (en) 1993-04-19 1994-11-08 Stuart A. Kauffman Random chemistry for the generation of new compounds
GB9315847D0 (en) * 1993-07-30 1993-09-15 Isis Innovation Tag reagent and assay method
US5482845A (en) * 1993-09-24 1996-01-09 The Trustees Of Columbia University In The City Of New York Method for construction of normalized cDNA libraries
ATE424927T1 (de) * 1993-10-28 2009-03-15 Houston Advanced Res Ct Mikrofabriziertes poröses durchflussgerät zur diskreten bestimmung von bindungsreaktionen
US5429807A (en) * 1993-10-28 1995-07-04 Beckman Instruments, Inc. Method and apparatus for creating biopolymer arrays on a solid support surface
AU8124694A (en) 1993-10-29 1995-05-22 Affymax Technologies N.V. In vitro peptide and antibody display libraries
GB9401833D0 (en) * 1994-02-01 1994-03-30 Isis Innovation Method for discovering ligands
US5928905A (en) * 1995-04-18 1999-07-27 Glaxo Group Limited End-complementary polymerase reaction
US5834252A (en) * 1995-04-18 1998-11-10 Glaxo Group Limited End-complementary polymerase reaction
AU710504B2 (en) 1994-03-15 1999-09-23 Brown University Research Foundation Polymeric gene delivery system
JP2556293B2 (ja) * 1994-06-09 1996-11-20 日本電気株式会社 Ｍｏｓ ｏｔａ
US5512490A (en) * 1994-08-11 1996-04-30 Trustees Of Tufts College Optical sensor, optical sensing apparatus, and methods for detecting an analyte of interest using spectral recognition patterns
US5604097A (en) * 1994-10-13 1997-02-18 Spectragen, Inc. Methods for sorting polynucleotides using oligonucleotide tags
US6013445A (en) * 1996-06-06 2000-01-11 Lynx Therapeutics, Inc. Massively parallel signature sequencing by ligation of encoded adaptors
US5795716A (en) * 1994-10-21 1998-08-18 Chee; Mark S. Computer-aided visualization and analysis system for sequence evaluation
FR2726286B1 (fr) 1994-10-28 1997-01-17 Genset Sa Procede d'amplification d'acides nucleiques en phase solide et trousse de reactifs utile pour la mise en oeuvre de ce procede
US5919673A (en) * 1995-03-22 1999-07-06 The Scripps Research Institute One-pot enzymatic sulfation process using 3'-phosphoadenosine-5'-phosphosulfate and recycled phosphorylated adenosine intermediates
EP0735144B1 (fr) * 1995-03-28 2002-06-05 Japan Science and Technology Corporation Procédé pour l'indexation moléculaire de gènes utilisant des enzymes de restriction
GB9507238D0 (en) * 1995-04-07 1995-05-31 Isis Innovation Detecting dna sequence variations
US5750341A (en) * 1995-04-17 1998-05-12 Lynx Therapeutics, Inc. DNA sequencing by parallel oligonucleotide extensions
KR19990008000A (ko) 1995-04-24 1999-01-25 로버트 에스. 화이트 헤드 새로운 대사 경로를 만들고 이를 스크리닝하는 방법
US5648245A (en) * 1995-05-09 1997-07-15 Carnegie Institution Of Washington Method for constructing an oligonucleotide concatamer library by rolling circle replication
DE19518505A1 (de) * 1995-05-19 1996-11-21 Max Planck Gesellschaft Verfahren zur Genexpressionsanalyse
US5690894A (en) * 1995-05-23 1997-11-25 The Regents Of The University Of California High density array fabrication and readout method for a fiber optic biosensor
US5910408A (en) 1995-06-07 1999-06-08 The General Hospital Corporation Catalytic DNA having ligase activity
US5728529A (en) * 1995-06-23 1998-03-17 Baylor College Of Medicine Alternative dye-labeled ribonucleotides, deoxyribonucleotides, and dideoxyribonucleotides for automated DNA analysis
US6200737B1 (en) * 1995-08-24 2001-03-13 Trustees Of Tufts College Photodeposition method for fabricating a three-dimensional, patterned polymer microstructure
US5843655A (en) * 1995-09-18 1998-12-01 Affymetrix, Inc. Methods for testing oligonucleotide arrays
US5871697A (en) * 1995-10-24 1999-02-16 Curagen Corporation Method and apparatus for identifying, classifying, or quantifying DNA sequences in a sample without sequencing
DE19646372C1 (de) 1995-11-11 1997-06-19 Evotec Biosystems Gmbh Genotyp und Phänotyp koppelnde Verbindung
US5780231A (en) * 1995-11-17 1998-07-14 Lynx Therapeutics, Inc. DNA extension and analysis with rolling primers
US5962228A (en) * 1995-11-17 1999-10-05 Lynx Therapeutics, Inc. DNA extension and analysis with rolling primers
DK0862656T3 (da) 1995-11-21 2001-04-09 Univ Yale Unimolekylær segmentamplifikation og -detektering
US5854033A (en) 1995-11-21 1998-12-29 Yale University Rolling circle replication reporter systems
US5633972A (en) * 1995-11-29 1997-05-27 Trustees Of Tufts College Superresolution imaging fiber for subwavelength light energy generation and near-field optical microscopy
US5814524A (en) * 1995-12-14 1998-09-29 Trustees Of Tufts College Optical sensor apparatus for far-field viewing and making optical analytical measurements at remote locations
US5851772A (en) * 1996-01-29 1998-12-22 University Of Chicago Microchip method for the enrichment of specific DNA sequences
US5770637A (en) * 1996-05-01 1998-06-23 Johnson & Johnson Vision Products, Inc. Anti-bacterial, UV absorbable, tinted, metal-chelating polymers
US6022688A (en) * 1996-05-13 2000-02-08 Sequenom, Inc. Method for dissociating biotin complexes
US5846727A (en) * 1996-06-06 1998-12-08 Board Of Supervisors Of Louisiana State University And Agricultural & Mechanical College Microsystem for rapid DNA sequencing
CZ397998A3 (cs) * 1996-06-06 1999-07-14 Lynx Therapeutics, Inc. Způsob sekvenční analýzy ligací kódovaného adaptoru
US6083693A (en) 1996-06-14 2000-07-04 Curagen Corporation Identification and comparison of protein-protein interactions that occur in populations
US5916524A (en) 1997-07-23 1999-06-29 Bio-Dot, Inc. Dispensing apparatus having improved dynamic range
US5846721A (en) * 1996-09-19 1998-12-08 The Trustees Of Columbia University In The City Of New York Efficient and simpler method to construct normalized cDNA libraries with improved representations of full-length cDNAs
GB9620209D0 (en) 1996-09-27 1996-11-13 Cemu Bioteknik Ab Method of sequencing DNA
WO1998013502A2 (fr) 1996-09-27 1998-04-02 Icos Corporation Procedes d'identification de composes pour la rupture des interactions entre proteines
US6124092A (en) 1996-10-04 2000-09-26 The Perkin-Elmer Corporation Multiplex polynucleotide capture methods and compositions
US5900481A (en) * 1996-11-06 1999-05-04 Sequenom, Inc. Bead linkers for immobilizing nucleic acids to solid supports
US6133436A (en) * 1996-11-06 2000-10-17 Sequenom, Inc. Beads bound to a solid support and to nucleic acids
US6887665B2 (en) * 1996-11-14 2005-05-03 Affymetrix, Inc. Methods of array synthesis
DE19648372A1 (de) 1996-11-22 1998-05-28 Serck Como Gmbh Verfahren und Vorrichtung zum Eindampfen von Abwässern
US6395524B2 (en) 1996-11-27 2002-05-28 University Of Washington Thermostable polymerases having altered fidelity and method of identifying and using same
US6310354B1 (en) 1996-12-03 2001-10-30 Erkki Soini Method and a device for monitoring nucleic acid amplification reactions
US20020172965A1 (en) * 1996-12-13 2002-11-21 Arcaris, Inc. Methods for measuring relative amounts of nucleic acids in a complex mixture and retrieval of specific sequences therefrom
GB9626815D0 (en) 1996-12-23 1997-02-12 Cemu Bioteknik Ab Method of sequencing DNA
EP1712623B1 (fr) 1997-01-21 2011-10-19 The General Hospital Corporation Sélection de protéines par fusions de proteénes et d'ARN
US6136543A (en) * 1997-01-31 2000-10-24 Hitachi, Ltd. Method for determining nucleic acids base sequence and apparatus therefor
CA2196496A1 (fr) 1997-01-31 1998-07-31 Stephen William Watson Michnick Epreuve de complementation de fragments de proteines pour la detection d'interactions entre proteines
ATE273381T1 (de) * 1997-02-12 2004-08-15 Eugene Y Chan Verfahren zur analyse von polymeren
GB9703369D0 (en) 1997-02-18 1997-04-09 Lindqvist Bjorn H Process
AU6571598A (en) 1997-03-18 1998-10-12 Chromaxome Corporation Methods for screening compounds using encapsulated cells
US5891477A (en) 1997-03-28 1999-04-06 Biohybrid Technologies, Inc. Non-steroidal anti-inflammatory agents inhibition of fibrotic response to an implanted device
AU6846698A (en) * 1997-04-01 1998-10-22 Glaxo Group Limited Method of nucleic acid amplification
ATE269908T1 (de) 1997-04-01 2004-07-15 Manteia S A Methode zur sequenzierung von nukleinsäuren
US6143496A (en) 1997-04-17 2000-11-07 Cytonix Corporation Method of sampling, amplifying and quantifying segment of nucleic acid, polymerase chain reaction assembly having nanoliter-sized sample chambers, and method of filling assembly
US6406845B1 (en) 1997-05-05 2002-06-18 Trustees Of Tuft College Fiber optic biosensor for selectively detecting oligonucleotide species in a mixed fluid sample
EP1138764A3 (fr) * 1997-05-13 2001-10-24 Azign Bioscience A/S Transcription inverse à deux étapes
JP3610231B2 (ja) * 1997-08-01 2005-01-12 キヤノン株式会社 反応場アレー、反応場アレーの製造方法、反応場アレーを用いた反応方法及び反応場アレーを用いた試料溶液中の物質の定量方法
EP0895083B1 (fr) 1997-08-01 2009-09-23 Canon Kabushiki Kaisha Réseau de site de réaction, procédé de son fabrication, procédé de réaction le utilisant, et procédé de détermination quantitatif d'une substance dans un échantillon le utilisant
US5961228A (en) * 1997-08-22 1999-10-05 Paxar Corporation Modular printer
US20010006630A1 (en) * 1997-09-02 2001-07-05 Oron Yacoby-Zeevi Introducing a biological material into a patient
US6087099A (en) * 1997-09-08 2000-07-11 Myriad Genetics, Inc. Method for sequencing both strands of a double stranded DNA in a single sequencing reaction
US6475722B1 (en) 1997-12-03 2002-11-05 Curagen Corporation Surface treatments for DNA processing devices
NL1007781C2 (nl) 1997-12-12 1999-06-15 Packard Instr Bv Microtiterplaat.
DE69822206T2 (de) 1997-12-19 2005-02-17 Affymetrix, Inc., Santa Clara Erkenntnisse der genomforschung für die suche nach neuartigen wirkstoffen
ATE506449T1 (de) 1997-12-22 2011-05-15 Hitachi Chemical Co Ltd Direkte rt-pcr auf oligonukleotid-immobilisierten pcr-mikroplatten
KR100280219B1 (ko) * 1998-02-26 2001-04-02 이수빈 삼핵산 반복 서열을 이용한 신경정신 질환의 진단 방법 및 진단 시약
US5882874A (en) * 1998-02-27 1999-03-16 The Trustees Of Columbia University In The City Of New York Reciprocal subtraction differential display
US6210910B1 (en) * 1998-03-02 2001-04-03 Trustees Of Tufts College Optical fiber biosensor array comprising cell populations confined to microcavities
US6378527B1 (en) 1998-04-08 2002-04-30 Chondros, Inc. Cell-culture and polymer constructs
WO1999055886A1 (fr) * 1998-04-24 1999-11-04 Genova Pharmaceuticals Corporation Decouverte de genes fonctionnels
JP2981547B1 (ja) 1998-07-02 1999-11-22 農林水産省食品総合研究所長 クロスフロー型マイクロチャネル装置及び同装置を用いたエマルションの生成または分離方法
WO2000004139A1 (fr) 1998-07-17 2000-01-27 Mirus Corporation Solutions de tensio-actifs
US6210896B1 (en) * 1998-08-13 2001-04-03 Us Genomics Molecular motors
US6263286B1 (en) * 1998-08-13 2001-07-17 U.S. Genomics, Inc. Methods of analyzing polymers using a spatial network of fluorophores and fluorescence resonance energy transfer
GB9820185D0 (en) 1998-09-15 1998-11-11 Dynal As Method
AR021833A1 (es) 1998-09-30 2002-08-07 Applied Research Systems Metodos de amplificacion y secuenciacion de acido nucleico
US6203989B1 (en) * 1998-09-30 2001-03-20 Affymetrix, Inc. Methods and compositions for amplifying detectable signals in specific binding assays
AU2595300A (en) * 1998-12-31 2000-07-31 City Of Hope Method for detecting mutations in nucleic acids
GB9900298D0 (en) * 1999-01-07 1999-02-24 Medical Res Council Optical sorting method
US20020150909A1 (en) 1999-02-09 2002-10-17 Stuelpnagel John R. Automated information processing in randomly ordered arrays
EP1157131A2 (fr) * 1999-02-22 2001-11-28 Lynx Therapeutics, Inc. Fragments d'adn polymorphes et leurs utilisations
US6255476B1 (en) * 1999-02-22 2001-07-03 Pe Corporation (Ny) Methods and compositions for synthesis of labelled oligonucleotides and analogs on solid-supports
US6225061B1 (en) * 1999-03-10 2001-05-01 Sequenom, Inc. Systems and methods for performing reactions in an unsealed environment
DK1159453T3 (da) * 1999-03-10 2008-10-06 Asm Scient Inc Fremgangsmåde til direkte nukleinsyresekventering
US7371851B1 (en) * 1999-03-18 2008-05-13 Complete Genomics As Methods of cloning and producing fragment chains with readable information content
US6506594B1 (en) 1999-03-19 2003-01-14 Cornell Res Foundation Inc Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
GB9907812D0 (en) 1999-04-06 1999-06-02 Medical Biosystems Ltd Sequencing
US6284465B1 (en) * 1999-04-15 2001-09-04 Agilent Technologies, Inc. Apparatus, systems and method for locating nucleic acids bound to surfaces
ATE413467T1 (de) 1999-04-20 2008-11-15 Illumina Inc Detektion von nukleinsäurereaktionen auf kügelchen-arrays
US20030108867A1 (en) * 1999-04-20 2003-06-12 Chee Mark S Nucleic acid sequencing using microsphere arrays
US6355431B1 (en) * 1999-04-20 2002-03-12 Illumina, Inc. Detection of nucleic acid amplification reactions using bead arrays
US6221653B1 (en) * 1999-04-27 2001-04-24 Agilent Technologies, Inc. Method of performing array-based hybridization assays using thermal inkjet deposition of sample fluids
CA2374390A1 (fr) 1999-05-20 2000-12-14 Illumina, Inc. Decodage combinatoire de jeux d'acides nucleiques aleatoires
US20020051971A1 (en) * 1999-05-21 2002-05-02 John R. Stuelpnagel Use of microfluidic systems in the detection of target analytes using microsphere arrays
US6300070B1 (en) * 1999-06-04 2001-10-09 Mosaic Technologies, Inc. Solid phase methods for amplifying multiple nucleic acids
US6340589B1 (en) 1999-07-23 2002-01-22 Mj Research, Inc. Thin-well microplate and methods of making same
GB9921155D0 (en) 1999-09-08 1999-11-10 Medical Res Council Selection system
US7211390B2 (en) 1999-09-16 2007-05-01 454 Life Sciences Corporation Method of sequencing a nucleic acid
US7244559B2 (en) 1999-09-16 2007-07-17 454 Life Sciences Corporation Method of sequencing a nucleic acid
WO2001046471A1 (fr) 1999-12-21 2001-06-28 The Government Of The United States Of America As Represented By The Secretary Of The Navy Expression de proteines a partir d'acides nucleiques immobilises et amplifies
AU2282801A (en) * 1999-12-29 2001-07-09 Mergen Ltd. Methods for amplifying and detecting multiple polynucleotides on a solid phase support
JP2003535576A (ja) 2000-01-20 2003-12-02 ロゼッタ・インファーマティクス・インコーポレーテッド 薬物標的を同定するためのバーコード化された合成的致死スクリーニング
ATE360095T1 (de) 2000-02-07 2007-05-15 Illumina Inc Nukleinsäure nachweisverfahren mit universellem priming
US7582420B2 (en) 2001-07-12 2009-09-01 Illumina, Inc. Multiplex nucleic acid reactions
US6714874B1 (en) 2000-03-15 2004-03-30 Applera Corporation Method and system for the assembly of a whole genome using a shot-gun data set
JP3442338B2 (ja) * 2000-03-17 2003-09-02 株式会社日立製作所 Ｄｎａ分析装置、ｄｎａ塩基配列決定装置、ｄｎａ塩基配列決定方法、および反応モジュール
CN1189159C (zh) 2000-05-05 2005-02-16 欧莱雅 含水溶性美容活性组分水性核的微胶囊及含其的组合物
US6808874B2 (en) 2000-06-13 2004-10-26 Cyclacel Ltd. Methods of monitoring enzyme activity
CA2419058A1 (fr) 2000-08-09 2002-02-14 Illumina, Inc. Traitement automatise de l'information dans des matrices organisees de facon aleatoire
GB0021977D0 (en) 2000-09-07 2000-10-25 Pyrosequencing Ab Method of sequencing DNA
GB0022069D0 (en) 2000-09-08 2000-10-25 Pyrosequencing Ab Method
GB0022458D0 (en) 2000-09-13 2000-11-01 Medical Res Council Directed evolution method
WO2002027029A2 (fr) * 2000-09-27 2002-04-04 Lynx Therapeutics, Inc. Procede de mesure de l'abondance relative de sequences d'acides nucleiques
US6632610B2 (en) 2000-10-12 2003-10-14 Gensat S.A. Methods of identification and isolation of polynucleotides containing nucleic acid differences
US20020172980A1 (en) * 2000-11-27 2002-11-21 Phan Brigitte Chau Methods for decreasing non-specific binding of beads in dual bead assays including related optical biodiscs and disc drive systems
JP2002257070A (ja) 2001-02-28 2002-09-11 Toyota Industries Corp 真空ポンプにおける軸封構造
US6936264B2 (en) 2001-03-05 2005-08-30 The Procter & Gamble Company Delivery of reactive agents via multiple emulsions for use in shelf stable products
US6996287B1 (en) 2001-04-20 2006-02-07 Adobe Systems, Inc. Method and apparatus for texture cloning
GB0114856D0 (en) 2001-06-18 2001-08-08 Medical Res Council Selection by avidity capture
GB0114854D0 (en) * 2001-06-18 2001-08-08 Medical Res Council Selective gene amplification
WO2003004690A2 (fr) * 2001-07-06 2003-01-16 454$m(3) CORPORATION Methode utilisant un filtre poreux pour isoler en parallele des micro-reactions chimiques independantes
US20030064400A1 (en) 2001-08-24 2003-04-03 Li-Cor, Inc. Microfluidics system for single molecule DNA sequencing
US6956114B2 (en) 2001-10-30 2005-10-18 '454 Corporation Sulfurylase-luciferase fusion proteins and thermostable sulfurylase
US6902921B2 (en) 2001-10-30 2005-06-07 454 Corporation Sulfurylase-luciferase fusion proteins and thermostable sulfurylase
GB0127564D0 (en) 2001-11-16 2002-01-09 Medical Res Council Emulsion compositions
US20030165935A1 (en) 2001-11-21 2003-09-04 Vann Charles S. Digital assay
US7198897B2 (en) * 2001-12-19 2007-04-03 Brandeis University Late-PCR
EP1495137B1 (fr) * 2002-04-04 2005-09-14 Biotage AB Procede base sur l'extension d'amorce et employant des nucleotides marques via un element de liaison clivable
AU2003302770B2 (en) 2002-12-20 2007-07-12 Caliper Life Sciences, Inc. Single molecule amplification and detection of DNA
EP1583831A2 (fr) * 2003-01-15 2005-10-12 Wyeth Nouveau procede a haut debit de production et de purification de cibles d'arnc marquees pour l'analyse de l'expression genique
US7575865B2 (en) 2003-01-29 2009-08-18 454 Life Sciences Corporation Methods of amplifying and sequencing nucleic acids
WO2004069849A2 (fr) 2003-01-29 2004-08-19 454 Corporation Amplification d'acides nucleiques par emulsion de billes
US8150627B2 (en) 2003-05-15 2012-04-03 Illumina, Inc. Methods and compositions for diagnosing lung cancer with specific DNA methylation patterns
JP5183063B2 (ja) * 2003-07-05 2013-04-17 ザ ジョンズ ホプキンス ユニバーシティ 遺伝的変異の検出および列挙のための方法ならびに組成物
CA2553833C (fr) 2004-01-28 2012-10-02 454 Corporation Amplification d'acide nucleique avec emulsion a flux continu
US7682816B2 (en) 2005-04-07 2010-03-23 454 Life Sciences Corporation Thin film coated microwell arrays and methods of using same
US7785862B2 (en) 2005-04-07 2010-08-31 454 Life Sciences Corporation Thin film coated microwell arrays
WO2007145612A1 (fr) 2005-06-06 2007-12-21 454 Life Sciences Corporation Séquençage d'extrémités appariées
US8301394B2 (en) 2006-02-16 2012-10-30 454 Life Sciences Corporation System and method for correcting primer extension errors in nucleic acid sequence data
US8364417B2 (en) 2007-02-15 2013-01-29 454 Life Sciences Corporation System and method to correct out of phase errors in DNA sequencing data by use of a recursive algorithm
EP2038427A4 (fr) 2006-06-19 2010-07-07 Univ Johns Hopkins Pcr de molecule unique sur des microparticules dans des emulsions d'eau dans l'huile
US7585865B2 (en) 2006-07-21 2009-09-08 The Penn State Research Foundation Protein kinase C zeta inhibition to treat vascular permeability
JP2010521156A (ja) 2007-03-16 2010-06-24 ４５４ ライフ サイエンシーズ コーポレイション Ｈｉｖ薬物耐性バリアントの検出のためのシステムおよび方法
EP3404009B1 (fr) 2017-05-16 2019-12-25 Arkema France Procédé de fabrication de 1,4-bis(4-phénoxybenzoyle)benzène dans des conditions de sursaturation

Patent Citations (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629158A (en) * 1989-03-22 1997-05-13 Cemu Bitecknik Ab Solid phase diagnosis of medical conditions
US5508169A (en) * 1990-04-06 1996-04-16 Queen's University At Kingston Indexing linkers
US5506100A (en) * 1990-10-11 1996-04-09 Indiana University Foundation Process and apparatus for fragmenting biomaterials
US5610010A (en) * 1990-10-11 1997-03-11 Indiana University Foundation Process and apparatus for fragmenting biomaterials
US5728524A (en) * 1992-07-13 1998-03-17 Medical Research Counsil Process for categorizing nucleotide sequence populations
US6004783A (en) * 1994-03-18 1999-12-21 The General Hospital Corporation Cleaved amplified RFLP detection methods
US5863722A (en) * 1994-10-13 1999-01-26 Lynx Therapeutics, Inc. Method of sorting polynucleotides
US5814444A (en) * 1995-06-07 1998-09-29 University Of Washington Methods for making and using single-chromosome amplfication libraries
US5989892A (en) * 1995-06-14 1999-11-23 Tonen Corporation Microorganisms, demulsifiers and processes for breaking an emulsion
US6270966B1 (en) * 1996-02-09 2001-08-07 The United States Of America As Represented By The Department Of Health And Human Services Restriction display (RD-PCR) of differentially expressed mRNAs
US6468748B1 (en) * 1996-03-04 2002-10-22 Sequenom, Inc. Methods of screening nucleic acids using volatile salts in mass spectrometry
US6184012B1 (en) * 1996-04-25 2001-02-06 Medical Research Council Isolation of enzymes
US6060245A (en) * 1996-12-13 2000-05-09 Stratagene Methods and adaptors for generating specific nucleic acid populations
US5994068A (en) * 1997-03-11 1999-11-30 Wisconsin Alumni Research Foundation Nucleic acid indexing
US6023540A (en) * 1997-03-14 2000-02-08 Trustees Of Tufts College Fiber optic sensor with encoded microspheres
US6266459B1 (en) * 1997-03-14 2001-07-24 Trustees Of Tufts College Fiber optic sensor with encoded microspheres
US6489103B1 (en) * 1997-07-07 2002-12-03 Medical Research Council In vitro sorting method
US6287825B1 (en) * 1998-09-18 2001-09-11 Molecular Staging Inc. Methods for reducing the complexity of DNA sequences
US6274320B1 (en) * 1999-09-16 2001-08-14 Curagen Corporation Method of sequencing a nucleic acid
US6475736B1 (en) * 2000-05-23 2002-11-05 Variagenics, Inc. Methods for genetic analysis of DNA using biased amplification of polymorphic sites

Cited By (447)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10669538B2 (en) 2001-06-20 2020-06-02 Nuevolution A/S Templated molecules and methods for using such molecules
US8932992B2 (en) 2001-06-20 2015-01-13 Nuevolution A/S Templated molecules and methods for using such molecules
US20100016177A1 (en) * 2001-06-20 2010-01-21 Henrik Pedersen Templated molecules and methods for using such molecules
US20050009022A1 (en) * 2001-07-06 2005-01-13 Weiner Michael P. Method for isolation of independent, parallel chemical micro-reactions using a porous filter
US20030096268A1 (en) * 2001-07-06 2003-05-22 Michael Weiner Method for isolation of independent, parallel chemical micro-reactions using a porous filter
US20040056018A1 (en) * 2001-09-25 2004-03-25 Beru Ag Method for operating a multi-stage electrical heater comprised of several heating elements
US10731151B2 (en) 2002-03-15 2020-08-04 Nuevolution A/S Method for synthesising templated molecules
US8808984B2 (en) 2002-03-15 2014-08-19 Neuvolution A/S Method for synthesising templated molecules
US10730906B2 (en) 2002-08-01 2020-08-04 Nuevolutions A/S Multi-step synthesis of templated molecules
US20060121470A1 (en) * 2002-08-01 2006-06-08 Henrik Pedersen Multi-step synthesis of templated molecules
US20060292603A1 (en) * 2002-10-30 2006-12-28 Gouliaev Alex H Method for selecting a chemical entity from a tagged library
US8206901B2 (en) 2002-10-30 2012-06-26 Nuevolution A/S Method for the synthesis of a bifunctional complex
US10077440B2 (en) 2002-10-30 2018-09-18 Nuevolution A/S Method for the synthesis of a bifunctional complex
US8722583B2 (en) 2002-10-30 2014-05-13 Nuevolution A/S Method for selecting a chemical entity from a tagged library
US9284600B2 (en) 2002-10-30 2016-03-15 Neuvolution A/S Method for the synthesis of a bifunctional complex
US11001835B2 (en) 2002-10-30 2021-05-11 Nuevolution A/S Method for the synthesis of a bifunctional complex
US9109248B2 (en) 2002-10-30 2015-08-18 Nuevolution A/S Method for the synthesis of a bifunctional complex
US20080193983A1 (en) * 2002-12-19 2008-08-14 Nuevolution A/S Quasirandom Structure and Function Guided Synthesis Methods
US9121110B2 (en) 2002-12-19 2015-09-01 Nuevolution A/S Quasirandom structure and function guided synthesis methods
US20080132693A1 (en) * 2003-01-29 2008-06-05 Jan Berka Bead emulsion nucleic acid amplification
US10982274B2 (en) 2003-01-29 2021-04-20 Roche Molecular Systems, Inc. Bead emulsion nucleic acid amplification
US20090011959A1 (en) * 2003-01-29 2009-01-08 Costa Gina L Method for preparing single-stranded DNA libraries
US10240192B2 (en) 2003-01-29 2019-03-26 454 Life Sciences Corporation Bead emulsion nucleic acid amplification
US8765380B2 (en) 2003-01-29 2014-07-01 454 Life Sciences Corporation Bead emulsion nucleic acid amplification
US8012690B2 (en) 2003-01-29 2011-09-06 454 Life Sciences Corporation Bead emulsion nucleic acid amplification
US8748102B2 (en) 2003-01-29 2014-06-10 454 Life Sciences Corporation Bead emulsion nucleic acid amplification
US9096951B2 (en) 2003-02-21 2015-08-04 Nuevolution A/S Method for producing second-generation library
USRE43365E1 (en) 2003-03-14 2012-05-08 Lawrence Livermore National Security, Llc Apparatus for chemical amplification based on fluid partitioning in an immiscible liquid
USRE48788E1 (en) 2003-03-14 2021-10-26 Lawrence Livermore National Security, Llc Chemical amplification based on fluid partitioning
USRE45539E1 (en) 2003-03-14 2015-06-02 Lawrence Livermore National Security, Llc Method for chemical amplification based on fluid partitioning in an immiscible liquid
US11187702B2 (en) 2003-03-14 2021-11-30 Bio-Rad Laboratories, Inc. Enzyme quantification
USRE47080E1 (en) 2003-03-14 2018-10-09 Lawrence Livermore National Security, Llc Chemical amplification based on fluid partitioning
USRE41780E1 (en) 2003-03-14 2010-09-28 Lawrence Livermore National Security, Llc Chemical amplification based on fluid partitioning in an immiscible liquid
USRE46322E1 (en) 2003-03-14 2017-02-28 Lawrence Livermore National Security, Llc Method for chemical amplification based on fluid partitioning in an immiscible liquid
US8048627B2 (en) 2003-07-05 2011-11-01 The Johns Hopkins University Method and compositions for detection and enumeration of genetic variations
US20070065823A1 (en) * 2003-07-05 2007-03-22 Devin Dressman Method and compositions for detection and enumeration of genetic variations
US9328343B2 (en) 2003-07-05 2016-05-03 The Johns Hopkins University Method and compositions for detection and enumeration of genetic variations
WO2005010145A3 (fr) * 2003-07-05 2005-08-11 Univ Johns Hopkins Procede et compositions de detection et d'enumeration de variations genetiques
US10604797B2 (en) 2003-07-05 2020-03-31 The Johns Hopkins University Method and compositions for detection and enumeration of genetic variations
US20090286687A1 (en) * 2003-07-05 2009-11-19 The Johns Hopkins University Method and Compositions for Detection and Enumeration of Genetic Variations
US20080305957A1 (en) * 2003-09-18 2008-12-11 Thomas Thisted Method for Obtaining Structural Information Concerning an Encoded Molecule and Method for Selecting Compounds
US11965209B2 (en) 2003-09-18 2024-04-23 Nuevolution A/S Method for obtaining structural information concerning an encoded molecule and method for selecting compounds
US11118215B2 (en) 2003-09-18 2021-09-14 Nuevolution A/S Method for obtaining structural information concerning an encoded molecule and method for selecting compounds
US10953379B2 (en) 2004-01-07 2021-03-23 Illumina Cambridge Limited Methods and compositions of localizing nucleic acids to arrays
US9889422B2 (en) 2004-01-07 2018-02-13 Illumina Cambridge Limited Methods of localizing nucleic acids to arrays
US11654411B2 (en) 2004-01-07 2023-05-23 Illumina Cambridge Limited Methods and compositions of localizing nucleic acids to arrays
EP3175914A1 (fr) * 2004-01-07 2017-06-07 Illumina Cambridge Limited Perfectionnements apportés ou se rapportant à des réseaux moléculaires
US10525437B2 (en) 2004-01-07 2020-01-07 Illumina Cambridge Limited Methods and compositions of localizing nucleic acids to arrays
US20110177587A1 (en) * 2004-01-28 2011-07-21 454 Corporation Nucleic acid amplification with continuous flow emulsion
US20090239211A1 (en) * 2004-02-17 2009-09-24 Nuevolution A/S Method For Enrichment Involving Elimination By Mismatch Hybridisation
US9708652B2 (en) * 2004-03-08 2017-07-18 Rubicon Genomics, Inc. Methods and compositions for generating and amplifying DNA libraries for sensitive detection and analysis of DNA methylation
US20130309668A1 (en) * 2004-03-08 2013-11-21 Rubicon Genomics, Inc. Methods and compositions for generating and amplifying dna libraries for sensitive detection and analysis of dna methylation
US9109251B2 (en) 2004-06-25 2015-08-18 University Of Hawaii Ultrasensitive biosensors
US10563252B2 (en) 2004-06-25 2020-02-18 University Of Hawaii Ultrasensitive biosensors
US9752185B2 (en) 2004-09-15 2017-09-05 Integenx Inc. Microfluidic devices
US8551714B2 (en) 2004-09-15 2013-10-08 Integenx Inc. Microfluidic devices
US8476063B2 (en) 2004-09-15 2013-07-02 Integenx Inc. Microfluidic devices
US8431390B2 (en) 2004-09-15 2013-04-30 Integenx Inc. Systems of sample processing having a macro-micro interface
US8431340B2 (en) 2004-09-15 2013-04-30 Integenx Inc. Methods for processing and analyzing nucleic acid samples
US11786872B2 (en) 2004-10-08 2023-10-17 United Kingdom Research And Innovation Vitro evolution in microfluidic systems
US20060110764A1 (en) * 2004-10-25 2006-05-25 Tom Tang Large-scale parallelized DNA sequencing
US8753812B2 (en) 2004-11-12 2014-06-17 The Board Of Trustees Of The Leland Stanford Junior University Charge perturbation detection method for DNA and other molecules
US9228971B2 (en) 2004-11-12 2016-01-05 The Board Of Trustees Of The Leland Stanford Junior University Charge perturbation detection system for DNA and other molecules
US10822641B2 (en) 2004-11-12 2020-11-03 The Board Of Trustees Of The Leland Stanford Junior University Charge perturbation detection system for DNA and other molecules
US20090325184A1 (en) * 2005-03-16 2009-12-31 Life Technologies Corporation Compositions and Methods for Clonal Amplification and Analysis of Polynucleotides
US7604940B1 (en) 2005-03-16 2009-10-20 Applied Biosystems, Llc Compositions and methods for analyzing isolated polynucleotides
US20060269934A1 (en) * 2005-03-16 2006-11-30 Applera Corporation Compositions and methods for clonal amplification and analysis of polynucleotides
US20090233291A1 (en) * 2005-06-06 2009-09-17 454 Life Sciences Corporation Paired end sequencing
US9376716B2 (en) 2005-06-23 2016-06-28 Keygene N.V. Strategies for high throughput identification and detection of polymorphisms
US9898576B2 (en) 2005-06-23 2018-02-20 Keygene N.V. Strategies for high throughput identification and detection of polymorphisms
US9896721B2 (en) 2005-06-23 2018-02-20 Keygene N.V. Strategies for high throughput identification and detection of polymorphisms
US9898577B2 (en) 2005-06-23 2018-02-20 Keygene N.V. Strategies for high throughput identification and detection of polymorphisms
US10978175B2 (en) 2005-06-23 2021-04-13 Keygene N.V. Strategies for high throughput identification and detection of polymorphisms
US10095832B2 (en) 2005-06-23 2018-10-09 Keygene N.V. Strategies for high throughput identification and detection of polymorphisms
US9447459B2 (en) 2005-06-23 2016-09-20 Keygene N.V. Strategies for high throughput identification and detection of polymorphisms
US9453256B2 (en) * 2005-06-23 2016-09-27 Keygene N.V. Strategies for high throughput identification and detection of polymorphisms
US9493820B2 (en) * 2005-06-23 2016-11-15 Keygene N.V. Strategies for high throughput identification and detection of polymorphisms
US10235494B2 (en) 2005-06-23 2019-03-19 Keygene N.V. Strategies for high throughput identification and detection of polymorphisms
US20070031865A1 (en) * 2005-07-07 2007-02-08 David Willoughby Novel Process for Construction of a DNA Library
US20110171748A1 (en) * 2005-08-22 2011-07-14 Life Technologies Corporation Device And Method For Making Discrete Volumes Of A First Fluid In Contact With A Second Fluid, Which Are Immiscible With Each Other
US8361807B2 (en) 2005-08-22 2013-01-29 Applied Biosystems, Llc Device and method for making discrete volumes of a first fluid in contact with a second fluid, which are immiscible with each other
US9285297B2 (en) 2005-08-22 2016-03-15 Applied Biosystems, Llc Device, system, and method for depositing processed immiscible-fluid-discrete-volumes
US7955864B2 (en) 2005-08-22 2011-06-07 Life Technologies Corporation Device and method for making discrete volumes of a first fluid in contact with a second fluid, which are immiscible with each other
US20070039866A1 (en) * 2005-08-22 2007-02-22 Schroeder Benjamin G Device, system, and method for depositing processed immiscible-fluid-discrete-volumes
US10041113B2 (en) 2005-08-22 2018-08-07 Applied Biosystems, Llc Apparatus, system, and method using immiscible-fluid-discrete-volumes
US20070062583A1 (en) * 2005-08-22 2007-03-22 Cox David M Device and method for making discrete volumes of a first fluid in contact with a second fluid, which are immiscible with each other
EP2660482B1 (fr) * 2005-08-22 2019-08-07 Life Technologies Corporation Appareil, système et procédé utilisant des volumes discrets de fluides non miscibles
US11162137B2 (en) 2005-08-22 2021-11-02 Applied Biosystems Llc Apparatus, system, and method using immiscible-fluid-discrete-volumes
US20070068573A1 (en) * 2005-08-22 2007-03-29 Applera Corporation Device and method for microfluidic control of a first fluid in contact with a second fluid, wherein the first and second fluids are immiscible
US20070141593A1 (en) * 2005-08-22 2007-06-21 Lee Linda G Apparatus, system, and method using immiscible-fluid-discrete-volumes
EP2660482A1 (fr) 2005-08-22 2013-11-06 Life Technologies Corporation Appareil, système et procédé utilisant des volumes discrets de fluides non miscibles
US11319585B2 (en) 2005-08-22 2022-05-03 Applied Biosystems, Llc Device and method for making discrete volumes of a first fluid in contact with a second fluid, which are immiscible with each other
US20070117121A1 (en) * 2005-09-16 2007-05-24 Hutchison Stephen K cDNA library preparation
US10316364B2 (en) 2005-09-29 2019-06-11 Keygene N.V. Method for identifying the source of an amplicon
US10233494B2 (en) 2005-09-29 2019-03-19 Keygene N.V. High throughput screening of populations carrying naturally occurring mutations
US11649494B2 (en) 2005-09-29 2023-05-16 Keygene N.V. High throughput screening of populations carrying naturally occurring mutations
US10538806B2 (en) 2005-09-29 2020-01-21 Keygene N.V. High throughput screening of populations carrying naturally occurring mutations
US9574189B2 (en) 2005-12-01 2017-02-21 Nuevolution A/S Enzymatic encoding methods for efficient synthesis of large libraries
US11702652B2 (en) 2005-12-01 2023-07-18 Nuevolution A/S Enzymatic encoding methods for efficient synthesis of large libraries
US9334536B2 (en) 2005-12-22 2016-05-10 Keygene N.V. Method for high-throughput AFLP-based polymorphism detection
US9062348B1 (en) 2005-12-22 2015-06-23 Keygene N.V. Method for high-throughput AFLP-based polymorphism detection
US11008615B2 (en) 2005-12-22 2021-05-18 Keygene N.V. Method for high-throughput AFLP-based polymorphism detection
US9777324B2 (en) 2005-12-22 2017-10-03 Keygene N.V. Method for high-throughput AFLP-based polymorphism detection
US8815512B2 (en) 2005-12-22 2014-08-26 Keygene N.V. Method for high-throughput AFLP-based polymorphism detection
US9328383B2 (en) 2005-12-22 2016-05-03 Keygene N.V. Method for high-throughput AFLP-based polymorphism detection
US9702004B2 (en) 2005-12-22 2017-07-11 Keygene N.V. Method for high-throughput AFLP-based polymorphism detection
US8911945B2 (en) 2005-12-22 2014-12-16 Keygene N.V. Method for high-throughput AFLP-based polymorphism detection
US10106850B2 (en) 2005-12-22 2018-10-23 Keygene N.V. Method for high-throughput AFLP-based polymorphism detection
US20180355350A1 (en) * 2006-01-11 2018-12-13 Raindance Technologies, Inc. Microfluidic devices and methods of use in the formation and control of nanoreactors
US10633652B2 (en) * 2006-01-11 2020-04-28 Bio-Rad Laboratories, Inc. Microfluidic devices and methods of use in the formation and control of nanoreactors
US20180080020A1 (en) * 2006-01-11 2018-03-22 Raindance Technologies, Inc. Microfluidic devices and methods of use in the formation and control of nanoreactors
US20070172839A1 (en) * 2006-01-24 2007-07-26 Smith Douglas R Asymmetrical adapters and methods of use thereof
US20150197789A1 (en) * 2006-02-08 2015-07-16 Illumina Cambridge Limited End modification to prevent over-representation of fragments
US10006081B2 (en) * 2006-02-08 2018-06-26 Illumina Cambridge Limited End modification to prevent over-representation of fragments
US7993842B2 (en) 2006-03-23 2011-08-09 Life Technologies Corporation Directed enrichment of genomic DNA for high-throughput sequencing
US20070231823A1 (en) * 2006-03-23 2007-10-04 Mckernan Kevin J Directed enrichment of genomic DNA for high-throughput sequencing
EP2963127A1 (fr) * 2006-04-04 2016-01-06 Keygene N.V. Détection à haut débit de marqueurs moléculaires sur la base de fragments de restriction
EP3239304A1 (fr) * 2006-04-04 2017-11-01 Keygene N.V. Détection à haut débit de marqueurs moléculaires sur la base d'aflp et de séquençage à haut débit
US10023907B2 (en) 2006-04-04 2018-07-17 Keygene N.V. High throughput detection of molecular markers based on AFLP and high through-put sequencing
US20120135871A1 (en) * 2006-04-04 2012-05-31 Keygene N.V. High throughput detection of molecular markers based on aflp and high through-put sequencing
US20120202698A1 (en) * 2006-04-04 2012-08-09 Keygene N.V. High throughput detection of molecular markers based on aflp and high through-put sequencing
US11351510B2 (en) 2006-05-11 2022-06-07 Bio-Rad Laboratories, Inc. Microfluidic devices
US10202608B2 (en) 2006-08-31 2019-02-12 Gen9, Inc. Iterative nucleic acid assembly using activation of vector-encoded traits
US20090318298A1 (en) * 2006-09-28 2009-12-24 President And Fellows Of Harvard College Methods for Sequencing DNA
US20100143908A1 (en) * 2006-11-15 2010-06-10 Biospherex, Llc, A Limited Liability Company Multitag sequencing ecogenomics analysis-us
US8603749B2 (en) * 2006-11-15 2013-12-10 Biospherex, LLC Multitag sequencing ecogenomics analysis-US
US8349167B2 (en) 2006-12-14 2013-01-08 Life Technologies Corporation Methods and apparatus for detecting molecular interactions using FET arrays
US8293082B2 (en) 2006-12-14 2012-10-23 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
US20080145898A1 (en) * 2006-12-14 2008-06-19 Applera Corporation Sequencing methods
US8450781B2 (en) 2006-12-14 2013-05-28 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
US8658017B2 (en) 2006-12-14 2014-02-25 Life Technologies Corporation Methods for operating an array of chemically-sensitive sensors
US8685230B2 (en) 2006-12-14 2014-04-01 Life Technologies Corporation Methods and apparatus for high-speed operation of a chemically-sensitive sensor array
US8692298B2 (en) 2006-12-14 2014-04-08 Life Technologies Corporation Chemical sensor array having multiple sensors per well
US10415079B2 (en) 2006-12-14 2019-09-17 Life Technologies Corporation Methods and apparatus for detecting molecular interactions using FET arrays
US8445945B2 (en) 2006-12-14 2013-05-21 Life Technologies Corporation Low noise chemically-sensitive field effect transistors
US8492800B2 (en) 2006-12-14 2013-07-23 Life Technologies Corporation Chemically sensitive sensors with sample and hold capacitors
US8492799B2 (en) 2006-12-14 2013-07-23 Life Technologies Corporation Methods and apparatus for detecting molecular interactions using FET arrays
US10502708B2 (en) 2006-12-14 2019-12-10 Life Technologies Corporation Chemically-sensitive sensor array calibration circuitry
US10203300B2 (en) 2006-12-14 2019-02-12 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
US8742472B2 (en) 2006-12-14 2014-06-03 Life Technologies Corporation Chemically sensitive sensors with sample and hold capacitors
US20090325183A1 (en) * 2006-12-14 2009-12-31 Life Technologies Corporation Sequencing methods
US8496802B2 (en) 2006-12-14 2013-07-30 Life Technologies Corporation Methods for operating chemically-sensitive sample and hold sensors
US9269708B2 (en) 2006-12-14 2016-02-23 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
US8441044B2 (en) 2006-12-14 2013-05-14 Life Technologies Corporation Methods for manufacturing low noise chemically-sensitive field effect transistors
US11732297B2 (en) * 2006-12-14 2023-08-22 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
US8502278B2 (en) 2006-12-14 2013-08-06 Life Technologies Corporation Chemically-sensitive sample and hold sensors
US20100282617A1 (en) * 2006-12-14 2010-11-11 Ion Torrent Systems Incorporated Methods and apparatus for detecting molecular interactions using fet arrays
US10633699B2 (en) 2006-12-14 2020-04-28 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
US8766328B2 (en) 2006-12-14 2014-07-01 Life Technologies Corporation Chemically-sensitive sample and hold sensors
US8764969B2 (en) 2006-12-14 2014-07-01 Life Technologies Corporation Methods for operating chemically sensitive sensors with sample and hold capacitors
US8435395B2 (en) 2006-12-14 2013-05-07 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
US8426898B2 (en) 2006-12-14 2013-04-23 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
US7948015B2 (en) 2006-12-14 2011-05-24 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
US9989489B2 (en) 2006-12-14 2018-06-05 Life Technnologies Corporation Methods for calibrating an array of chemically-sensitive sensors
US10816506B2 (en) 2006-12-14 2020-10-27 Life Technologies Corporation Method for measuring analytes using large scale chemfet arrays
US9134269B2 (en) 2006-12-14 2015-09-15 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
US8575664B2 (en) 2006-12-14 2013-11-05 Life Technologies Corporation Chemically-sensitive sensor array calibration circuitry
US8519448B2 (en) 2006-12-14 2013-08-27 Life Technologies Corporation Chemically-sensitive array with active and reference sensors
US8426899B2 (en) 2006-12-14 2013-04-23 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
US8558288B2 (en) 2006-12-14 2013-10-15 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
US9951382B2 (en) 2006-12-14 2018-04-24 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
US8262900B2 (en) 2006-12-14 2012-09-11 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
US8415716B2 (en) 2006-12-14 2013-04-09 Life Technologies Corporation Chemically sensitive sensors with feedback circuits
US11435314B2 (en) 2006-12-14 2022-09-06 Life Technologies Corporation Chemically-sensitive sensor array device
US8264014B2 (en) 2006-12-14 2012-09-11 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
US8890216B2 (en) 2006-12-14 2014-11-18 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
US8269261B2 (en) 2006-12-14 2012-09-18 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
US8530941B2 (en) 2006-12-14 2013-09-10 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
US9404920B2 (en) 2006-12-14 2016-08-02 Life Technologies Corporation Methods and apparatus for detecting molecular interactions using FET arrays
US8540868B2 (en) 2006-12-14 2013-09-24 Life Technologies Corporation Methods and apparatus for detecting molecular interactions using FET arrays
US8306757B2 (en) 2006-12-14 2012-11-06 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
US8535513B2 (en) 2006-12-14 2013-09-17 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
US8313625B2 (en) 2006-12-14 2012-11-20 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
US8540865B2 (en) 2006-12-14 2013-09-24 Life Technologies Corporation Methods and apparatus for detecting molecular interactions using FET arrays
US8317999B2 (en) 2006-12-14 2012-11-27 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
US20220340965A1 (en) * 2006-12-14 2022-10-27 Life Technologies Corporation Methods and Apparatus for Measuring Analytes Using Large Scale FET Arrays
US8313639B2 (en) 2006-12-14 2012-11-20 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
US8540867B2 (en) 2006-12-14 2013-09-24 Life Technologies Corporation Methods and apparatus for detecting molecular interactions using FET arrays
US9023189B2 (en) 2006-12-14 2015-05-05 Life Technologies Corporation High density sensor array without wells
US9039888B2 (en) 2006-12-14 2015-05-26 Life Technologies Corporation Methods and apparatus for detecting molecular interactions using FET arrays
US8540866B2 (en) 2006-12-14 2013-09-24 Life Technologies Corporation Methods and apparatus for detecting molecular interactions using FET arrays
US8557518B2 (en) 2007-02-05 2013-10-15 Integenx Inc. Microfluidic and nanofluidic devices, systems, and applications
US20110039303A1 (en) * 2007-02-05 2011-02-17 Stevan Bogdan Jovanovich Microfluidic and nanofluidic devices, systems, and applications
US11819849B2 (en) 2007-02-06 2023-11-21 Brandeis University Manipulation of fluids and reactions in microfluidic systems
US11224876B2 (en) 2007-04-19 2022-01-18 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
US10960397B2 (en) 2007-04-19 2021-03-30 President And Fellows Of Harvard College Manipulation of fluids, fluid components and reactions in microfluidic systems
US11618024B2 (en) 2007-04-19 2023-04-04 President And Fellows Of Harvard College Manipulation of fluids, fluid components and reactions in microfluidic systems
US20100267043A1 (en) * 2007-06-01 2010-10-21 Braverman Michael S System and method for identification of individual samples from a multiplex mixture
US20090105959A1 (en) * 2007-06-01 2009-04-23 Braverman Michael S System and method for identification of individual samples from a multiplex mixture
US20090053724A1 (en) * 2007-06-28 2009-02-26 454 Life Sciences Corporation System and method for adaptive reagent control in nucleic acid sequencing
US20100136557A1 (en) * 2007-06-29 2010-06-03 Sydney Brenner Methods and Compositions for Isolating Nucleic Acid Sequence Variants
US8241850B2 (en) * 2007-06-29 2012-08-14 Population Genetics Technologies Ltd. Methods and compositions for isolating nucleic acid sequence variants
US11339430B2 (en) 2007-07-10 2022-05-24 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
US8748165B2 (en) 2008-01-22 2014-06-10 Integenx Inc. Methods for generating short tandem repeat (STR) profiles
US20090203086A1 (en) * 2008-02-06 2009-08-13 454 Life Sciences Corporation System and method for improved signal detection in nucleic acid sequencing
US9194000B2 (en) 2008-06-25 2015-11-24 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
US8470164B2 (en) 2008-06-25 2013-06-25 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
US8524057B2 (en) 2008-06-25 2013-09-03 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
US8344123B2 (en) 2008-07-01 2013-01-01 454 Life Sciences Corporation System and method for detection of HIV tropism variants
US7888034B2 (en) 2008-07-01 2011-02-15 454 Life Sciences Corporation System and method for detection of HIV tropism variants
USRE46293E1 (en) 2008-07-01 2017-01-31 454 Life Sciences Corporation System and method for detection of HIV tropism variants
US11534727B2 (en) 2008-07-18 2022-12-27 Bio-Rad Laboratories, Inc. Droplet libraries
US11596908B2 (en) 2008-07-18 2023-03-07 Bio-Rad Laboratories, Inc. Droplet libraries
US11511242B2 (en) 2008-07-18 2022-11-29 Bio-Rad Laboratories, Inc. Droplet libraries
US8808986B2 (en) 2008-08-27 2014-08-19 Gen9, Inc. Methods and devices for high fidelity polynucleotide synthesis
US11015191B2 (en) 2008-08-27 2021-05-25 Gen9, Inc. Methods and devices for high fidelity polynucleotide synthesis
US9856471B2 (en) 2008-08-27 2018-01-02 Gen9, Inc. Methods and devices for high fidelity polynucleotide synthesis
US20100261189A1 (en) * 2008-10-03 2010-10-14 Roche Molecular Systems, Inc. System and method for detection of HLA Variants
US9944981B2 (en) 2008-10-22 2018-04-17 Life Technologies Corporation Methods and apparatus for measuring analytes
US20100137143A1 (en) * 2008-10-22 2010-06-03 Ion Torrent Systems Incorporated Methods and apparatus for measuring analytes
US9964515B2 (en) 2008-10-22 2018-05-08 Life Technologies Corporation Integrated sensor arrays for biological and chemical analysis
US11874250B2 (en) 2008-10-22 2024-01-16 Life Technologies Corporation Integrated sensor arrays for biological and chemical analysis
US8936763B2 (en) 2008-10-22 2015-01-20 Life Technologies Corporation Integrated sensor arrays for biological and chemical analysis
US11448613B2 (en) 2008-10-22 2022-09-20 Life Technologies Corporation ChemFET sensor array including overlying array of wells
US11137369B2 (en) 2008-10-22 2021-10-05 Life Technologies Corporation Integrated sensor arrays for biological and chemical analysis
US8672532B2 (en) 2008-12-31 2014-03-18 Integenx Inc. Microfluidic methods
US11517864B2 (en) 2009-03-13 2022-12-06 President And Fellows Of Harvard College Scale-up of microfluidic devices
US9486757B2 (en) 2009-03-13 2016-11-08 President And Fellows Of Harvard College Scale-up of microfluidic devices
US10518230B2 (en) 2009-03-13 2019-12-31 President And Fellows Of Harvard College Scale-up of microfluidic devices
US8263336B2 (en) 2009-05-29 2012-09-11 Life Technologies Corporation Methods and apparatus for measuring analytes
US9927393B2 (en) 2009-05-29 2018-03-27 Life Technologies Corporation Methods and apparatus for measuring analytes
US8776573B2 (en) 2009-05-29 2014-07-15 Life Technologies Corporation Methods and apparatus for measuring analytes
US11768171B2 (en) 2009-05-29 2023-09-26 Life Technologies Corporation Methods and apparatus for measuring analytes
US8748947B2 (en) 2009-05-29 2014-06-10 Life Technologies Corporation Active chemically-sensitive sensors with reset switch
US10809226B2 (en) 2009-05-29 2020-10-20 Life Technologies Corporation Methods and apparatus for measuring analytes
US8673627B2 (en) 2009-05-29 2014-03-18 Life Technologies Corporation Apparatus and methods for performing electrochemical reactions
US8592154B2 (en) 2009-05-29 2013-11-26 Life Technologies Corporation Methods and apparatus for high speed operation of a chemically-sensitive sensor array
US20100301398A1 (en) * 2009-05-29 2010-12-02 Ion Torrent Systems Incorporated Methods and apparatus for measuring analytes
US10612017B2 (en) 2009-05-29 2020-04-07 Life Technologies Corporation Scaffolded nucleic acid polymer particles and methods of making and using
US8592153B1 (en) 2009-05-29 2013-11-26 Life Technologies Corporation Methods for manufacturing high capacitance microwell structures of chemically-sensitive sensors
US11692964B2 (en) 2009-05-29 2023-07-04 Life Technologies Corporation Methods and apparatus for measuring analytes
US8822205B2 (en) 2009-05-29 2014-09-02 Life Technologies Corporation Active chemically-sensitive sensors with source follower amplifier
US10718733B2 (en) 2009-05-29 2020-07-21 Life Technologies Corporation Methods and apparatus for measuring analytes
US8698212B2 (en) 2009-05-29 2014-04-15 Life Technologies Corporation Active chemically-sensitive sensors
US8912580B2 (en) 2009-05-29 2014-12-16 Life Technologies Corporation Active chemically-sensitive sensors with in-sensor current sources
US10451585B2 (en) 2009-05-29 2019-10-22 Life Technologies Corporation Methods and apparatus for measuring analytes
US8766327B2 (en) 2009-05-29 2014-07-01 Life Technologies Corporation Active chemically-sensitive sensors with in-sensor current sources
US8742469B2 (en) 2009-05-29 2014-06-03 Life Technologies Corporation Active chemically-sensitive sensors with correlated double sampling
US8994076B2 (en) 2009-05-29 2015-03-31 Life Technologies Corporation Chemically-sensitive field effect transistor based pixel array with protection diodes
US8388908B2 (en) 2009-06-02 2013-03-05 Integenx Inc. Fluidic devices with diaphragm valves
US8562918B2 (en) 2009-06-05 2013-10-22 Integenx Inc. Universal sample preparation system and use in an integrated analysis system
US9012236B2 (en) 2009-06-05 2015-04-21 Integenx Inc. Universal sample preparation system and use in an integrated analysis system
US8394642B2 (en) 2009-06-05 2013-03-12 Integenx Inc. Universal sample preparation system and use in an integrated analysis system
US20110087016A1 (en) * 2009-10-09 2011-04-14 454 Life Sciences Corporation System and Method for Emulsion Breaking and Recovery of Biological Elements
US8609339B2 (en) 2009-10-09 2013-12-17 454 Life Sciences Corporation System and method for emulsion breaking and recovery of biological elements
WO2011042189A1 (fr) 2009-10-09 2011-04-14 Roche Diagnostics Gmbh Système et procédé pour la rupture d'émulsion et la récupération d'éléments biologiques
US20120220497A1 (en) * 2009-11-03 2012-08-30 Gen 9, Inc. Methods and Microfluidic Devices for the Manipulation of Droplets in High Fidelity Polynucleotide Assembly
US10207240B2 (en) * 2009-11-03 2019-02-19 Gen9, Inc. Methods and microfluidic devices for the manipulation of droplets in high fidelity polynucleotide assembly
WO2011056872A3 (fr) * 2009-11-03 2011-11-03 Gen9, Inc. Procédés et dispositifs microfluidiques pour la manipulation de gouttelettes dans un ensemble polynucléotidique haute fidélité
US9968902B2 (en) 2009-11-25 2018-05-15 Gen9, Inc. Microfluidic devices and methods for gene synthesis
US9216414B2 (en) 2009-11-25 2015-12-22 Gen9, Inc. Microfluidic devices and methods for gene synthesis
US9422600B2 (en) 2009-11-25 2016-08-23 Gen9, Inc. Methods and apparatuses for chip-based DNA error reduction
US10829759B2 (en) 2009-11-25 2020-11-10 Gen9, Inc. Methods and apparatuses for chip-based DNA error reduction
US8584703B2 (en) 2009-12-01 2013-11-19 Integenx Inc. Device with diaphragm valve
US20110126911A1 (en) * 2009-12-01 2011-06-02 IntegenX Inc., a California Corporation Composite Plastic Articles
US9925510B2 (en) 2010-01-07 2018-03-27 Gen9, Inc. Assembly of high fidelity polynucleotides
US11071963B2 (en) 2010-01-07 2021-07-27 Gen9, Inc. Assembly of high fidelity polynucleotides
US9217144B2 (en) 2010-01-07 2015-12-22 Gen9, Inc. Assembly of high fidelity polynucleotides
US11254968B2 (en) 2010-02-12 2022-02-22 Bio-Rad Laboratories, Inc. Digital analyte analysis
US11390917B2 (en) 2010-02-12 2022-07-19 Bio-Rad Laboratories, Inc. Digital analyte analysis
WO2011106314A3 (fr) * 2010-02-25 2012-02-23 Advanced Liquid Logic, Inc. Procédé de fabrication de banques d'acide nucléique
AU2011221243B2 (en) * 2010-02-25 2016-06-02 Advanced Liquid Logic, Inc. Method of making nucleic acid libraries
US9938553B2 (en) 2010-03-03 2018-04-10 Gen9, Inc. Methods and devices for nucleic acid synthesis
US20110217738A1 (en) * 2010-03-03 2011-09-08 Gen9, Inc. Methods and Devices for Nucleic Acid Synthesis
US8716467B2 (en) 2010-03-03 2014-05-06 Gen9, Inc. Methods and devices for nucleic acid synthesis
US9388407B2 (en) 2010-03-03 2016-07-12 Gen9, Inc. Methods and devices for nucleic acid synthesis
US8512538B2 (en) 2010-05-28 2013-08-20 Integenx Inc. Capillary electrophoresis device
US8742471B2 (en) 2010-06-30 2014-06-03 Life Technologies Corporation Chemical sensor array with leakage compensation circuit
US9164070B2 (en) 2010-06-30 2015-10-20 Life Technologies Corporation Column adc
US9957564B2 (en) 2010-06-30 2018-05-01 Bgi Genomics Co., Ltd. Application of a PCR sequencing method, based on DNA barcoding technique and DNA incomplete shearing strategy, in HLA genotyping
US8217433B1 (en) 2010-06-30 2012-07-10 Life Technologies Corporation One-transistor pixel array
US8858782B2 (en) 2010-06-30 2014-10-14 Life Technologies Corporation Ion-sensing charge-accumulation circuits and methods
US8983783B2 (en) 2010-06-30 2015-03-17 Life Technologies Corporation Chemical detection device having multiple flow channels
US8524487B2 (en) 2010-06-30 2013-09-03 Life Technologies Corporation One-transistor pixel array with cascoded column circuit
US10641729B2 (en) 2010-06-30 2020-05-05 Life Technologies Corporation Column ADC
EP2599877B1 (fr) * 2010-06-30 2017-09-27 BGI Genomics Co., Limited Nouvelle méthode de séquençage par pcr et son utilisation dans le génotypage hla
US8415177B2 (en) 2010-06-30 2013-04-09 Life Technologies Corporation Two-transistor pixel array
EP2599877A1 (fr) * 2010-06-30 2013-06-05 BGI Shenzhen Co., Limited Nouvelle méthode de séquençage par pcr et son utilisation dans le génotypage hla
US8415176B2 (en) 2010-06-30 2013-04-09 Life Technologies Corporation One-transistor pixel array
US8455927B2 (en) 2010-06-30 2013-06-04 Life Technologies Corporation One-transistor pixel array with cascoded column circuit
US8421437B2 (en) 2010-06-30 2013-04-16 Life Technologies Corporation Array column integrator
US8487790B2 (en) 2010-06-30 2013-07-16 Life Technologies Corporation Chemical detection circuit including a serializer circuit
US8823380B2 (en) 2010-06-30 2014-09-02 Life Technologies Corporation Capacitive charge pump
US11231451B2 (en) 2010-06-30 2022-01-25 Life Technologies Corporation Methods and apparatus for testing ISFET arrays
US8432150B2 (en) 2010-06-30 2013-04-30 Life Technologies Corporation Methods for operating an array column integrator
US8432149B2 (en) 2010-06-30 2013-04-30 Life Technologies Corporation Array column integrator
US8741680B2 (en) 2010-06-30 2014-06-03 Life Technologies Corporation Two-transistor pixel array
US10481123B2 (en) 2010-06-30 2019-11-19 Life Technologies Corporation Ion-sensing charge-accumulation circuits and methods
US8772698B2 (en) 2010-06-30 2014-07-08 Life Technologies Corporation CCD-based multi-transistor active pixel sensor array
US9239313B2 (en) 2010-06-30 2016-01-19 Life Technologies Corporation Ion-sensing charge-accumulation circuits and methods
US8247849B2 (en) 2010-06-30 2012-08-21 Life Technologies Corporation Two-transistor pixel array
US8731847B2 (en) 2010-06-30 2014-05-20 Life Technologies Corporation Array configuration and readout scheme
US11307166B2 (en) 2010-07-01 2022-04-19 Life Technologies Corporation Column ADC
US8653567B2 (en) 2010-07-03 2014-02-18 Life Technologies Corporation Chemically sensitive sensor with lightly doped drains
US9960253B2 (en) 2010-07-03 2018-05-01 Life Technologies Corporation Chemically sensitive sensor with lightly doped drains
US9121058B2 (en) 2010-08-20 2015-09-01 Integenx Inc. Linear valve arrays
US9731266B2 (en) 2010-08-20 2017-08-15 Integenx Inc. Linear valve arrays
US8763642B2 (en) 2010-08-20 2014-07-01 Integenx Inc. Microfluidic devices with mechanically-sealed diaphragm valves
US9618475B2 (en) 2010-09-15 2017-04-11 Life Technologies Corporation Methods and apparatus for measuring analytes
US9958414B2 (en) 2010-09-15 2018-05-01 Life Technologies Corporation Apparatus for measuring analytes including chemical sensor array
US9958415B2 (en) 2010-09-15 2018-05-01 Life Technologies Corporation ChemFET sensor including floating gate
US8685324B2 (en) 2010-09-24 2014-04-01 Life Technologies Corporation Matched pair transistor circuits
US9110015B2 (en) 2010-09-24 2015-08-18 Life Technologies Corporation Method and system for delta double sampling
US8796036B2 (en) 2010-09-24 2014-08-05 Life Technologies Corporation Method and system for delta double sampling
US8912005B1 (en) 2010-09-24 2014-12-16 Life Technologies Corporation Method and system for delta double sampling
US11635427B2 (en) 2010-09-30 2023-04-25 Bio-Rad Laboratories, Inc. Sandwich assays in droplets
US11396651B2 (en) 2010-10-08 2022-07-26 President And Fellows Of Harvard College High-throughput single cell barcoding
US10246703B2 (en) 2010-10-08 2019-04-02 President And Fellows Of Harvard College High-throughput single cell barcoding
GB2497912B (en) * 2010-10-08 2014-06-04 Harvard College High-throughput single cell barcoding
US9902950B2 (en) 2010-10-08 2018-02-27 President And Fellows Of Harvard College High-throughput single cell barcoding
US10752895B2 (en) 2010-10-08 2020-08-25 President And Fellows Of Harvard College High-throughput single cell barcoding
US11845054B2 (en) 2010-11-12 2023-12-19 Gen9, Inc. Methods and devices for nucleic acids synthesis
US10457935B2 (en) 2010-11-12 2019-10-29 Gen9, Inc. Protein arrays and methods of using and making the same
US10982208B2 (en) 2010-11-12 2021-04-20 Gen9, Inc. Protein arrays and methods of using and making the same
US11084014B2 (en) 2010-11-12 2021-08-10 Gen9, Inc. Methods and devices for nucleic acids synthesis
US11077415B2 (en) 2011-02-11 2021-08-03 Bio-Rad Laboratories, Inc. Methods for forming mixed droplets
US11768198B2 (en) 2011-02-18 2023-09-26 Bio-Rad Laboratories, Inc. Compositions and methods for molecular labeling
US11965877B2 (en) 2011-02-18 2024-04-23 Bio-Rad Laboratories, Inc. Compositions and methods for molecular labeling
US11747327B2 (en) 2011-02-18 2023-09-05 Bio-Rad Laboratories, Inc. Compositions and methods for molecular labeling
US11168353B2 (en) 2011-02-18 2021-11-09 Bio-Rad Laboratories, Inc. Compositions and methods for molecular labeling
WO2012130681A1 (fr) 2011-03-25 2012-10-04 Roche Diagnostics Gmbh Système et procédé de détection de variants de l'intégrase du vih
US11754499B2 (en) 2011-06-02 2023-09-12 Bio-Rad Laboratories, Inc. Enzyme quantification
US9752176B2 (en) 2011-06-15 2017-09-05 Ginkgo Bioworks, Inc. Methods for preparative in vitro cloning
US9513253B2 (en) 2011-07-11 2016-12-06 Advanced Liquid Logic, Inc. Droplet actuators and techniques for droplet-based enzymatic assays
US11898193B2 (en) 2011-07-20 2024-02-13 Bio-Rad Laboratories, Inc. Manipulating droplet size
US11702662B2 (en) 2011-08-26 2023-07-18 Gen9, Inc. Compositions and methods for high fidelity assembly of nucleic acids
US10865440B2 (en) 2011-10-21 2020-12-15 IntegenX, Inc. Sample preparation, processing and analysis systems
US10525467B2 (en) 2011-10-21 2020-01-07 Integenx Inc. Sample preparation, processing and analysis systems
US11684918B2 (en) 2011-10-21 2023-06-27 IntegenX, Inc. Sample preparation, processing and analysis systems
US10598723B2 (en) 2011-12-01 2020-03-24 Life Technologies Corporation Method and apparatus for identifying defects in a chemical sensor array
US9970984B2 (en) 2011-12-01 2018-05-15 Life Technologies Corporation Method and apparatus for identifying defects in a chemical sensor array
US10365321B2 (en) 2011-12-01 2019-07-30 Life Technologies Corporation Method and apparatus for identifying defects in a chemical sensor array
US9951384B2 (en) 2012-01-13 2018-04-24 Data2Bio Genotyping by next-generation sequencing
US10704091B2 (en) 2012-01-13 2020-07-07 Data2Bio Genotyping by next-generation sequencing
US20180201996A1 (en) * 2012-01-13 2018-07-19 Data2Bio Genotyping by next-generation sequencing
US8821798B2 (en) 2012-01-19 2014-09-02 Life Technologies Corporation Titanium nitride as sensing layer for microwell structure
US8747748B2 (en) 2012-01-19 2014-06-10 Life Technologies Corporation Chemical sensor with conductive cup-shaped sensor surface
US10308931B2 (en) 2012-03-21 2019-06-04 Gen9, Inc. Methods for screening proteins using DNA encoded chemical libraries as templates for enzyme catalysis
US10081807B2 (en) 2012-04-24 2018-09-25 Gen9, Inc. Methods for sorting nucleic acids and multiplexed preparative in vitro cloning
US10927369B2 (en) 2012-04-24 2021-02-23 Gen9, Inc. Methods for sorting nucleic acids and multiplexed preparative in vitro cloning
US10192024B2 (en) 2012-05-18 2019-01-29 454 Life Sciences Corporation System and method for generation and use of optimal nucleotide flow orders
US10404249B2 (en) 2012-05-29 2019-09-03 Life Technologies Corporation System for reducing noise in a chemical sensor array
US8552771B1 (en) 2012-05-29 2013-10-08 Life Technologies Corporation System for reducing noise in a chemical sensor array
US9270264B2 (en) 2012-05-29 2016-02-23 Life Technologies Corporation System for reducing noise in a chemical sensor array
US8786331B2 (en) 2012-05-29 2014-07-22 Life Technologies Corporation System for reducing noise in a chemical sensor array
US9985624B2 (en) 2012-05-29 2018-05-29 Life Technologies Corporation System for reducing noise in a chemical sensor array
US11072789B2 (en) 2012-06-25 2021-07-27 Gen9, Inc. Methods for nucleic acid assembly and high throughput sequencing
US11591637B2 (en) 2012-08-14 2023-02-28 10X Genomics, Inc. Compositions and methods for sample processing
US11441179B2 (en) 2012-08-14 2022-09-13 10X Genomics, Inc. Methods and systems for processing polynucleotides
US11359239B2 (en) 2012-08-14 2022-06-14 10X Genomics, Inc. Methods and systems for processing polynucleotides
EP3901273A1 (fr) * 2012-08-14 2021-10-27 10X Genomics, Inc. Compositions de microcapsule et procédés
US11434523B2 (en) 2012-09-04 2022-09-06 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
US11913065B2 (en) 2012-09-04 2024-02-27 Guardent Health, Inc. Systems and methods to detect rare mutations and copy number variation
WO2014043140A1 (fr) * 2012-09-12 2014-03-20 The Regents Of The University Of California Séquençage précis du génome de cellules individuelles par l'amplification et le séquençage d'un seul brin
US10752945B2 (en) 2012-09-12 2020-08-25 The Regents Of The University Of California Accurate genome sequencing of single cells by single-stranded amplification and sequencing
WO2014068407A3 (fr) * 2012-10-26 2014-06-26 Sysmex Corporation Systèmes d'émulsion et amplification à base d'émulsion d'acide nucléique
US9803226B2 (en) 2012-10-26 2017-10-31 Sysmex Corporation Emulsion systems and emulsion-based amplification of nucleic acid
US11421274B2 (en) 2012-12-14 2022-08-23 10X Genomics, Inc. Methods and systems for processing polynucleotides
US11473138B2 (en) 2012-12-14 2022-10-18 10X Genomics, Inc. Methods and systems for processing polynucleotides
US9080968B2 (en) 2013-01-04 2015-07-14 Life Technologies Corporation Methods and systems for point of use removal of sacrificial material
US9852919B2 (en) 2013-01-04 2017-12-26 Life Technologies Corporation Methods and systems for point of use removal of sacrificial material
US9841398B2 (en) 2013-01-08 2017-12-12 Life Technologies Corporation Methods for manufacturing well structures for low-noise chemical sensors
US10436742B2 (en) 2013-01-08 2019-10-08 Life Technologies Corporation Methods for manufacturing well structures for low-noise chemical sensors
US8962366B2 (en) 2013-01-28 2015-02-24 Life Technologies Corporation Self-aligned well structures for low-noise chemical sensors
US11193121B2 (en) 2013-02-08 2021-12-07 10X Genomics, Inc. Partitioning and processing of analytes and other species
US9995708B2 (en) 2013-03-13 2018-06-12 Life Technologies Corporation Chemical sensor with sidewall spacer sensor surface
US8963216B2 (en) 2013-03-13 2015-02-24 Life Technologies Corporation Chemical sensor with sidewall spacer sensor surface
US8841217B1 (en) 2013-03-13 2014-09-23 Life Technologies Corporation Chemical sensor with protruded sensor surface
US10392614B2 (en) 2013-03-15 2019-08-27 Abvitro Llc Methods of single-cell barcoding and sequencing
US10119134B2 (en) 2013-03-15 2018-11-06 Abvitro Llc Single cell bar-coding for antibody discovery
US9823217B2 (en) 2013-03-15 2017-11-21 Life Technologies Corporation Chemical device with thin conductive element
US11118176B2 (en) 2013-03-15 2021-09-14 Abvitro Llc Single cell bar-coding for antibody discovery
US9128044B2 (en) 2013-03-15 2015-09-08 Life Technologies Corporation Chemical sensors with consistent sensor surface areas
US9816088B2 (en) 2013-03-15 2017-11-14 Abvitro Llc Single cell bar-coding for antibody discovery
US9835585B2 (en) 2013-03-15 2017-12-05 Life Technologies Corporation Chemical sensor with protruded sensor surface
US9116117B2 (en) 2013-03-15 2015-08-25 Life Technologies Corporation Chemical sensor with sidewall sensor surface
EP2971168B1 (fr) 2013-03-15 2021-05-05 Guardant Health, Inc. Méthodes pour détecter cancer
US10422767B2 (en) 2013-03-15 2019-09-24 Life Technologies Corporation Chemical sensor with consistent sensor surface areas
US10876107B2 (en) 2013-03-15 2020-12-29 Abvitro Llc Single cell bar-coding for antibody discovery
US10481124B2 (en) 2013-03-15 2019-11-19 Life Technologies Corporation Chemical device with thin conductive element
US9671363B2 (en) 2013-03-15 2017-06-06 Life Technologies Corporation Chemical sensor with consistent sensor surface areas
US10655175B2 (en) 2013-05-09 2020-05-19 Life Technologies Corporation Windowed sequencing
US10100357B2 (en) 2013-05-09 2018-10-16 Life Technologies Corporation Windowed sequencing
US11028438B2 (en) 2013-05-09 2021-06-08 Life Technologies Corporation Windowed sequencing
US10816504B2 (en) 2013-06-10 2020-10-27 Life Technologies Corporation Chemical sensor array having multiple sensors per well
US11499938B2 (en) 2013-06-10 2022-11-15 Life Technologies Corporation Chemical sensor array having multiple sensors per well
US11774401B2 (en) 2013-06-10 2023-10-03 Life Technologies Corporation Chemical sensor array having multiple sensors per well
US10458942B2 (en) 2013-06-10 2019-10-29 Life Technologies Corporation Chemical sensor array having multiple sensors per well
US9624519B2 (en) 2013-08-23 2017-04-18 454 Life Sciences Corporation System and method for nucleic acid amplification
EP2840148A1 (fr) 2013-08-23 2015-02-25 F. Hoffmann-La Roche AG Procédé et système pour l'amplification d'acides nucléiques
US9808806B2 (en) 2013-08-26 2017-11-07 454 Life Sciences Corporation System and method for automated nucleic acid amplification
EP2848698A1 (fr) 2013-08-26 2015-03-18 F. Hoffmann-La Roche AG Système et méthode pour une amplification automatisée dacide nucléique
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification
US10191071B2 (en) 2013-11-18 2019-01-29 IntegenX, Inc. Cartridges and instruments for sample analysis
US10989723B2 (en) 2013-11-18 2021-04-27 IntegenX, Inc. Cartridges and instruments for sample analysis
US11174509B2 (en) 2013-12-12 2021-11-16 Bio-Rad Laboratories, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample
US11639525B2 (en) 2013-12-28 2023-05-02 Guardant Health, Inc. Methods and systems for detecting genetic variants
US11639526B2 (en) 2013-12-28 2023-05-02 Guardant Health, Inc. Methods and systems for detecting genetic variants
US11767555B2 (en) 2013-12-28 2023-09-26 Guardant Health, Inc. Methods and systems for detecting genetic variants
US11434531B2 (en) 2013-12-28 2022-09-06 Guardant Health, Inc. Methods and systems for detecting genetic variants
US11959139B2 (en) 2013-12-28 2024-04-16 Guardant Health, Inc. Methods and systems for detecting genetic variants
US11767556B2 (en) 2013-12-28 2023-09-26 Guardant Health, Inc. Methods and systems for detecting genetic variants
US11649491B2 (en) 2013-12-28 2023-05-16 Guardant Health, Inc. Methods and systems for detecting genetic variants
US11667959B2 (en) 2014-03-05 2023-06-06 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
US11447813B2 (en) 2014-03-05 2022-09-20 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
US11891650B2 (en) 2014-05-21 2024-02-06 IntegenX, Inc. Fluid cartridge with valve mechanism
US10961561B2 (en) 2014-05-21 2021-03-30 IntegenX, Inc. Fluidic cartridge with valve mechanism
US10208332B2 (en) 2014-05-21 2019-02-19 Integenx Inc. Fluidic cartridge with valve mechanism
US11713457B2 (en) 2014-06-26 2023-08-01 10X Genomics, Inc. Methods and systems for processing polynucleotides
US11629344B2 (en) 2014-06-26 2023-04-18 10X Genomics, Inc. Methods and systems for processing polynucleotides
US10590483B2 (en) 2014-09-15 2020-03-17 Abvitro Llc High-throughput nucleotide library sequencing
EP3208343A4 (fr) * 2014-10-13 2018-03-21 BGI Shenzhen Co., Limited Procédé de fragmentation d'acide nucléique et combinaison de séquences
US10344317B2 (en) 2014-10-13 2019-07-09 Mgi Tech Co., Ltd Method and a sequence combination for producing nucleic acid fragments
US10690627B2 (en) 2014-10-22 2020-06-23 IntegenX, Inc. Systems and methods for sample preparation, processing and analysis
US10379079B2 (en) 2014-12-18 2019-08-13 Life Technologies Corporation Methods and apparatus for measuring analytes using large scale FET arrays
US11536688B2 (en) 2014-12-18 2022-12-27 Life Technologies Corporation High data rate integrated circuit with transmitter configuration
US10077472B2 (en) 2014-12-18 2018-09-18 Life Technologies Corporation High data rate integrated circuit with power management
US10767224B2 (en) 2014-12-18 2020-09-08 Life Technologies Corporation High data rate integrated circuit with power management
US10605767B2 (en) 2014-12-18 2020-03-31 Life Technologies Corporation High data rate integrated circuit with transmitter configuration
US10421993B2 (en) 2015-02-11 2019-09-24 Paragon Genomics, Inc. Methods and compositions for reducing non-specific amplification products
US9464318B2 (en) * 2015-02-11 2016-10-11 Paragon Genomics, Inc. Methods and compositions for reducing non-specific amplification products
US11319588B2 (en) 2015-02-17 2022-05-03 Mgi Tech Co., Ltd. DNA sequencing using controlled strand displacement
US10227647B2 (en) 2015-02-17 2019-03-12 Complete Genomics, Inc. DNA sequencing using controlled strand displacement
AU2016220404B2 (en) * 2015-02-17 2021-05-27 Mgi Tech Co., Ltd. DNA sequencing using controlled strand displacement
EP3259372A4 (fr) * 2015-02-17 2018-11-07 Complete Genomics, Inc. Séquençage de l'adn à l'aide d'un déplacement de brin régulé
US10301660B2 (en) 2015-03-30 2019-05-28 Takara Bio Usa, Inc. Methods and compositions for repair of DNA ends by multiple enzymatic activities
WO2016160965A1 (fr) * 2015-03-30 2016-10-06 Rubicon Genomics, Inc. Procédés et compositions permettant la réparation des extrémités de l'adn par de multiples activités enzymatiques
US10640809B2 (en) * 2015-05-29 2020-05-05 Epicentre Technologies Corporation Methods of analyzing nucleic acids
US20180148767A1 (en) * 2015-05-29 2018-05-31 Epicentre Technologies Corporation Methods of analyzing nucleic acids
US11339422B2 (en) 2015-05-29 2022-05-24 Illumina, Inc. Methods of analyzing nucleic acids
US11795578B2 (en) 2015-05-29 2023-10-24 Illumina, Inc. Methods of analyzing nucleic acids
US10344336B2 (en) 2015-06-09 2019-07-09 Life Technologies Corporation Methods, systems, compositions, kits, apparatus and computer-readable media for molecular tagging
US11124842B2 (en) 2015-06-09 2021-09-21 Life Technologies Corporation Methods, systems, compositions, kits, apparatus and computer-readable media for molecular tagging
WO2018049260A1 (fr) * 2016-09-09 2018-03-15 Tl Biolabs Corp . Compositions de microréseau réutilisables et procédés
CN110062809A (zh) * 2016-12-20 2019-07-26 豪夫迈·罗氏有限公司 用于环状共有序列测序的单链环状dna文库
US10100358B2 (en) 2017-01-10 2018-10-16 Paragon Genomics, Inc. Methods and compositions for reducing redundant molecular barcodes created in primer extension reactions
CN110719958A (zh) * 2017-04-06 2020-01-21 王磬 构建核酸文库的方法和试剂盒
CN110719958B (zh) * 2017-04-06 2023-07-18 康博国际有限公司 构建核酸文库的方法和试剂盒
WO2018186930A1 (fr) * 2017-04-06 2018-10-11 MyOmicsDx, Inc Procédé et kit de construction d'une bibliothèque d'acides nucléiques
CN111133135A (zh) * 2017-07-17 2020-05-08 希昆斯生物科学公司 用于高通量测序的快速文库构建
US11667952B2 (en) 2017-08-24 2023-06-06 Takara Bio Usa, Inc. Methods of producing nucleic acids using oligonucleotides modified by a stimulus
CN108588200A (zh) * 2018-05-06 2018-09-28 湖南大地同年生物科技有限公司 一种R-Loop高通量测序文库构建方法
CN109853047A (zh) * 2019-04-10 2019-06-07 翌圣生物科技（上海）有限公司 一种基因组dna测序文库快速构建方法及配套试剂盒
CN111455469A (zh) * 2020-04-07 2020-07-28 深圳易倍科华生物科技有限公司 一种单链快速建库方法及建库仪器
US10941453B1 (en) 2020-05-20 2021-03-09 Paragon Genomics, Inc. High throughput detection of pathogen RNA in clinical specimens
WO2023175040A3 (fr) * 2022-03-15 2023-11-02 Illumina, Inc. Séquençage simultané de brins complémentaires sens et antisens sur des polynucléotides concaténés pour la détection de méthylation
US11680293B1 (en) 2022-04-21 2023-06-20 Paragon Genomics, Inc. Methods and compositions for amplifying DNA and generating DNA sequencing results from target-enriched DNA molecules

Also Published As

Publication number Publication date
CA2513899C (fr) 2013-03-26
EP2261372B1 (fr) 2012-08-22
EP1997889A2 (fr) 2008-12-03
EP2159285B1 (fr) 2012-09-26
ES2342665T3 (es) 2010-07-12
CA2513899A1 (fr) 2005-01-13
US8790876B2 (en) 2014-07-29
EP1594980B2 (fr) 2017-08-16
US10240192B2 (en) 2019-03-26
JP4480715B2 (ja) 2010-06-16
AU2004254552A1 (en) 2005-01-13
EP2159285A2 (fr) 2010-03-03
EP1594950A2 (fr) 2005-11-16
JP2007525151A (ja) 2007-09-06
US20120238475A1 (en) 2012-09-20
EP2145955A2 (fr) 2010-01-20
EP2261372A3 (fr) 2011-04-06
CA2727850C (fr) 2013-04-30
US7323305B2 (en) 2008-01-29
EP1594981B1 (fr) 2010-03-17
US8012690B2 (en) 2011-09-06
CA2728746A1 (fr) 2005-01-13
EP2145955B1 (fr) 2012-02-22
ATE461291T1 (de) 2010-04-15
JP2013066475A (ja) 2013-04-18
EP1590477B1 (fr) 2009-07-29
WO2005003375A3 (fr) 2007-08-23
JP2012231799A (ja) 2012-11-29
ATE448302T1 (de) 2009-11-15
WO2004070005A2 (fr) 2004-08-19
EP1997889A3 (fr) 2009-09-23
AU2004209001A1 (en) 2004-08-19
AU2004254552B2 (en) 2008-04-24
US20160298175A1 (en) 2016-10-13
US20050130173A1 (en) 2005-06-16
WO2004069849A2 (fr) 2004-08-19
ES2380893T3 (es) 2012-05-21
EP1594981A4 (fr) 2008-03-05
WO2004070007A3 (fr) 2005-12-22
CN101128601B (zh) 2011-06-08
EP1594950A4 (fr) 2007-07-25
US20130078638A1 (en) 2013-03-28
CA2513535A1 (fr) 2004-08-19
CA2727850A1 (fr) 2005-01-13
AU2004209416A1 (en) 2004-08-19
EP1590477A4 (fr) 2008-04-09
EP2261372A2 (fr) 2010-12-15
JP2006515522A (ja) 2006-06-01
DE602004036672C5 (de) 2012-11-29
ES2338654T3 (es) 2010-05-11
US20190203263A1 (en) 2019-07-04
US8765380B2 (en) 2014-07-01
JP2007523627A (ja) 2007-08-23
EP2145955A3 (fr) 2011-03-30
JP5495399B2 (ja) 2014-05-21
US20110201526A1 (en) 2011-08-18
CN102212614A (zh) 2011-10-12
US7842457B2 (en) 2010-11-30
JP4473878B2 (ja) 2010-06-02
JP2010178744A (ja) 2010-08-19
EP1590477A2 (fr) 2005-11-02
WO2004069849A3 (fr) 2005-03-24
JP4768598B2 (ja) 2011-09-07
US20150099672A1 (en) 2015-04-09
ATE437945T1 (de) 2009-08-15
AU2004209416B2 (en) 2007-08-02
ATE546525T1 (de) 2012-03-15
ES2330339T3 (es) 2009-12-09
US8748102B2 (en) 2014-06-10
CA2728746C (fr) 2018-01-16
ES2338654T5 (es) 2017-12-11
WO2004069849A8 (fr) 2007-04-19
ES2396245T3 (es) 2013-02-20
DE602004024034D1 (de) 2009-12-24
AU2004209001B2 (en) 2007-10-11
US20090011959A1 (en) 2009-01-08
EP2159285A3 (fr) 2011-06-29
WO2004070005B1 (fr) 2005-01-20
WO2004070007A2 (fr) 2004-08-19
US20090048124A1 (en) 2009-02-19
JP5726155B2 (ja) 2015-05-27
US20060134633A1 (en) 2006-06-22
US20110009275A1 (en) 2011-01-13
AU2004209426A1 (en) 2004-08-19
US20050079510A1 (en) 2005-04-14
EP1594981A2 (fr) 2005-11-16
US10982274B2 (en) 2021-04-20
CA2513541A1 (fr) 2004-08-19
EP1594980A2 (fr) 2005-11-16
WO2005003375A2 (fr) 2005-01-13
US20140162885A1 (en) 2014-06-12
US8158359B2 (en) 2012-04-17
CA2513889A1 (fr) 2004-08-19
EP1594980B1 (fr) 2009-11-11
EP1594980A4 (fr) 2007-05-02
AU2004209426B2 (en) 2008-04-17
US7244567B2 (en) 2007-07-17
DE602004022253D1 (de) 2009-09-10
JP2010142233A (ja) 2010-07-01
US20080132693A1 (en) 2008-06-05
CN102212614B (zh) 2013-12-25
DE602004026033D1 (de) 2010-04-29
CA2513535C (fr) 2012-06-12
CN101128601A (zh) 2008-02-20
WO2004070005A3 (fr) 2004-11-11
JP5258822B2 (ja) 2013-08-07
JP2013090635A (ja) 2013-05-16
JP2007535892A (ja) 2007-12-13

Similar Documents

Publication Publication Date Title
AU2004209426B2 (en) Method for preparing single-stranded DNA libraries
US20050221341A1 (en) Sequence-based karyotyping
KR102592367B1 (ko) 게놈 및 치료학적 적용을 위한 핵산 분자의 클론 복제 및 증폭을 위한 시스템 및 방법
AU2008200151B2 (en) Bead Emulsion Nucleic Acid Amplification
KR20220034716A (ko) 고체 지지물 상에 고정된 crispr/cas9를 사용하여 핵산 서열분석 라이브러리를 제조하기 위한 조성물 및 방법
CA2773059C (fr) Amplification d'acides nucleiques par emulsion de billes
CN110997932A (zh) 用于甲基化测序的单细胞全基因组文库

Legal Events

Date Code Title Description
AS Assignment

Owner name: 454 CORPORATION, CONNECTICUT

Free format text: CHANGE OF ADDRESS OF THE ASSIGNEE;ASSIGNORS:COSTA, GINA L.;LEAMON, JOHN H.;ROTHBERG, JONATHAN M.;AND OTHERS;REEL/FRAME:015388/0227;SIGNING DATES FROM 20040430 TO 20040514

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION